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Abstract
The adsorption conditions for a range of different immunoreactants to both polystyrene and
ultrasmooth silanised silicon surfaces are optimised.

The conditions studied were

concentration of protein, time and temperature of incubation, pH, molarity and ionic strength
of the buffer. The anti-ferritin surface was selected as our model system. This immunosensor
was used to develop and evaluate a millispot ELISA for ferritin. The millispot ferritin ELISA
developed utilises a sample volume of 6pl and a sample incubation time of 10 minutes.
Precision and accuracy studies show the assay to have a dynamic assay range of 7.8-lOOng/ml
ferritin.

The millispot ELISA detected a minimum ferritin concentration of 13ng/ml.

alternative method of immunecomplex detection was also studied.

An

An Atomic force

microscope was successfully applied to directly detect the presence of ferritin and alphafetoprotein antigens on the appropriate immunosensor surface, while further work is required
to directly detect smaller proteins such as hCG. The detection of the ferritin protein was taken
a step further with the development of a novel system to quantify the ferritin in the bulk
solution via the Atomic Force Microscope (AFM). The number of binding events and surface
roughness (Ra) over 5 pm^ areas was determined for a range of different ferritin concentrations.
Both parameters show a linear response to ferritin concentration for the concentration range
(7.8 - 500ng/ml).

XI

Literature Review

1.1. Introduction

The review of the literature is divided into four parts.

Firstly an overview of the protein

adsorption process is outlined. This poorly understood process is integral to the experimental
approach taken in this investigation, since the proteins are physically adsorbed to the sorbent
surface to produce the immunosensor surface. This section involves a review of protein
structure, an overview of the adsorption process and the factors that influence the process. A
description of the experimental approach taken in the elucidation of this complex process is
given together with an account of the conformational changes which occur in the protein
structure following attachment to a sorbent surface.
This is followed by a review of immunoassay.

Emphasis is placed on the role protein

adsorption played in the development of these assays which has revolutionised the assay of a
wide variety of analytes both in the clinical and industrial environments. The various strategies
used by investigators in an attempt to increase the sensitivities of these assays is outlined
together with a detailed review of the area of immunoassay sensitivity. An overview of the
principle of the Microspot assay (Ekins and Chu,1991) is given, an assay whose principle is
thought to revolutionise the field of immunoassay technology.
An outline of the principle of the atomic force microscope (AFM) is given.

An instrument

largely used to date in a research setting, particularly in the semiconductor field, to study the
surface features of various materials. A detailed description of the role atomic force
microscopy has played to date in the area of biological research is outlined.
Finally a review of the literature to date on the role this instrument has played in the area of
immunoassay is given. A role which has largely focused on the measurement of the interactive

forces between the immunoreactant molecules involved in the specific recognition processes
inherent in these systems.

1.2:

Protein -Adsorption

1.2.1: Introduction
Protein molecules are polymers built up from twenty different amino acids, linked end to end
by peptide bonds. The general structure of an amino acid (Fig. 1) consists of an amino group
attached to the a-carbon, the carbon next to the carboxyl group. The a-carbon of every amino
acid is also attached to a hydrogen atom and a side chain (R).

Different amino acids are

distinguished by their different side chains of varying hydrophobicity.

As a consequence

proteins are therefore usually highly surface active.

H

O

NH

OH

R

Figure 1. General structure of an amino acid.

The adsorption process involves the transfer of a protein molecule from solution to the sorbent
surface and the concomitant displacement of solvent molecules.

It is the first readily

observable event at the interface between a material and a biological fluid. A large number of
review papers are available on protein adsorption (MacRitchie, 1978; Andrade, 1985, Horbett
and Brash, 1987; Haynes and Norde, 1994).

The information present may be divided into

three broad categories; (i) fundamental surface science at the air/water interface; (ii) solid liquid chromatography literature, (iii) protein interactions with plastic and other materials used

in medical and diagnostic devices.

Despite the extensive interdisciplinary studies, a

fundamental understanding of protein adsorption has not yet been achieved. A major obstacle
in achieving this understanding is the limited numbers of proteins and sorbent types studied to
date.
In this review section a brief overview of protein structure is given which is fundamental to our
understanding of the adsorption process. The treatment of the adsorption process is subdivide
into, (i) attachment of the protein to the interface; (ii) attachment of the protein to the solid
surface, and (iii) conformational changes of the protein on adsorption.
description of desorption and competitive adsorption is given.

Finally a brief

1.2.2: Protein structure
The study of protein adsorption requires familiarity with the modem concepts of protein
stmcture. In discussing the architecture of proteins it is convenient to refer to four levels of
structure.
Primary structure is the sequence of amino acids in the polypeptide chain. It is a complete
description of the covalent connections of a protein. Secondary structure involves the manner
in which the polypeptide chain is arranged via hydrogen bonds along one dimension. The three
important types of secondary stmcture are the a helix, the P-conformation and the collagen
helix. Tertiary structure is the manner in which the polypeptide chain of globular proteins is
folded, via intramolecular associations into a compact globular shape.

These intramolecular

associations include ionic interactions, hydrophobic interactions, hydrogen bonding and
covalent disulphide bonds.

Quaternary structure is defined as the manner in which the

individual polypeptide chains of an oligomeric protein can associate to form a multi-chain
stmcture.

Forces involved in protein structure (Matthews, van Holde, 1990):(1) Electrostatic interaction.
(2) Hydrophobic interaction.
(3) Hydrogen bonding.
(4) Van der Waals forces.

Electrostatic interaction
Occurs due to the attraction or repulsion of two or more groups carrying a net charge. Most
of the amino acid residues carrying an electric charge are located at the aqueous periphery of
the protein molecule. If charged groups are present in the apolar interior, they usually have
5

formed ion pairs. In the isoelectric point region, if the positive and negative charges are more
or less evenly distributed over the molecule, this results in intramolecular electrostatic
attraction, favouring a compact structure.

However, excess of either positive or negative

charge leads to intramolecular repulsion and therefore promotes an expanded structure.

Hydrophobic interaction
The term hydrophobic interaction refers to the spontaneous dehydration and subsequent
aggregation of non-polar components in an aqueous environment.

When an unfolded

polypeptide chain is introduced into an aqueous environment the hydrophobic groups will be in
contact with water and cause the ordering of water into a cage like structure around the
protein.

This ordering corresponds to a loss of randomness in the system, the entropy is

decreased.

When the polypeptide chain folds into a globular structure, these hydrophobic

residues can be buried within the molecule. The water molecules that have ordered will then
be released and gain freedom of motion.

Thus, internalisation of hydrophobic groups can

increase the randomness of the whole system (protein and water) and therefore yield an
entropy increase.
If all the hydrophobic residues are buried in the interior and all the hydrophilic residues are at
the periphery of the molecule, intramolecular hydrophobic interaction would maximally
contribute to a compact structure. However, restrictions due to other types of interactions and
geometrical restrictions a fraction of the hydrophobic residues are often exposed to the
aqueous environment.

Hydrogen Bonding
A hydrogen bond is formed between a covalently bonded hydrogen atom on a donor group and
a pair of non bonding electrons on an acceptor group. The hydrogen bond has characteristics

of both noncovalent and covalent interactions. On the one hand, there is a major electrostatic
contribution to the interaction.

While the covalent character of the bond is indicated by

closeness of the atoms involved and the highly directional nature of the bond.

Hydrogen

bonding is not expected to have a strong stabilising effect in the aqueous environment. Water
is at least as good at forming hydrogen bonds as any of the groups in a polypeptide. However,
where the polypeptide chain is shielded from water, hydrogen bonding between peptide units
stabilises the helical and pleated sheet structure

Van der Waals
The term Van der Waals forces refer to two types of interactions, one attractive and one
repulsive.

The attractive forces are due to favourable interactions among the induced

instantaneous dipole moments that develop from fluctuations in the electron charge densities of
neighbouring non-bonded atoms. These forces tend to be individually small, but can add up as
the number of interactions between the two molecules increases. When the atoms come closer
together a repulsive Van der Waals force develops due to overlap of the electron charge
clouds.

Where two molecules are held together over time by Van der Waals forces, their

average separation will be dictated by a balance between the Van der Waals attractive and
repulsive forces.

1.2.3: Protein Adsorption Process
The adsorption process can be considered to occur in three steps (Fig. 2).
(1) Protein transport to the interface.
(2) Attachment of protein to the sorbent surface.
(3) Relaxation of the adsorbed protein to its steady-state conformation.

Native - State
Conformation

Transport to
Interfacial Region

Attachment to
Surface

if
Further Structural

Steady-State
Perturbed Structure

Rearrangement

/ / // // / // // // // /

Figure 2. Protein adsorption process

1.2.3.1: Protein Transport to the Interface
Protein adsorption at the surface is partly controlled by the rate of transport of proteins from
the bulk protein solution across the concentration boundary layer near the surface.

This

transport phenomenon is characterised by:
(i) diffusion
(ii) thermal convection
(iii) flow
(iv) coupled transport.
If we make the following assumptions; (i) a freshly prepared surface is optimally thermostated
to minimise thermal convection and; (ii) there is no energy barrier to adsorption during the
initial stage of adsorption.

Then all molecules near the surface will be rapidly adsorbed

resulting in a depletion of protein in the volume adjacent to the surface, called the sublayer.
This concentration gradient drives diffusion from the bulk of the protein solution to the
depleted sublayer.

Under these conditions the rate of adsorption is equal to the rate of

diffusion (Andrade and Hlady, 1986).

dt

\7ltJ

where n = number of molecules
C = bulk solution concentration
D = diffusion coefficient
t = time

Thus the rate of adsorption is proportional to D

and t

Diffusion coefficients vary widely among proteins (D = lO"^ - lO'^cm^/s), depending on their
concentration and the electrostatic conditions of the solution (Cussler, 1989).

The initial

adsorption rate of protein molecules onto a solid surface is transport-limited at low or high
9

concentrations (Lok ^

1983). This indicates that the rate of protein binding to the surface

is faster than the rate of protein transport from the solution to the surface. Once the surface is
partially saturated with adsorbed solute molecules, the rate of adsorption falls below the rate of
diffusion suggesting an energy barrier to adsorption (Wojciechowski and Brash, 1990). This
energy barrier may involve electrostatic, (Ramsden, 1995), steric and osmotic effects close to
the surface.

10

1.2.3.2: Attachment of Protein to Sorbent Surface
The interactions recognised as occurring in protein adsorption are mostly non-covalent, i.e.
hydrogen bonding, electrostatic and hydrophobic interactions.

The ability of water to

hydrogen bond to the usually charged surface chemistry of solid sorbents,

and the

amphipolar, amphoteric, compact nature of native proteins combined with their marginal
structural stabilities suggest the possibility of a role for numerous molecular interactions. The
role these interactions play depends on the chemistries of the protein and sorbent surface and
on the environmental characteristics (Fig. 3).

Polar
Donor -Acceptor
Interaction

Hydrophobic
Domain

Figure 3. Interactions involved in protein adsorption to sorbent surface (Modified
from Andrade, 1985)

Protein folding involves a considerable loss in the conformational entropy of the polypeptide
chain.

Under certain solution conditions, other effects, particularly dehydration

of

hydrophobic residues, outweigh this entropic opposition to folding and the native state is
11

marginally preferred.

However, there is now substantial evidence that solid (especially

hydrophobic) /water interfaces upset this balance by providing a region on which the
polypeptide backbone can unfold without exposing hydrophobic residues to the aqueous
environment (Haynes and Norde, 1994).

The high intra-atomic packing densities of native

state globular proteins suggest that protein unfolding at a surface leads to an increase in the
conformational entropy of the polypeptide chain, and thereby provides a second entropic
driving force. If these conformational changes involve a breakdown in the ordered secondary
structure (Chan and Brash, 1981), this gives rise to increased backbone flexibility.

This

increased flexibility allows the protein to form strong electrostatic interactions with oppositely
charged structures on the sorbent surface and to reduce lateral electrostatic repulsion with
proximal proteins.

This is an example of how hydrophobic and electrostatic forces can

interplay to drive the adsorption process.
On a hydrophilic interface, it is likely that electrostatic interactions play a more significant role.
Although there has been many investigations into the role electrostatics play in the adsorption
process no clear consensus has developed as to its effects. It seems obvious that attractive
interactions should dominate between opposite charges and repulsive interactions between like
charges.

While this is often the case, other factors can also play a role such as small

multivalent counterions, which can reduce the attractive/repulsive interaction force (Luey et
d., 1991). Also the question arises as to whether the protein behaves as a particle with a net
“point” charge or as a mass of individual charges.

12

1.2.3.3: Factors which Effect the Adsorbed Amount
Effect of Electrostatics
Protein adsorption at a charged surface in an aqueous environment involves overlap of the
electrical double layers. This overlap results in an attractive force where the surfaces have
oppositely charged signs and a repulsive force if the signs are the same. However, electrostatic
interactions of protein appear to be relatively short range due to the high dielectric constant of
water. Therefore, it is unlikely that electrostatic interactions would be responsible for directing
a protein to a charged surface.

However, once the protein becomes close to the charged

interface, then the appropriate electrostatic coupling could become significant.
Interactions between charges are screened by the presence of low molecular weight
electrolytes (e.g. Na^, Cf, Ca^^ etc.) in the system. Increased adsorbed amounts are usually
found on increasing the ionic strength of the medium. If this increase occurs in the case where
the sorbent surface and protein surface are oppositely charged it suggests that these
electrolytes must have a more intricate role than non-specifically screening between interacting
charges. The relationship between adsorbed mass and changes in pH and ionic strengths must
also be related to the conformational stability of the protein. In general pH and ionic strengths
conditions that lead to an increased adsorbed mass renders the protein more stable on the solid
surface than in solution (Luey ct d., 1991).

Effect of hydrophobicity
Protein molecules dissolved in water tend to minimise the exposure of their hydrophobic
groups to the aqueous environment. However, as discussed in section 1.2.2., a fraction of the
protein exterior is hydrophobic.

Dehydration of these hydrophobic regions of the protein

surface and sorbent surface is driven by entropy gain and, therefore, promotes adsorption to
occur spontaneously.
13

Determining the influence of surface hydrophobicity on adsorbed amount is difficult.
varying the hydrophobicity automatically varies the chemical composition.

Since

However, it is

generally found that greater values of adsorbed mass are found on hydrophobic as opposed to
hydrophilic surfaces. The hydrophobicity “rule” is supported by studies carried out using
hydrophobicity gradient surfaces (Elwing et

1997). The hydrophobicity gradient surface

consists of a single surface specimen spanning a wide range of hydrophobicity enabling
adsorption properties over the entire range to be examined in the same experiment.
Protein molecules are assumed to change conformation to a greater extent on hydrophobic
surfaces than on hydrophilic surfaces. This is due to the presence of hydrophobic interactions
between the solid surface and the hydrophobic “pockets” in the protein molecule.

The

repulsive force normally acting between native protein molecules is expected to be decreased
for such conformationally changed molecules. This means that one should expect a greater
number of adsorbed molecules per unit area on a hydrophobic surface.

On a hydrophilic

surface, the forces acting between the surface and the molecule may be smaller in magnitude,
and since the resulting conformational change will be smaller, a larger repulsive force will be
present between the molecules.

Effect of Temperature (T)
Widely contrasting results have been reported on the effect of temperature on the adsorption
process .

Many investigators (Slack and Horbett 1991, Nicholov et

1995) report a

decreased adsorption on increasing the temperature. Norde and Lyklema (1979) observed that
the influence of temperature on the adsorption of human plasma albumin to polystyrene is
dependent on the pH of the system. At pH values close to the isoelectric point (pi), the pH of
the system had little effect on the adsorption process. However, at pH values away from the
14

isoelectric point an increase in temperature results in a steeper initial slope of the isotherm (plot
of temperature versus adsorbed amount) and a lower plateau value.

They proposed the

following explanation. At pH values away from the pi, the adsorbing molecules undergo an
endothermic structural rearrangement which results in lower plateau values of the isotherm
(Norde and Lyklema, 1979). Andrade M M (1992) propose that higher temperatures are likely
to cause the proteins to be more irreversibly bonded by increasing their tendency to denature
(Andrade

1992).
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1.2.3.4: Conformational Effects of Protein Adsorption
In addition to adsorbed amounts, the orientation and conformation of the adsorbed protein are
critical.

Conformation refers to the secondary, tertiary and quaternary structure.

It is

reasonable to suppose that proteins adsorbed to solid surfaces may undergo some
conformational change because of the relatively low structural stability of proteins and their
tendency to unfold to allow formation of additional contacts with the surface (Horbett, 1993).
Consequently, several theories of protein adsorption include a transition from a reversibly
adsorbed state to a more tightly held state, the latter is brought about by denaturation of the
protein on the surface (Andrade, 1985).

The adsorbent surface itself may also be

conformationally altered or “denatured”, due to its interaction with the protein.
We will review the studies carried out to date on conformational effect of protein adsorption,
on the basis of the techniques used to study these effects.

Ellipsometry
The ellipsometer is an optical instrument that measures the changes in the polarisation state of
a light beam upon reflection from a surface. If proteins are allowed to adsorb to that surface,
ellipsometry makes it possible to determine thickness, the refractive index, and the specific
amount of adsorbed molecules (Sadana, 1992).
The adsorption of immunoglobulin G (IgG) and secretory fibronectin on silica was studied by
in situ ellipsometry (Jonnsson ^ M., 1987).

Adsorption isotherms were obtained by either

direct or successive adsorption of the proteins. On hydrophobic silica a significant difference
exists between the direct and successive - addition isotherms. While on hydrophilic silica the
isotherms coincide. These results are interpreted as time-dependent conformational changes in
the adsorbed protein layer. These changes were more significant on hydrophobic silica. These
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authors also report a flatter adsorbed conformation at low surface concentration while at high
surface concentration intermolecular repulsion causes a more extended conformation.
Elwing Qi

(1987) used ellipsometry in conjunction with a wettability technique.

They

measured the adsorption of human fibrinogen and IgG to a hydrophobic gradient surface. They
noted a difference in the amounts of fibrinogen and IgG adsorbed at the hydrophobic end (0.7
and 0.55 pm/cm^ respectively), of the gradient and (0.3pm/cm^) at the hydrophilic end. In
between the hydrophobic and the hydrophilic end there was a non-linear decrease. A possible
explanation for this non-linear response is that the varying conformational state of the adsorbed
protein on the surface can overplay the influence of heterogeneity in adsorption (Elwing ^
1987).

Infra-red Spectroscopy
Both conventional transmission absorbance spectroscopy and its evanescent counterpart,
attenuated total reflection spectroscopy, are based on measuring the light characteristics after it
has passed through the sample. Spectroscopy in the infra-red region has been used extensively
in protein adsorption studies.
Morrissey and Stoneberg (1977) used transmission infra-red spectroscopy to study protein
adsorption onto silica particles in a heavy water buffer. By observing the shift in the amide I
absorption band, they determined the fraction of protein carbonyl groups involved in binding to
silica. They reported, that at low bulk concentration the IgG had a bound fraction of 0.2, while
at high bulk concentration the IgG had a bound fraction of 0.02. They concluded that at low
solution concentration, the protein can optimally adapt to the surface, maximising the number
of binding interactions.

At high solution concentrations steric hindrance minimises the

probability that it can conformationally adapt to the surface (Morrissey, 1977).
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Fourier transform infra-red spectroscopy has been used in conjunction with attenuated total
reflection spectroscopy (FTIR - ATR) by Lu and Park (Lu and Park, 1991). They reported
that some a-helical structures were changed into unordered structures and that the contact of
P turns was increased upon protein adsorption as the hydrophobicity of the surface increased.

Circular Dichroic (CD) Spectroscopy and Fluorescence
Specific information concerning the secondary structure of a protein molecule can be derived
from CD spectroscopy. Circular Dichroism (CD) has been utilised by various authors to study
structural changes in proteins associated with adsorption. Chan and Brash (1981) utilised CD
to study the protein structure of fibrinogen following elution from a surface. They discovered
large changes in the a helical content of fibrinogen, (Chan and Brash, 1981). While Soderquist
and Walton (1980) adsorbed the human blood proteins albumin, fibrinogen and y globulin to a
polypeptide surface of varying charge density. Following adsorption they treated the surface
with a solvent which resulted in the partial removal of the protein from the surface.

CD

measmurements showed that the a helical content in the desorbed protein was reduced in
albumin, the reduction was to a lesser extent in y globulin and only slightly in fibrinogen. No
correlation between structure perturbation and charge density of the sorbent surface was
established (Soderquist and Walton, 1980).
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1.2.4: Modelling Protein Adsorption
1.2.4.1: Langmuir Model
Adsorption data can be analysed in terms of multiple equilibria models (Adamson, 1983;
Andrade, 1985, Andrade and Haldy, 1986).

However, it is important that carefiil

considerations are given to the assumptions made.
1. Only one molecule can be adsorbed per site
2. Only one type of site is present
3. The adsorption of one molecule does not effect the adsorption energy of
other molecules
4. Only one adsorbing species is present
5. Dilute solutions
6. Reversible adsorption.

Under these conditions a Protein - Ligand model can be applied to protein adsorption.

lP]+[A] o [PA]
K =

[PA]
[P][A]

Vs =

[PA]
pr

Vs

KA
1 + K[A]

where
[P] = site cone.
[A] = ligand cone, at equilibrium
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Vs = number of moles of solute per area of surface
K = equilibrium constant
T = Temperature

Application of the Langmuir model
1. Adsorption data is taken over a wide range of protein concentrations preferably as both a
function of protein solution concentration and immobilised ligand concentration.
2. An adsorption isotherm is then plotted (Adsorbed amount versus [P]) and the
shape of the curve is interpreted as discussed.
3. A Scathard plot is then constructed V/P versus P. If the plot is linear (Fig. 4a) an estimate
of n and k can be derived. If the plot has a strong concavity approximation techniques can
be used to derive a set of n (no of binding sites) and k (affinity constant) for two assumed
site populations. The shape and concavity of the Scathard plot indicated several things. If
it is concave down (Fig. 4b) this is indicative of positive co-operatively, (Cooper, 1980). If
it is concave up (Fig. 4c) it indicated negative co-operativity.

Figure 4 Scathard Plots (a) linear, (b) concave down, (c ) concave up
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4. A Hill plot

In

V

n-V

F5[P]

is constructed from the estimate of the upper value of n

determined from the Scathard plot. The Hill plot gives information on co-operativity. If
the slope of the line is greater than one, this indicates positive co-operativity (Fig 5a). If
the slope is less than one this indicates negative co-operativity (Fig. 5b).

(b)

(a)

>
1

M<1
Positive
Cooperativity

1
^
^

/
/
/
/

M>1
Negative
Cooperativity

ln[A]

ln[A]

Figure 5 Hill plot (a) positive co-operativity, (b) negative co-operativity (where m signifies
the slope of the plot).

Limitations of Langmuir Model
Unlike ions, proteins cannot be assumed to be conformationally rigid. Also for many protein
surface interactions the adsorption process is irreversible which results in a Scathard plot with
a shape which is difficult to interpret. Finally protein adsorption does not take place on fixed
sites. In view of these limitations scientists have turned their attention to the development of a
kinetic model.

Coj
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1.2.4.2: Kinetic Model
Most of the phenomena observed to date can be interpreted by a suitable combination of non
zero rate coefficients in the model depicted by Ramsden (Ramsden, 1995) (Fig. 6).

Cb
Solution

Ci
kd
ks

A

K

Mi
M
////////// 7 7 7~r7~/
Figure 6. Kinetic adsorption model. Where Cb is the concentration of protein in the bulk solution; Ci is
the concentration of protein at the interface site; Mi and Mr are the different conformational states of
the protein. Proteins in the Mi conformation are irreversibly bound to he surface while proteins in the
Mr state are reversibly bound, k*, Ki, ka and kc are the different rate constants; k, represents the rate
constant for the adsorption of the protein to the surface in the Mi conformation; kd represents the rate
constant for adsorption to the surface in the Mr conformation; kd reprents the desorption rate of the
protein in Mr conformation; while kc represents the rate constant for the transition feom the protein
bound in the Mr conformation to the Mi conformation, (modified from Ramsden, 1995)

By setting Ka = Kd = Kc = 0, we have a system representing irreversible adsorption with an
affinity constant Ks. Where Ks = Kc = 0, we have a completely reversible adsorption process.
The most likely case to model protein adsorption is a combination of reversible and irreversible
adsorption which leads to a progressive irreversibility (Kurrat et

1994).

If only Kc = 0,

then adsorption to either of two different orientations with respect to the surface can be
inferred, one tightly bound and one loosely bound.
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The rate coefficient of the chosen mode, as well as the area occupied by adsorbed molecules
may be obtained by fitting the integrated model to the kinetic data collected during both
adsoiption and desorption experiments. Kinetic aspects of protein adsorption at solid liquid
interfaces has not been studied extensively and only a few papers are available in this area of
research (Sarkar and Chattoraj, 1992). A possible reason for this phenomena in the past, is the
lack of suitable experimental techniques.

However, with the advert of modern, accurate

experimental techniques, scientists studying the field of protein adsorption have realised that
the most accurate and significant data is obtained from kinetic studies.
Ramsden classified the techniques used to study the kinetics of protein adsorption (Ramsden,
1993). (Table 1). A brief outline of the six different types of techniques is given.
Table 1
Classification of Methods used to measure Protein
Adsorption Kinetics
1. Solution Depletion Techniques
The well-mixed vessel
The packed bed
2. Gravimetric Methods
The quartz crystal microbalance
Surface acoustic wave device
3. Hydrodynamic Methods
The difflisitivity of colloid spheres
Capillarity
4. Electrical Methods
Impedance measurement
Electrokinetic methods
5. Optical Methods
Ellipsometry
Scanning angle reflectometry
Integrated optics
Total internal reflexion spectroscopy
Surface plasmon resonance
Evanescent wave light scattering
6. Labelling Techniques
Radiolabelling
Enzyme - linked immunoassay (ELISA)
Total internal reflection fluorescence microscopy
_______Resonance energy transfer___________________
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Solution Depletion Techniques
In these techniques a sorbent surface of known surface area is exposed to a protein solution of
known concentration (Ci).

Following adsorption the protein concentration in solution is

measured (C2). The difference (C2 - Ci) is related to the time of adsorption. The method has
the advantage of almost unlimited flexibility regarding the nature of the solid adsorbent, and of
the method used to determine the concentration of protein in the supernatant. On the other
hand, it possesses the obvious disadvantage of being intermittent, and is therefore only useful
for slow kinetics, since the adsorption process must be interrupted in order to measure C2.

Gravimetric Methods
The application of an alternating electric field to a piezoelectric crystal results in acoustic
standing waves in the crystal. These vibrations occur at a characteristic resonant frequency (f).
The resonant frequency is inversely proportional to the square root of the oscillating mass.
This principle is used in gravimetric methods, where adsorption is allowed to occur on the
surface of a vibrating quartz crystal thus diminishing its resonant frequency (Schumacher,
1990).

Hydrodynamic Methods
These techniques rely on the friction developed between solid and liquid phases in relative
motion to each other. After an initial period of acceleration under a constant applied force, a
steady state is reached and the characteristic velocity of particles or liquid is observed. The
adsorption of proteins at the solid - liquid interface increases the frictional co-efficient, and
from this increase the amount of adsorbed material can be determined.
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Electrical Methods
When a protein dissolves in an aqueous solution the ionisable amino acids in the peptide chain
will become charged. The adsorption of proteins at an interface therefore implies the build up
of charge. These methods measure this change and relate it to the amount of protein adsorbed.
Two basic strategies have been applied to electrical methods. In the first the alteration of the
charge distribution at the interface due to the adsorbed proteins is analysed empirically. In the
second, the accumulated charge at the solid surface per unit area is measured.

Optical methods
Most of these methods are based on the following principle. When a ray of light is incident
upon the plane separating two media of different refractive indices, the ratios of reflected and
incident angle is given by the Fresnel equations;

Rs = -sin (0 - 0*)/(sin (0 + 0^))
Rp = tan (0 - 0’)/(tan (0 + 0^))
where 0 is angle between the incident light and the normal.
0^ is the corresponding angle of the refracted beam.
Rs is for light polarised perpendicular to the plane of reflexion.
Rp is for light polarised parallel to the plane of reflexion.
The attributes of the reflected light are altered by the presence of a layer of adsorbed
molecules at the solid liquid interface.
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Labelling Techniques
This group includes techniques in which some characteristic of the molecule under
investigation is enhanced to make its detection easier.

The most common example is the

attachment of a fluorescent or radioactive label to a protein prior to exposure to a sorbent
surface. When the protein is exposed to the surface the amount adsorbed relative to time can
be deduced from the activity of the fluorescent or radioactive label. The general disadvantage
of the labelling procedure is that the properties of the protein may be prone to alteration due to
the addition of these groups.
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1.2.5: Desorption, Exchange and Competitive Adsorption
Desorption refers to the process of detachment of a protein from a sorbent surface. Protein
adsorption differs from that of low molecular substances in a number of ways. Firstly, the
adsorbed molecule is attached via many segments thus, the molar free energy of adsorption
amounts to large values. Secondly the proteins can undergo conformational and orientation
changes on a surface, they can optimise their interfacial interactions so as to provide the
maximum free energy of adsorption.

If such changes occur, the desorption process is not

simply the reverse of the adsorption process. In order to desorp upon dilution, the protein has
to overcome the sum of the free energies of adsorption and rearrangement. The activation free
energy for adsorption is much suialler than for desorption, therefore the desorption process is
much slower.
The tendency for an adsorbed protein to undergo desorption is protein and surface specific as
well as time-dependent. The readiness for a protein to desorb is related to the hydrophobicity
of the sorbent surface. In general protein molecules are assumed to change conformation to a
greater extent on hydrophobic surfaces than on hydrophilic surfaces.

Also at hydrophilic

surfaces, proteins are less tightly bound than at hydrophobic surfaces (Gibbs, 1995b). Proteins
with a high concentration of binding sites on their surface may adsorb via a multipoint
attachment and high adsorption free energy, even without any conformational adjustment.
Soderquist and Walton showed the time dependency of desorption. They reported;
(i) At short residence times where adsorption is reversible, assume no time available for
conformational change.
(ii) At longer times where slow conformational change occur, the process is semi-reversible
and desorption occurs very slowly.
(iii) At longer times where the conformational change is completed adsorption is irreversible,
and desorption is improbable.
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Those proteins which do not undergo any significant conformational change at a particular
interface may not show any significant time dependence.
The desorption process is also reported to be dependent on the degree of surface coverage.
Larger desorption rates have been reported at high surface coverage. This could be explained
by assuming a heterogeneous sorbent surface at which the most favourable adsorption sites are
occupied first. However, desorption from fully covered surface may be difficult due to lateral
interactions between packed molecules.

1.2.5.1: Exchange
This term refers to the displacement of the adsorbed protein molecule by another protein. In a
study, Vroman observed that a layer of adsorbed protein, irreversible with respect to dilution
of the bulk solution undergoes exchange containing a different protein (Vroman and Leonard,
1977). This puzzling phenomenon has recently been investigated in more detail and modelled,
(Dickinson, 1992).

It can be explained as follows; the protein adsorbs irreversibly due to

multiple weak bonds; the probability of breaking them all simultaneously is vanishingly small,
but a few can break and transiently liberate a patch of the surface. Once this occurs a protein
from solution has a chance to occupy the patch and gain a foothold on the surface with a few
weak bonds, with which it can effectively compete with the previously adsorbed protein for
complete adsorption . While protein desorption may be very slow or non existent, protein
exchange can be rapid.

1.2.5.2: Competitive Adsorption
Most biological systems contain different kinds of proteins. The proteins mutually compete for
adsorption at any exposed surface.

Initially, the sorbent surface will be populated by the

smaller and more abundantly occurring molecules because their rate of diffusion is faster. At
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later stages, the adsorbed molecules may be displaced by other molecules that have a stronger
tendency to adsorb.

The final composition of the adsorbed layer is determined by the

concentrations of the various kinds of protein in solution and their intrinsic affinities
(Shirahama ^

1990).
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1.3:

Immunoassay and Protein Adsorption

1.3.1: Introduction
An immunoassay is defined as an analytical technique which uses antibodies or antibody
related reagents for the selective determination of sample components. In 1959, Berson and
Yalow reported insulin antibodies in diabetics (Yalow and Berson, 1959). This discovery led
these researchers to the development of a method for measurement of serum insulin whereby
minute quantities of antigen in a complex biological mixture could be determined by its ability
to inhibit the binding of a known amount of the same iodinated antigen to its specific antibody
(Berson and Yalow, 1973).

Soon afterwards Ekins reported an RIA method for serum

thyroxine. RIA did not, however involve interfacial antigen - antibody interactions, but rather
tedious solution phase immunochemistry.

The time required for separation essentially

determines the number of samples which could be assayed over a period of time.

A major

technological advancement came about from the studies of Catt and Tregear who, in 1967,
showed that proteins (antigen or antibodies) readily and stably become adsorbed on plastic
surfaces (Catt and Tregear, 1967). Hence a plastic test tube, or as currently used a microtiter
well, could be simultaneously used as a reaction vessel and as a receptor covered solid phase,
thus permitting rapid separation of bound and free analyte by washing the tube or well.

During the period 1960 - 1980 the “competitive” or “saturation” assay approach relying on the
use of radiolabelled analyte markers (RIA) dominated the immunoassay field. Radiolabelled
antibody methods, usually referred to as “immunoradiometric assays” (IRMA’s), were
developed in the late 1960’s by Wide (Wide ^

1967). Immunometric methods can be sub

classified as competitive and non-competitive, immunometric assay of competitive design
being essentially identical in sensitivity to competitive assays relying on labelled analyte.
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In

theory the non-competitive assays are potentially capable of greater sensitivity and may require
far shorter incubation times (Jackson ^ d., 1983). However, the low specific activities of the
radionuclides used has not facilitated these sensitive assays. This led to the development of a
second generation of immunoassays involving high activity non-isotopic labels. The first of
this generation developed by Ekins relied on high specific activity lanthanide chelate labels and
time resolution techniques (Jackson and Ekins, 1986). Subsequently other manufacturers have
also introduced ultra-sensitive methods based on the use of other high specific activity, non
isotopic labels (e g. chemiluminesent substances, enzymes etc.). The principal modifications in
the technology appear to follow several directions. Firstly immunoassays have been modified
according to purpose, either antigen or antibody quantitation. The diversity within this area is
extraordinary and includes antigens ranging from synthetic peptides to whole cells and from
antibody present in serum and secretions to those made in vitro by cultured plasma cells.
Secondly immunoassays have been modified to improve their sensitivity through the use of
new high specific activity labels.

In a recent report, Ekins introduces the use of microspot assays to increase assay sensitivity
(Ekins and Chu, 1991).

Such assays are intended to make up a third generation of

immunoassays involving the miniaturisation of existing formats. They report on the increased
sensitivities attained with these microspot assays.

It is intended in this review section to

concentrate on the development of an immunosensor surface which is retained in the
miniaturised format and also to address the different types of labels used to detect interfacial
antibody - antigen interactions.
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1.3.2: Classification
Immunoassays have been classified and characterised in several ways (Gosling, 1990; Persoon,
1992). One of the earlier classifications divided immunoassays into those using a non-labelled
reagent and those using a labelled reagent. However, with the development of a multitude of
advanced assay formulations a more extensive classification is required.

Gosling divided

immunoassay techniques into six groups (Gosling, 1990);

Group 1

Competitive assay of antigen or hapten with labelled analyte

Group 2

Competitive assay of antigen or hapten with labelled antibody

Group 3

Endpoint immunoassay that is dependent on direct detection of immune
complexes

Group 4

Immunoassay that involves labels and principal reagents used in excess

Group 5

Immunoassays for quantification of specific antibodies

Group 6

Immunoassays involving labelled reagents in which the antigen antibody reaction results in modulation of the signal.

While in a more recent report Persoon classified immunoassay techniques into those using a
non-labelled reagent and those using a labelled reagent.

In addition, he subclassified the

labelled immunoassays into four categories (Persoon, 1992).

A. Immunoassays using non-labelled reagents
The non-labelled immunoassays have limitations in sensitivity, because large antigen - antibody
complexes must be formed for successful detection. Examples are immunoprecipitin methods,
agglutination methods and light scattering techniques for the detection of antigen - antibody
complexes by equilibrium or kinetic approaches.

These methods are often used to assay

proteins and the sensitivity is often in the range of micromoles per litre.
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B. Immunoassays using labelled reagents
Type I Single site non-competitive immunoassay
Antibody labelled with a reporter reacts with an analyte antigen in solution. Excess antibody is
removed by reacting it with antigen bound to a solid phase. The reporter antibody remaining
in solution is measured.

The reporter signal is directly proportional to the analyte

concentration in solution.

Type II Two site non-competitive immunoassay
An excess of primary antibody is attached to the solid phase. On incubation of sample the
analyte if present becomes captured by the immobilised antibody.

The solid phase is then

exposed to an excess of reporter antibody directed against a second epitope on the analyte.
The reporter signal measured is directly proportional to the concentration of analyte (fig.7).
This type of assay can also be used to measure antibodies by attaching capture antigens to the
solid phase and using a second reporter antigen or reporter anti-immunoglobulin. Thus, in the
two site non-competitive immunoassay, the reporter measures the occupied binding sites. This
group includes immunochemiluminometric assays, immunoradiometric assays (IRMA),
immunofluorometric assays (IFMA) and most enzyme-linked immunosorbent assays (ELISA).
A very large number of variations on the basic two site sandwich assay for antigens have been
described.
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Figure 7. Schematic representation of a two site non-competitive enzyme-labelled immunoassay.

Type Ill Homogeneous competitive immunoassay
Homogeneous assays allow binding to be monitored without the need of a separation step.
Analyte antigen and labelled analyte compete for a limited number of binding sites available on
an antibody directed towards the analyte antigen.

The law of mass action states that the

relative binding of analyte antigen and labelled antigen will be proportional to the
concentration of the analyte in solution.

The activity of the label is either increased or

decreased by the binding reaction (Fig. 8).

An ideal homogeneous assay requires binding to

effect 100% modulation of the signal from the label. In practice this is very difficult to achieve
with the result that separation-free assays are generally much less sensitive than immunoassays
with separation steps.

These type assays are widely used to monitor the concentration of

therapeutic drugs and drugs of abuse in blood when low detection limits (<10|j.mol/L) are not
required e g. EMIT assay.
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Figure 8. Principle of homogeneous enzyme-labelled immunoassay

Type IV Non-homogeneous competitive immunoassays
These assays can involve the detection of analyte by either a labelled analyte or labelled
antibody.

In the labelled analyte assay the components are, a limited concentration of

antibody, analyte and labelled analyte, thereby giving rise to competition for antibody binding
sites between analyte and labelled analyte. Antibody-bound label and free label are separated
to allow one of them, often the bound fraction to be quantified. The limit of detection may be
lowered by adding the labelled analyte some time after the analyte and antibody this promotes
disequilibrium. A plot of concentration of analyte versus signal gives an inverse non-linear
standard curve.

The most sensitive of these assays can detect <1 fmol of analyte

(Peterson, 1993), (Fig. 9).
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Figure 9. A schematic representation of a non-homogeneous competitive immunoassay

In the labelled antibody assay, the components involved are a limited amount of labelled
antibody reagent, analyte and a constant limited amount of immobilised analyte in each vessel.
This is usually achieved by conjugating analyte to a protein and using this to coat the surfaces
of the microtitre plate. Partition of the limited concentration of label between the immobilised
analyte and free analyte depends on the concentration of analyte. It is important to use highly
purified immunoglobulins to prevent non-specific binding of label to irrelevant antibodies in the
sample. The sensitivity of the assay depends on the affinity of the labelled antibody. A plot of
analyte concentration versus signal yields an inverse relationship.
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Within each of these four categories are many different system configurations.
configuration consists of the primary reaction,
measurement of the reporter signal.
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A system

sometimes secondary reactions and

1.3.3: Antigen -Antibody Reaction
The binding of antibodies with antigens in the fluid phase follows the principles of the law of
mass action.

The reactions are governed by an association rate constant (ki) and a

dissociation constant (k2) which results in an equilibrium constant (Keq) generally ranging
ft-om 10^ to 10^^ M'*s'^(Karush, 1978) (Fig. 10).

k,

Ab:Ag

Ab + Ag
k

kx
k2

^

[AgAb]
{Ag][Ah]

Figure 10. Kinetic model for fluid phase antibody - antigen reaction

Where [AgAb], [Ab] and [Ag] are the molar concentrations of complex, free antibody and free
antigen, respectively at equilibrium.
When one of the reactants is immobilised to a solid phase the kinetics of the reaction changes
(Fig. 11) (Nygren et d., 1987). The solid phase reactant may express a different conformation
than its solution phase counterpart.

This may introduce factors such as steric hindrance,

epitope alteration and changes in antibody affinity. Also it is difficult to define the reaction
volume of an interfacial antigen antibody reaction.

K^A

KjD
^SOL)

^

^SLD)
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Figure 11.

----AI^SOL)

Kinetic model of interfacial antibody - antigen interaction.

Where KD represents the

diffusion rate constant; KA the association rate constant; Ag(soL) solution phase antigen; Ag(SLD) solid
phase antigen; Ab^sou solution phase antibody; and Ab (sld) solid phase antibody.
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Interfacial reaction kinetics involve a more pronounced diffusion - dependent set of rate
constants than their fluid phase counterparts. This diffusion dependence results in an overall
increase in the time required for the reaction to reach equilibrium. The diffusion phase of the
reaction can be significantly reduced by: (1) vigorous agitation, (2) confinement of reaction
volume to the liquid - solid interface, or (3) the use of micro particles capable of diffusion.
There is additional evidence that the kinetics governing the interfacial reaction of antibody and
antigen (kiR and k2R) also differ from those reported for solution phase interaction.

For

example, the forward rate (ki) of antibody - antigen reactions are generally in the range of
lO^m'^s'^ (Karush, 1978, Absolom and van Oss, 1986) but may show up to a 2 log slower rate
when the antigen is immobilised on a solid phase (Li, 1985; Nygren et M, 1986). The relative
constant rates of forward reactions can be utilised to estimate Keq values by measuring only
the slower and more manageable dissociation rate constants and then calculating Keq (Herron,
1984).
The slow rate of dissociation of antibodies from synthetic interfaces is particularly noteworthy.
The k2 values for solution phase interactions differ, values of 10'^ m‘'s‘^ or higher are most
common. By contrast, k2 rates reported for interfacial systems are in the range of lO^^m'^s'^ to

10‘VVs'V
Calculations of keq for interfacial antigen - antibody reactions leads to the conclusion that
solid phase interactions, once established, are virtually irreversible within the time period over
which solid phase immunoassays are usually conducted (Nygren ^

1985).

This

characteristic of the solid phase antibody - antigen reaction has practical importance in that it
facilitates the multiple and often vigorous washing steps required for separation of bound and
freecomponents.
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1.3.4: Separation Systems
In heterogeneous immunoassays a separation step is required to separate free antibody or
antigen from immune complexes. The separation systems can be classified as shown in Table
2.

The first separation system used in immunoassay utilised chromatographic or

electrophoretic techniques. However, these techniques were slow and gave high non-specific
binding (NSB).

They were replaced by the dextran-coated charcoal and fractional

precipitation which were widely used in the 1970’s. While these techniques were found to be
more practical they still gave unacceptably high NSB. In addition, like the chromatographic
and electrophoretic techniques they also suffer from an essential lack of specificity.
Principle

Examples

Physicochemical characteristics of
immunoreactant

electrophoresis:- charge
chromatography:-molecular size

Adsorption

coated charcoal - binds free fraction
ion-exchange: - charge
hydroxyapatite: -charge

Fractional precipitation

ethanol
polyethylene glycol
cross linked dextran
ammonium or sodium sulphate
anti-species secondary anti-serum

Immunological

primary antibody:-particles, membranes,
plates, tubes, etc.
secondary antibody:-particles, membranes,
plates, tubes, etc.

Table 2. Classification of separation techniques (modified from Price and Newman, 1992)
40

The introduction of a secondary anti-species antibody was a major advance in introducing
specificity to the separation system, bringing MSB’s down to the 5 - 10% region. The second
antibody binds to the immune complex to increase the size of the complex which facilitates
easier separation by centrifiagation. However, large amounts of antibody, long reaction times
and the use of refrigerated centrifuges are necessary.
The observation by Catt and Tregear that antibodies adsorbed to polystyrene could be used for
solid phase radioimmunoassay, led to immunological separation systems being almost
exclusively used in modern heterogeneous immunoassays (Catt and Tregear, 1967).

The

development of particulate and subsequent solid surface matrices has facilitated multiple
washing steps without the need of a centrifuge. These multiple washing steps brought about a
reduction in MSB to less than 1%.

The desired properties fo a solid phase are: (1) high

capacity for binding immunoreactant, (2) possibility of immobilisation of many different
immunoreactants; (.3) low desorption of immunoreactants during the assay, (4) bound
immunoreactant must retain its immunological activity; (5) stable on storage, and (6) low non
specific binding. The solid phases used in heterogeneous immunoassay can be divided into
two groups: particulate solid phase and solid surface matrices.
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1.3.4.1: Particulate Solid Phases
These are very efficient since they may be dispersed throughout the reaction mixture and have
a high surface area/volume ratio.

They can be divided into two types, magnetic and non

magnetic.

Magnetic Particulate Matrices
These matrices offer a high surface area, rapid analyte capture and do not require the use of a
centrifugation separation system. The most commonly used magnetic particle has been that
made from paramagnectic ferrous oxide (Robinson, et ^., 1973).

The ferrous oxide is

incorporated into a cellulose matrix to which the antibody is bound.

There have been

relatively few advances in magnectic particulate technology apart from the introduction of
chromium dioxide particles (Birkmeyer et d., 1987).

This particle does not have to be

incorporated into a polymer matrix, hence the system offers smaller particle size.

Non Magnetic Particulate Matrices
These include latex, glass, sephadex and nylon particles. The agaroses e g. sephadex have a
higher antibody binding capacity than polystyrene, glass and nylon. The particular type to be
used is dependent on the relative coupling capacities and the size and density of the individual
particles. The choice of appropriate size depends upon the reaction kinetics that are required.
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1.3.4.2: Solid Surface Matrices
A solid surface matrix is generally selected in an immunoassay design by a desire to simplify an
assay protocol.

The choice of which support is determined by the protein binding

characteristics and the desired reaction kinetics.

Cellulose Membranes
These membranes provide a high surface area with high antibody binding capacity. However,
they are not yet widely used but should replace plastic in many investigations in which:
(i) only the presence of an immunoreactant is to be established; (ii) only very small samples
(e.g.< Ipl) are available, and (iii) ionic detergent - solubilised antibody are to be tested.

Plastic Tubes and Plates
Plastic is by far the most popular solid phase, since it makes the procedure extremely simple.
Its effective use is critically dependent upon the reproducibility of the coupling of the antibody
to each tube or well. Plastic solid phases can produce extremely low NSB. However, plastics
may also have some important limitations: (i)

low binding capacity, (ii) the avidity of

immobilised antibodies for large antigens decreases by 1-2 order of magnitude and, (iii) a
reduced rate of antibody binding.
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1.3.4.3: Immunoreactant Immobilisation to Solid Phase
The immunoreactant can be attached to the solid phase by:
(i) covalent attachment
(ii) protein adsorption
(iii) linking agents

1.3.4.4: Covalent Attachment
While covalent coupling is obligatory for the coating of solid phases other than plastics; it may
also be advantageous for plastics.

Its merits over physical adsorption include: (i)

immobilisation of a more native immunoreactant; (ii) generation of a higher surface coverage
of immunoreactant, and(iii) less desorption of immunoreactant during the assay. Covalent
immobilisation can be especially valuable for molecules that have little affinity for adsorption
on synthetic surfaces, e.g. polysaccharides, native DNA, small oligopeptides and haptens.
Some of the methods for covalent linkage of proteins are quite undemanding and useful for the
large scale preparation of immunoreactant - coated solid phases. The commonly used covalent
chemistries may be divided into two main categories:
(1)the intermediate non-covalent coating of a polymer on the well surface that
contains functional or reactive groups that can be coupled to a ligand.
(2) the direct covalent modification of the surface with a compound that also has such
functionalities.
(a) Glutaraldehvde modification of polystyrene plate. A simple example of this
is to use gluteraldehyde - treated plates to immobilise proteins via their
amino groups.

44

(b) Gluteraldehvde modification of aminophenvl groups.

Involves using a

crosslinking agent to first derivatize the polystyrene surface to create
aminophenyl residues, then modifying these groups with gluteraldehyde.
(c) Use of cross photoactivatable cross-linking reagents.

A cross-linking

reagent containing a photochemical coupling group on one end may be used
to modify the surface of a polystyrene microplate.
The covalent chemistry selected must not affect subsequent reaction steps or the optical
properties of plastic.

The increase in the detectability of the immunoassay is usually

considerably less than the increase in the amount of the immunoreactant bound.

This is

thought to be due to masking of the epitopes at these high coverages. Also, while covalent
immobilisation may avoid adsorption-induced conformation change, this is thought to be only
the case when attachment is to a hydrophilic surface.
hydrophobic surfaces, especially if

Molecules covalently linked to

incubated for long periods, can eventually bind

hydrophobically as well.
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1.3.4.5: Protein Adsorption
The most common method for the immobilisation of antigens and antibodies in solid phase
immunoassay has been simple protein adsorption (Catt and Tregear, 1967).

Butler et d.

(1993) carried out a survey of articles appearing in 1991 issues of the Journal of Immunology
and found that 200 investigators immobilised antigens or antibodies and 82% of them
employed direct protein adsorption (Butler et

1993). Its popularity is surprising given the

vast evidence that passive adsorption of proteins on hydrophobic surfaces can give rise to
conformational and functional changes in proteins (Horbett, 1993).
In addition, Butler et M (1993) reported that less than 10% of monoclonal capture antibody
equivalents and approximately 22% of polyclonal capture antibody equivalents remain
functional after direct protein adsorption. While many capture antibodies immobilised using an
anti-globulin retained its full activity including the ability to bind two epitopes per molecule of
capture antibody. However, these authors conclude that these results, are not necessarily a
recommendation for the use of antiglobulin immobilisation.

Since the number of functional

capture antibody equivalents per well is not significantly greater than that which can be
achieved using passive adsorption (Butler et

1993).

The popularity of protein adsorption is due to (i) its simplicity, (ii) low background noise; and
(iii) adsorbed antibody or antigen still retains enough activity to generate data.
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Attachment via linking agents
These techniques were introduced to overcome the partial denaturation effects observed when
immunoreactants were immobilised by covalent and non-covalent processes.

Immunochemical Immobilisation
The use of a polyclonal antibody to immobilise a monoclonal capture antibody (Fig. 12a) for
use in two site or sandwich ELISA has been reported (Hirano ^

1989).

This method

yields a solid phase monoclonal capture antibody which has a higher affinity for antigen.
However, it has been shown empirically that much smaller amounts of the monoclonal
antibody will be bound to the solid phase than via direct adsorption (Joshi et al-, 1992). Also,
there is an increased risk of NSB, to the immobilised polyclonal antibody (Butler, 1988).

(a)

(b)

Figure 12. (a) Immunochemically immobilised antibody; (b) Immunochemically immobilised antigen,
(orientation of antibodies is for illustration purposes only)

Immunochemical Immobilisation of antigen (Fig. 12b) (Zigterman et

1988) faces the same

potential problem with background noise, but there is an additional concern. The antigen must
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be multivalent so that it can be both captured and still express determinants to be recognised
by detection antibody (McCullough et

1985).

Streptavidin - Biotin System
The high affinity of streptavidin for biotin renders it a suitable first level capture system (Lee M
al-, 1994).

However, streptavidin

has a very low affinity for polystyrene, and must be

immobilised using the protein - avidin - biotin capture (PABC) system (Suter and Butler,
1986) (Fig. 13a) or through covalent attachment (Peterman ^ d., 1988) (Fig. 13b).

The

P.\BC system utilises the multivalency of streptavidin to allow' it to link capture antibody or
antigen to an irrelevant, adsorbed, and biotinylated protein.

(b)

(a)

O---Biotinylated
Capture
Antibody

0

-

Biotinylated
Adsorbed
Protein

Streptavidin

Figure 13. (a) Immobilised immunoreactant using PABC system and (b) immobilised immunoreactant
using covalent linkage
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The antigen capture capacity of a biotinylated monoclonal is shown to increase five fold when
immobilised via the PABC system as opposed to direct adsorption on plastic (Suter et d.,
1989).

Similarly biotinylated monoclonals immobilised using covalently bound streptavidin

also have a higher capacity than when the molecule is directly attached covalently (Petermann
eta]., 1988).
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1.3.4.6: Factors which efTect protein adsorption in immunoassays
Let us now consider the factors which affect the highly popular and simple protein adsorption
procedure, in an attempt to better our understanding and application of the adsorption process
in immunoassays.

EfTect of concentration
The optimal concentration of antibodies or antigens for coating to plastic is commonly
between 1 and 10 pg/ml (Cantarero §t

1980).

There are a limited number of

immunoreactant binding sites on polystyrene and other plastics and increasing the
concentration of immunoreactant above 1 Opg/ml does not give a linear increase in antibody
bound

This may be due to saturation of binding sites or limitations in the total surface area

available for binding. Different types of plastic show widely different capacities (Craig ^ d.,
1989).

Not only does the protein binding capacity of microtitre plates from different

manufacturers vary, but there can be differences in the ability of individual proteins to bind
(Cantarero et d., 1980). Therefore, it is important when developing an assay to determine the
effect of concentration of a immunoreactant on immobilisation to a particular surface. The
most precise method for optimising immunoreactant concentration is the Checkerboard
Titration Method (Fig. 14).
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Figure 14. Checkerboard titration method Antibody is serially diluted across the plate, allowed to
immobilise to the surface , and excess is washed away. Antigen is serially diluted down the plate ,
allowed to react with the immobilised antibody. The third reagent, usually the labelled detection agent is
used at a constant concentration.

Following signal detection, select the optimum concentration (this

concentration corresponds to the reading just prior to the set of wells exhibiting the highest absorbance
readings). (Gibbs,1995a)

This method can be used to determine optimal coating concentrations for any type of
immobilised biomolecule. The immunoreactant is serially diluted across the plate allowed to
immobilise to the sorbent surface, and the excess protein is washed away. The surface is then
carried through the various assay steps. Following signal detection the optimal reading is just
prior to the set of wells exhibiting the highest readings. From the microwell corresponding to
the optimal reading, derive the optimal concentration of immobilised immunoreactant.
optimal concentration usually represents a monolayer coverage.
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This

It is critical that the immobilised immunoassay be coated to the surface as a monolayer or
close to monolayer coverage (Fig. 15a).

At sub-monolayer concentrations void areas are

present on the sorbent surface (Fig. 15b). These void areas are prone to non-specific binding
of analyte and other reacting molecules. At concentrations above monolayer coverage there is
a tendency for protein molecules to bind to each other because there is no space left on the
surface of the plastic (fig 15c).

Such protein interactions are generally weaker than those

between protein and plastic and can result in dissociation of bound protein during the assay.
The release of surface immunoreactant or immune complexes at these high concentrations
(Butler ^

1997b) is one of the causes of the so called ‘hook’ or prozone effect seen in

ELISA and other solid-phase immunoassay.

Low
Concentration

Void
Spaces

Optimum
Concentration

Monolayer
Coverage

High
Concentration

Figure 15. Optimum antibody coating concentration
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Effect of Time and Temperature
The immobilisation of immunoreactants is dependent on time and temperature of incubation
(Kemeny and Challacombe, 1988, Kemeny, 1992).

Generally, as the incubation time is

increased, the temperature can be decreased and vice versa. There are generally two protocols
used to coat the microtitre plate: (i) coating at 4°C for 16hrs (overnight); and (ii) coating at
37°C for 2hrs.

At 4°C the environment is free from air borne contaminants and is at a constant temperature.
The incubation time of 16hrs allow for equilibrium to occur between immobilised and free
immunoreactants. The overnight incubation may also be convenient as it allows the whole of
the following day to perform the assay. The main disadvantage is that the long incubation time
requires the assay to be carried out over a two day period.
When performed properly, an assay incubated at 37°C can decrease the required incubation
time and maintain precision. However, polystyrene is a poor conductor of heat and it takes
approximately 30 minutes for a microtitre plate to reach temperature equilibrium in a
laboratory incubator (Gibbs, 1995a). Therefore, a temperature gradient may exist, during this
time period, between the outer wells and the centre wells of the plate.
gradient is commonly referred to as the edge effect.

This temperature

Other explanations also exist for this

difference in behaviour between outer and centre wells such as the manufacturing process. To
perform precise immobilisation at elevated temperatures the method of heat transference to the
plate must be controlled. A heat block can be employed to apply even heat distribution to all
96 wells simultaneously by radiating heat through the bottom of the plate rather than across
the plate.
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The evaporation of immunoreactant solution can affect precise immobilisation at 4°C and more
so at 37°C. Evaporation (i) decreases the surface area available to bind the immunoreactants;
(ii)

increases the effective concentration of the immunoreactant in wells with the highest

amount of evaporation; and (iii) increases the chance of denaturation of immobilised
immunoreactant. Adhesive plate sealers are commonly used to reduce evaporation.

Effect of Buffer solution
Type of Buffer
The most widely used coating buffer is 50mM sodium bicarbonate, pH 9.6. Other buffers used
are lOmM Tris - HCl, pH 8.5, containing lOOmM NaCl, 50mM Phosphate Buffered Saline
(PBS), pH 7.4, containing 0.15M NaCl, lOOmM citrate acetate buffer, pH 5.0 (Kemeny, 1992,
Butler

§t ^., 1997b

and Gibbs, 1995a).

For the development of a new assay it is

recommended to investigate the most appropriate buffer. The frequent use of a given buffer,
50mM sodium bicarbonate, pH 9.6, is not proof of its superiority (Butler ^ d., 1997b). The
chemical composition of a buffer can affect immunoreactant immobilisation to a surface. For
example PBS is recommended as the buffer of choice for the dry storage of precoated
polystyrene surfaces. The phosphate in PBS has the ability to arrange water molecules around
the immobilised molecule, making them less susceptible to denaturing effects (Gibbs , 1995a).

pH and Ionic strength of Buffer
The effect that pH and ionic strength have on protein adsorption is dependent on; (i) which
interactions are predominant (i.e. electrostatic, hydrophobic or Van der Waals; and (ii) the
conformational stability of the protein. If we consider electrostatics to be the driving force in
the adsorption process, then for a negatively charged surface the adsorbed amount is greater at
pH values below the isoelectric point (pi) of the protein relative to pH values above the pi
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(Luey et M., 1991). At this pH the protein has a net positive charge and on approaching the
surface the electrical double layers overlap and the protein is attracted towards the
oppositively charged surface. At pH values above the isoelectric point the protein has a net
negative charge and on overlap of the electrical double layers a repulsive force exists between
the sorbent and protein surfaces (Fig. 16).

pH > pi

pH < pi

Hectnostatic

Attraction
/ / // // /7

/ ///r/ 7/

Figure 16. Effect of pH on protein adsorption

As the ionic strength is increased, the electrostatic interaction is reduced by a “shielding”
effect of the counterions.

Consequently, increasing the ionic strength should decrease

adsorbed mass at pH values less than the isoelectric point and increase the adsorbed mass at
greater values of pH (Fig. 17)(Ramsden and Prenosil,1994).

Increase in iwiic strength

Reduction in electrostatic
attraction

/ / / r? / 7 7 7 r 7 7 7

/ / /A 7 7 /

Figure 17. Effect of ionic strength on protein adsorption
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If hydrophobic and general non-electrostatic interactions comprise the major interactions, the
relationship between adsorbed mass and changes in pH and ionic strength become intimately
related to a proteins conformational stability. Norde and Lyklema have reported that plateau
amounts of protein adsorbed to negatively charged polystyrene surfaces are virtually
independent of pH for bovine ribonuclease (RNase), whereas those for human plasma albumin
(HPA) vary by as much as a factor of 2 compared to RNase, HPA exhibits a high degree of
conformational adaptability, which allows this protein to change its structure as conditions in
the solution change (Norde and Lyklema, 1978). Goat and rabbit immunoglobulin G have a
known structural form in the shape of a “Y”, with pH affecting adsorption by changing the
degree of repulsion in the protein “arms” (Bagchi and Bimbaum, 1981).

Triple helical

collagen monomers are a fairly stiff rod over most of their length, as a result of this stability
pH and ionic strength have little effect on their adsorption behaviour (Penners ^ al, 1981). In
general, where non-electrostatic forces are predominant, conditions that lead to a less stable
conformation for the protein in solution will lead to an increased adsorbed mass, assuming that
the protein molecule is more stable on the solid surface.
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1.3.4.7: Polystyrene surface
The selection of an appropriate surface for the immobilisation of biomolecules is crucial to the
development of accurate, precise and sensitive immunoassays. In choosing a surface and assay
format, one must consider the chemical properties of the surface. A surface that is attractive
to a large hydrophobic immunoreactant may not be appropriate for a small negatively charged
one.
Typical nomenclature for polystyrene adsorption surfaces includes Medium Binding (Coming
Costar Corp. Kennebunk) or PolySorp (Nunc, Roskilde) for hydrophobic surfaces and high
binding (Coming Costar Corp., Kennebunk) or MaxiSorp (Nunc, Roskilde) for surfaces that
are modified to have a small number of ionic carboxyl groups resulting in a slightly ionic,
hydrophobic surface.
Polystyrene is a long carbon chain with pendent benzene rings on every other carbon (Fig. 18).

-( c
H .

C

)n

H

Figure 18. Structure of polystyrene

Its stmcture makes it a very hydrophobic compound.

Non-modified polystyrene surfaces

(Medium binding or PolySorp) are hydrophobic and can only bind large immunoreactants,
that have large hydrophobic regions which can interact with the surface.
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Since the

immunoreactants immobilised in this manner require a large surface area the binding capacities
are typically low (100 - 200 IgG/cm^) (Gibbs, 1995b). In aqueous medium, a repelling effect
exists between the polysorp surface and hydrophilic macromolecules because these molecules
will rather tend to intermingle with the water molecules by the strong hydrogen bonds that
bind to the surface by the weak hydrophobic bonds. Since the mechanism of attachment is
solely due to hydrophobic interactions PolySorp surfaces are considered easy to block using
either inert proteins or non-ionic detergents. One drawback of hydrophobic immobilisation is
the denaturing effect it has on biomolecules as they unfold to expose hydrophobic regions
which can interact with the surface.
Polystyrene is easily modified to what is considered High Binding or MaxiSorp surface by the
use of radiation. Radiation causes the appearance of nucleophilic groups on the surface, a
process that is increased in the presence of water and decreased in the presence of oxygen.
The radiation effectively incorporates carboxylic acid on the accessible carbons of the
“broken” benzene ring. The resulting surface is primarily hydrophobic with a patchwork of
carboxyl

groups

immunoreactants.

capable

of ionic

interaction

with

positively

charged

groups

on

The mechanism of immobilisation is thus protein adsorption through

hydrophobic and ionic interactions. This is considered a general purpose surface capable of
binding medium and large immunoreactants that have ionic and hydrophobic regions. Since
ionic interactions require that a smaller portion of the molecule be in contact with the surface
to obtain stable immobilisation, the binding capacity of the High Binding surface is large,
approx. 400 - 500 ng IgG/cm^, relative to Polysorp surface (Gibbs, 1995b).

The negative

effects of denaturation are still evident on this surface. The effective blocking of this surface
requires both a non-ionic detergent and a protein blocking step.
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In summary, when no attention is paid to the maintenance of specific activities, hydrophobic
compounds bind preferably to PolySorp., and hydrophilic compounds preferably to Maxi Sorp
(Table 3).

PolySorp

MaxiSorp

Proteins & Peptides
Lipoproteins

Glycoproteins

Compound lipids

Compound polyglyans

Lipids

Polyglycans

Table 3. Theoretical PolySorp and MaxiSorp preferences for adsorption of various immunoreactants
(Esser, 1988)

However, with MaxiSorp binding events are more likely to occur, which means that sufficient
incubation conditions are more easy to attain.

Thus the MaxiSorp application range may

extend well into the theoretical PolySorp domain (Esser, 1988).
Nevertheless, considering the maintenance of the immunological function

of the molecule

which is critical to the assay, these recognition sites may be obscured or impaired through
binding to the surface. Therefore, when constructing a solid phase assay, it is recommended to
try adsorption to MaxiSorp initially (Esser, 1988).

If this surface does not give adequate

function, it may be due to the orientation or denaturation of the immobilised immunoreactant,
one should then try adsorption to a PolySorp surface whereby specific activities may be
maintained because of the different binding mechanism to this surface.
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1.3.4.8: Adsorption effect on Immunoglobulin function
The immobilisation of antibody to a solid surface results in the partial loss of biological activity
(Ollson et d., 1989).

The maximum specific reactivity of an immobilised antibody is two

(Chase, 1984). However, specific reactivities of less than two are usually reported. One of
the main reasons for this reduction is attributed to the random orientation of the antibodies on
support surfaces.

The immunoglobulin G (IgG) is composed of two different fragments,

(Fab’)2and Fc (Fig. 19).

Figure 19. Immunoglobulin G molecule (Modified from Lu et

1996)

The Fc fragment contains antibody effector functions, so it has no antigen binding affinity.
The antibody binding site is located at the amino end of each fragment. In protein adsorption
schemes, coupling does not discriminate between possible attachment points near or removed
from the antigen binding sites.

Thereby, this process results in the random orientation of

antibodies on the support, a fraction of which prohibits the formation of antibody - antigen
complex (Fig. 20).
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Figure 20. Random orientations of antibody on solid support

In addition to low specific activities, immobilised antibodies typically exhibit lower binding
affinities (K) than their soluble counterparts (Olson et af., 1989 and Guzov and Usanov, 1988).
Moreover, the affinity constant usually decreases as the concentration of immobilised antibody
is increased.

This trend is usually attributed to steric hindrance of neighbouring antibody

binding sites by bound antigen at high concentrations of immobilised immunoreactant.
However, Butler et d. (1997) tested the antigenicity of lgG2a adsorbed over a range of
concentrations with four different monoclonal antibodies. The results indicate that only two of
the monoclonal antibodies show a significant increase in detectability when sub-saturating
amounts of lgG2a were adsorbed. Since all monoclonal antibodies did not show this effect, it
suggests that differences are not merely due to epitope accessibility but rather to epitope
exposure resulting from conformational change at sub-saturating levels (Butler ot

1997c).

The difficulty lies in distinguishing between antigenic differences due to the molecular
environment surrounding the antibody binding sites and conformational changes in the epitope
itself
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Adsorption effect on Antigen
Passively adsorbed antigens may also undergo conformational changes as a consequence of
molecular folding to interact with the solid surface.
conformational change depends on (i)

The extent of the adsorption-induced

the concentration of adsorbed protein; (ii)

the

chemistry of the protein and sorbent surfaces; and (iii) the nature of the molecules, rigid
proteins like serum albumin appear less altered than more flexible molecules such as IgG.
Adsorbed proteins appear more distorted at low concentrations and this may be overcome by
co-adsorption of stabilising proteins (Dieks_et

1986). Jitsukawa ^

showed that the

binding of three monoclonal antibodies to recombinant interferon - gamma (rIFN - gamma)
was enhanced when a mixture of rIFN - gamma and bovine serum albumin was used for
coating (Jitsukawa et

1989).

Immobilisation induced conformation changes in antigen can produce:
(i) a reduction or loss in functional epitope concentration which effects the sensitivity of the
assay (Fig. 21a).

Adsorption

7^
Figure 21. (a) Masking of functional epitopes which decreases the sensitivity of the assay, (b) the
production of new epitopes which alters the specificity of the assay.
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(ii) An immobilised antigen which expresses “new epitopes that are not representative of the
antigen in vivo, affects the specificity of the assay (Fig 21b).
(iii) Clustering of the adsorbed antigen which accentuates competition through steric
hindrance.
Therefore, great care must be taken in developing a solid phase specific antibody
immunoassay.
Engbaek et ^used the surface induced conformational effect to advantage in an enzyme
immunoassay for glycated haemoglobin where the binding of haemoglobin to the surface
of the microtitre plate exposes the glycate epitope (Engbaek ^
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1989).

1.3.4.9: Strategies to improve immunosorbent surface
Partial denaturation of coating antibody
Studies have shown an improved solid phase following the prior exposure of antibody to
denaturants.

In 1980 Ishikawa et ^ showed that antibody exposure to pH 2.5 produced

ELISA activities 2.8 - 6.3 fold liigher than untreated antibody (Ishikawa et

1980).

Conradie et ^ found that the preexposure of antibody to low pH, 3 M urea and temperatures
as high as 82°C enhanced the colour in ELISA (Conradie M iL, 1983). It is thought that the
improvements obtained are due to an increase in the hydrophobicity of the molecule involved
in this phenomena, since increased binding of 1 - anilino - 8 - naphthalene - sulphonate (ANS)
to antibody was observed. Also small conformational change, which could have resulted in the
exposure of a hydrophobic region, were detected by circular dichroism (Conradie et

1983).

Alternative possibilities are that the denatured antibody can bind to sites on the sorbent surface
which have weaker affinity and are normally not coated.

It is postulated that the molecules

may orientate themselves in such a manner that a more favourable position for reaction with
antigen is taken.

This is a likely possibility since the Fc region is reported to be more

susceptible to denaturation than the Fab region.

In a more recent study, Davies ^ M used

scanning tunnelling microscopy and dynamic contact angle studies to determine the effect of
partial denaturation on immunoassay solid phase antibody.

They report that these

pretreatments induce a degree of antibody aggregation leading to a change in hydrophobicity
of the coated surface (Davies ^ d., 1995).
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Reduction in non-specific binding (NSB) of IgG to solid phase by altering the surface
charge
In a study to detect prostate-specific antigen in postcoital vaginal fluid by a sandwich ELISA,
it was noted that non-coital vaginal fluid contained substances which inhibited the non-specific
binding of the detecting antibody alkaline

phosphatase conjugate (Graves et

1985).

Vaginal fluid mucins are highly negatively charged glycoproteins rich in sialic acid. In a later
study, (Graves, 1988) studied the binding of IgG to a series of surface immobilised proteins
and synthetic polypeptide with differing isoelectric points. When the intermediately charged
prostate specific antigen, was co-coated on the test surface with polypeptides of varying
charge, the specificity of the surface binding between anti-prostate-specific IgG and nonimmune IgG was altered.

Co-coating prostate-specific antigen with the ionic glycoprotein

enhanced the binding specificity as reflected in an increased signal to noise ratio, whereas co
coating prostate-specific antigen with cationic proteins led to a decreased signal to noise ratio.
Therefore, in solid phase immunoassays which measure antigen specific antibody, non-specific
binding of immunoglobulins may be diminished by co-coating the surface with a hydrophilic
anionic matrix. However, it should be noted that the use of a matrix coat will cause a decrease
in assay sensitivity.

Use of AI (0H)3 as an adsorbent
Houen and Koch developed a non-denaturing ELISA system which employs the adsorption of
protein to Al (OH)3 gel prior to adsorption to the plastic surface (Houen and Koch, 1997).
They immobilised ovalbumin by direct protein adsorption to a polystyrene surface and
discovered that a significant proportion of ovalbumin underwent denaturation to such an
extent that it becomes reactive with monoclonal antibodies which only recognise ovalbumin in
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its denatured form. The simultaneous presence of A1 (OH)3 and ovalbumin during the coating
process abolishes the denaturation of the antigen.
They demonstrated that this non - denaturing ELISA system requires that: (i) Al(OH)3 comes
into contact with the immunoreactant before the immunoreactant becomes attached to the
surface; and (ii) requires the presence of phosphate groups. They also reported that protein
adsorbed onto Al(OH)3 is required for binding of Al(OH)3 onto the plastic surface.

They

proposed that this system may be employed where discrimination between the native and
denatured forms of immunoreactant is important.

Modification of short peptides using epsilon-aminocaproic acid
There are some limitations in using short synthetic peptides of 5 - 10 residues as an
immobilised immunoreactant in ELISA procedures, (i) peptides must, generally, be at least 15
residues long in order to be adsorbed onto plastic surface after overnight incubation (Plave and
Briand, 1988); (ii) short peptides may be partially lost during normal ELISA washing stages
leading to imprecision, and (iii)

the conformation of the peptide may be altered by its

interaction with antibody. Conventionally the immobilisation of these peptides was achieved
by the pre-treatment of polystyrene plates with direct coupling agents such as glutaraldehyde,
cyanogen bromide or poly -L- Lysine.

In a recent study, aminocaproic acid was used to

modify these short peptides (Pyun et

1997).

Aminocaproic acid, which has a n-pentyl

group as its side chain, increases the hydrophobicity of short peptides.

It functions as an

anchor for the peptide to be fixed on the surface of the microtitre plate. Pyun ^

applied

this modification method to a peptide representing an epitope of the 60 KDa RO/Ssa antigen.
The ELISA results from a clinical study of systemic lupus erythematosus (SLE) patients, show
that this method gave a higher signal to background ratio than conventional method without
altering the specificity of the assay (Pyun et

1997).
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1.3.5: Conventional methods for the detection of interfacial antibody - antigen reactions
To facilitate the observation of the reaction between an analyte and an antibody and implicitly
to attain the sensitivity required to determine the low concentrations in body fluids of
hormones and other comparable analytes reagent labels are generally employed these being
attached either to the antibody or to a trace amount of analyte added to the reaction mixture.
These reporter labels can be classified into five groups.
Group 1 Radioactive labels
Group 2 Enzyme labels
Group 3 Fluorescent labels
Group 4 Luminescent labels
Group 5 Miscellaneous

1.3.5.1: Group 1 Radioactive Labels
Immunoassays utilising radioactive labels continue to be primary analytic techniques for the
research laboratory, although its use in the clinical laboratory is diminishing. Iodine - 125 is
the nuclide most often attached to an antigen or antibody to make the reporter moiety.

In

contrast to fluorescenation, biotinylation, and conjugation with enzymes, the introduction of
one atom of iodine per mole of protein provides a strong detection signal, without alteration of
the biochemical or conformational properties of the protein.

The chemistry required for

iodination is well known, and iodinations are relatively inexpensive to perform.

Thus,

immunochemical assays for new analytes most often appear first with a radioactive reporter.
Braun ^

noted that citations of radioimmunoassays in the Medline database from 1989 to

1990 made up about a third of all immunoassays applications (Braun et

1992). However,

by the standards of 1990, iodinated reagents have numerous disadvantages for routine
diagnostics. These include the need for radiological protection, waste disposal protocols, both
67

I

and I

have short half - lives (57 and 9 days, respectively), necessitating the continues

generation or purchase of new signal generators.

1.3.5.2: Group 2 Enzyme labels
Until the late 1960s, enzymes as detection labels had only been used for the localisation of
antigens in tissues (Stenberger M

1970). At this time, horseradish peroxidase (HRP) and

alkaline phosphatase (AP) were introduced as “signal generators” in immunoassay to
quantitate antigens and antibodies (Avrameas and Guilbert, 1972).

The criteria for the

selection of a suitable enzyme reporter make only a limited number of enzymes suitable for
enzyme immunoassays (Table 4 ).

Enzyme

pH

Mol. wt

optimum

Chromogenic substrates
and measurements

Alkaline phosphatase

9-10

100 000

p - nitrophenophosphate

B-Galactosidase

6-8

540 000

o-nitrophenyl-(3-D
galactopyranoside

Peroxidase

5-7

40 000

H202/3,3,5,5-

T etramethylbenzidine
Glucose

4-7

186 000

Coupled enzyme reaction
Glucose + chromogen for

oxidase/peroxidase

peroxidase
Glucose + chromogen for

Urease peroxidase

peroxidase
Ureases

6.5-7.5

483 000

Urea/bromocresol yellow

Table 4. Enzymes commonly used as labels for solid phase immunoassays (Modified from Porstmann and
Kiessig,1992)
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Enzyme labels in the immunoassays are used to provide a starter substance for a secondary
system which can generate

a signal.

The change in absorbance caused by depletion of

substrate or formation of product is one such secondary system, having the advantage that it
can be measured on any chemical analyser that measures absorbance. However, these assays
lack sensitivity due to the limited absorptivity value for many of the chromogens examined and
have a limited dynamic range.

Secondary systems involving fluorescence or luminescence

products can result in increased sensitivity (Portsmann, ^ d.,1985). The marker enzyme of
choice for heterogeneous EIA is horseradish peroxidase (HRP). Both chromogenic (substrate:
H2O2 and 3, 3\ 5, 5^ -tetramethylbenzidine) and fluorogenic product measuring (substrate
H2O2 and 3 4- hydroxyphenyl propionic acid) produced a higher sensitivity in the two site EIA
than using alkaline phosphatase (AP) and (3-galactosidase (P-gal) as marker enzymes under
identical conditions of dose response (Portsmann ^ ^., 1985). Where AP and p-gal are used
as markers the sensitivity of the assay can be increased several times by prolonging the
substrate reaction. This, however, also increases the background noise levels.
Since all heterogeneous immunoenzymetric techniques involve, in their final step, the detection
of an enzyme associated with a solid phase, essentially two approaches have been developed to
obtain enzyme signal amplification. The first includes procedures leading to high accumulation
of enzyme label associated with the solid phase.

The second consists of procedures using

multi- enzyme cascades.
Amplification systems based on accumulation of enzyme labels;
1. Bridge antibody technique
A preformed enzyme/antienzyme antibody complex is bound via an anti-lgG antibody to the
analyte - antibody complex (Stemberger et d., 1970).
2. Avidin - biotin interactions
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Two methods have been devised. In the first a biotin labelled antibody is allowed to react with
the immobilised antigen. After a washing step avidin conjugated to an enzyme is added. In
the second approach biotin-labelled antibody, native unlabelled avidin and biotin-labelled
enzyme are used.

This assay is based on the principle that avidin has four active sites.

Because of steric hindrance all four active sites are not involved in the interaction with the
biotinylated antibody and the remaining free active sites act as acceptors for the subsequently
added biotinylated enzyme. This procedure has been simplified by the preparation of soluble
avidin biotinylated enzyme complexes, a technique known as ABC procedure (Hsu et d.,
1981).

Streptavidin

a neutral protein, expressing the same characteristics as avidin has

replaced avidin in this amplification system (Wilchek and Bayer, 1990).
biotin conjugate system is thought to give lower background signals.
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The streptavidin -

Amplification systems based on multi-enzyme cascades
These techniques are based on the generation of amplified enzymatic signals by using multi
enzyme cascades.

The first of these amplification procedures was developed for alkaline

phosphatase (Johannson, 1986) (Fig. 22).

NADP
Alkaline
Phosphatase
reduced

NAD

NADH

Figure 22.

Reaction scheme of the detection of alkaline phosphatase activity by means of a cycling

secondary enzyme reaction

The enzyme alkaline phosphatase converts the substrate nicotinamide adenine dinucleotide
phosphate (NADP") into nicotinamide adenine dinucleotide (NAD^).

NAD" is reduced by

alcohol dehyrogenase in the presence of ethanol to NADH. NADH is converted back into
NAD" by diaphorase with the simultaneous reduction of a tetrazolum salt also present in the
reaction medium.

This gives rise to the accumulation, of coloured soluble formazan dye,

which is proportional to the concentration of NAD^ generated by alkaline phosphatase. The
newly formed NAD" enters into the reaction and is recycled many times. It has been reported
that this procedure yields approx. 100 - fold increase in sensitivity. A modification of this
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technique has been described by which the addition of semi carbazide was found to increase
assay sensitivity 250 - fold (Brooks ^

1991).

In a second enzyme cascade procedure developed to measure alkaline phosphatase, a masked
inhibitor is acted on by alkaline phosphatase which converts it into an active inhibitor of liver
carboxylesterase. Measurement of the residual esterase activity enables an estimation of the
original alkaline phosphatase activity. The sensitivity of this procedure has been reported to be
approximately 125 - fold greater than that observed for the detection of alkaline phosphatase
activity with p-nitrophenyl phosphate (Mize et al., 1989).
To ensure the specificity and sensitivity of immunoenzymatic assays, involving amplification
systems it is necessary to select with particular care the purity of the reagents to be used and to
optimise all the reaction steps. In particular the non-specific binding of the enzyme - antibody
conjugate or the enzyme - amplifying construct to the solid phase must be kept to an absolute
minimum.
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1.3.5.3: Fluorescent labels
Antibodies labelled with fluorophores

have been used

since

1941

in

histological

immunofixation techniques, but immunoassay applications has taken longer to develop. Over
the last 20 years the introduction of fluorescent probes into immunoassay systems have
provided some alternative methods for analytes such as drugs or proteins which are present at
relatively high concentrations. Fluorescent labels account for approximately 15% of the labels
used in immunoassays cited on the medline database from 1989 to 1990 (Braun ^

1992).

Fluorescent molecules absorb energy in the form of radiation and emit energy as photons.
Absorbed light excites the electron cloud of the molecule from its ground state to an excited
state. Subsequently energy may be lost from (i) non-radiative conversion (e g. heat); (2) by
radiative transition to the ground state (i.e. fluorescence), or through a semi-stable triplet state
(phosphorescence).

Some rare earth ions, particularly europium (Eu^^) and terbium (Tb^')

form highly fluorescent chelates with suitable organic ligands. In this case, light absorption by
the ligand is followed by energy transfer from the excited state through its triple stable state to
the resonance energy levels of the lanthanide ion (La^^).

Characteristics of fluorescent probes and lanthanide chelates
Stokes shift;
The wavelength of emitted light is always longer than that of excited energy because of energy
losses prior to emission.

This wavelength difference is known as the Stoke’s shift.

The

Stoke’s shift is generally small in the region of 30 - 50nm, for fluorescent organic molecules.
The lanthanide chelates have a much greater Stoke’s shift (over 200nm for Eu^^).
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Decay times:
The decay time for fluorescent organic molecules is in the region of 10'^ to 10'* seconds.
While the lanthanide chelate fluorescence has a decay time of 10'^ to 10'^ seconds.

This

characteristic has facilitated the development of time-resolved fluorescence.

Quantum Yield;
The quantum yield is the ratio of absorbed to emitted light energy and is dependent on
temperature, polarity and pH of the solvent, concentration of fluorophore and other quenching
effects.

Flurophore

Stokes
Shift/nm

Decay
time (nsec)

Quantum
Yield

•

Fluorescein

28

4.5

0.85

•

35

3.0

0.7

•

Rhodamine B
isothiocyanate
Umbelliferones

•

Dansyl chloride

140

14

0.3

•

Anilo-napthalene

86

16

0.8

*rel
Fluor

70

sulphonic acid
.

Sm^Vp-NTA

260

65

1.5

•

Sm^*/PTA

305

60

0.3

•

Eu^VPTA

318

925

36

•

Eu^7p-NTA

•

Tb-’*/PTA

273
195

714

100

96

8

p-NTA - Pnapthoyltrifluroacetone, PTA - pivaloyltrifluoroacetone
* at emission maximum, compared to Eu^Vp-NTA fluorescence

Table 5.

Characteristics of fluorescent probes and lanthanide chelates (modified from Price and

Newman, 1992).
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The use of fluorescence probes together with non-competitive immunometric assay systems
could theoretically yield detection limits less than 10^ molecules/L (Jackson and Ekins, 1986).
However, conventional fluorescence labelled immunoassay techniques are limited to detection
limits in the range of 10'^ to 10'^^ mol/L (10^^ to 10^"^ molecules/L) due to high background
readings associated with light scattering fluorescence by the sample reagents and cuvettes.
Time-resolved fluorescence measurement with IFMA assays have yielded detection limits in
the order of 10'^^ mol/L or approximately 10^ molecules/L.

Time-resolved fluorescence
Excitation occurs with a flash of light lasting less than one microsecond.

The background

fluorescence in the sample decays rapidly with a half-life of less than 50 nanoseconds. The
much longer lived fluorescence of the Eu^" ion is measured during a time frame chosen so that
there is minimal interference from background fluorescence. The Eu^^ ion in aqueous solution
is surrounded by 8 or 9 water molecules in an inner hydration sphere (Diamandis, 1988). In
this state the europium ion is only veiy^ weakly fluorescent.

Exclusion of these water

molecules by organic ligands greatly enhances the Eu^^ fluorescence.
Two different systems have been developed to adapt Eu^^ fluorescence to immunoassays
systems. The first, time-resolved FIA and IFMA system to be developed commercially was
the DELFIA system (dissociation - enhanced ligand fluorescence immunoassay; Pharmacia
Ltd.) (Soini and Kojola, 1983). The DELFIA method utilises antibody or antigen labelled
with a stable europium chelate. In this form the europium ion is only weakly fluorescence. On
completion of the immunoassay or immunometric assay the europium Eu

is released from

the hydrophilic chelator into a highly lipophilic environment which enhances the fluorescence
of the europium ion.
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In 1988 an alternative system was developed (FIAgen - Cyberfluor Inc.) (Reichstein ^
1988). This is based on time-resolved fluorescence measurement in the solid phase and uses
biotinylated

antibodies

labelled

with

streptavidin
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europium

chelator

reagent.

1.3.5.4: Luminescence Labels
Luminescence is a general term that covers a range of processes which produce light. Two of
these processes, chemiluminescence and bioluminescence, are increasingly being used to
monitor immunoassays (McCapra, 1989).
during the

course

of a

chemical

Chemiluminescence is light emission that occurs

reaction,

while

bioluminescence

is

a type

of

chemiluminescence found in biological systems in which a catalytic protein increases the
efficiency of the chemiluminescence found in biological systems. Chemiluminescent reactions
provide a very sensitive detection system in immunoassays because no external light source is
required. Thereby, all the light reaching the detector is derieved from the chemical reaction.
Two major types of immunoassay application have emerged:
1. The use of a component of a chemiluminescent or bioluminescent reaction as a
label.
2. The use of these reactions to detect a conventional enzyme label.

1. Use of a component of a luminescent reaction as a label.
There are two main bioluminescent systems, one which is ATP-dependent and the other which
is NAD(P)/FMN dependent.

ATP - dependent systems
The most common representatives of this group are the glow-worms and fireflys .

The

enzymes are expensive, unstable in solution and are readily inactivated by heavy metals. These
characteristics have led to the search for alternative, stable and cheaper systems. The light
efficiency can be up to 80% of the theoretical light output (Wood, 1993).
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NAD(P) FMN-dependent systems
These are present in marine bacteria such as vibrio sp. The NAD(P)/FMN systems are not as
efficient as the ATP systems, around 35% of the theoretical light output (Brolin ^

1971).

Chemiluminescent labels
The majority of labels used in luminescence immunoassays are of a chemiluminescent nature.
They are stable, relatively cheap and convenient to couple to antigens and antibodies without
loss of activity.

The light output in aqueous solution is only between 1% and 5% of the

theoretical output (Wood, 1993). This is however sufficient for immunoassays, in which the
lower limit of detection is equal to or better than that of

Chemiluminescent labels can be

largely divided into two main groups, namely the derivatives of luminol, and the acridinium
esters.

Luminol derivatives
The structure of luminol is shown in figure 23. The amino group at position 5 of the ring is
substituted by an ethyl group and an alkylamino “tail” usually consisting of 4 carbon atoms (4aminobutyl residue).

This substance is known as aminobutyl ethyl isoluminol (ABEI).

Another member of this group is similar to ABEI but has a napthalene nucleus instead of the
benzene nucleus of ABEI. This compound is abbreviated ABEN. ABEN yields about two to
three times as much light as ABEI, but is less stable.
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o

NH

NH

Figure 23. Structure of luminol.

Acridinium derivatives
Acridinium derivatives used as labels in immunoassays have the general structure shown in
figure 24.

The stability and solubility of this group of compounds has been improved by

derivatisation and substitution at the ester linkage between the acridane moiety and the
coupling to the protein. They do not yield more light than ABEN but tend to have a lower
non-specific background due to reduced non-specific adsorption onto solid phases during
incubation. The result is that assays with “acridinium ester” labels tend to have a larger signal
to noise ratio and improved lower detection limit when compared with identical assays using
ABEN as a label.

R2

NH.

NH.

Figure 24. General structure of Acridinium esters
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2. Use of luminescent reactions to detect a conventional enzyme label
Luminescent end point measurements are available for all of the commonly used enzyme labels
including horseradish peroxidase, alkaline phosphatase, glucose oxidase, glucose - 6 phosphate dehydrogenase, and p-galactosidase.
have been attained (Kricka, ^

Detection limits in the subattomolar range

1992).

Alkaline phosphatase
Bioluminescence
luciferin - 0 - phosphate ------ ^ D-luciferin
D-luciferin + ATP------ ^ produce light

Alkaline phosphatase can be determined using the 0 - phosphate derivative of firefly luciferin
as a substrate.

Alkaline phosphatase cleaves the phosphate group to produce D-luciferin,

which, unlike the 0-phosphate derivative, reacts with luciferase and ATP to produce light.

Chemiluminescence
Alkaline phosphatase cleaves the phosphate group of adamantyl 1, 2 - dioxetane aryl
phosphate to produce an unstable intermediate which decomposes with the emission of light
(Wood, 1985).

Horseradish peroxidase
This enzyme can be rapidly and sensitively assayed by its ability to catalyse the
chemiluminescent oxidation of a range of substances such as cyclic diacyl hydrazides, phenol
derivatives and certain components of bioluminescent systems (Fig. 25).
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Oxidant

Peroxidase

Electronically
excited intermediate

Luminol

Light 425nm
Aminophthalate

Figure 25. Chemiluminescent oxidation of luminol by horseradish peroxidase

Chemiluminscent monitoring of peroxidase labels, using diacyl hydrazides such as luminol, has
been significantly improved by the discovery of a series of compounds which when added to
the reaction mixture increase light emission (McCapra, 1989). The addition of enhancers to the
reaction mixture either at the start of, or during the peroxidase catalysed oxidation of diacyl
hydrazides can produce increases in light emission of over two orders of magnitude ( Stott;
Kricka, 1986).
The disadvantage of the chemiluminescent labels described above is that they can only be
measured once, since the oxidation step is irreversible. This means in practical terms, that all
the immunoassay steps leading to the measurement of luminescence must be repeated if a fault
occurs at the signal measurement stage.
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1.3.5.5: DNA labels
DNA replication of antibody bound labels has the potential to greatly extend the sensitivity of
immunoassays (Sano et

1992).

This hybrid technology, known as immuno - PCR,

combines the specific molecular recognition of antibodies with the high amplification potential
of DNA replication (polymerase chain reaction (PCR)). Using immuno - PCR as few as 600
molecules of immobilised bovine serum albumin have been detected (Sano ei al., 1992). They
constructed a protein A - streptavidin chimera protein capable of simultaneously binding
antibody and biotinylated DNA label.

In a subsequent study Zhou M al developed a

‘^universal” reporter by employing streptavidin to link biotinylated DNA and antibody (Zhou ei
al., 1993). In the above reports the labelled DNA - antibody complexes are attached in situ
during the assay. This can lead to variable stoichiometry in the attachment of the DNA label.
In addition, extra steps are also required to remove excess reagents and to prevent non
specific binding.
Hendrickson Gt d report on an advancement in immuno - PCR that reduces assay complexity
and permits multiple analytes to be simultaneously detected (Hendrickson ^

1995). In this

approach the analyte specific antibody and the 5^-amino-modified DNA oligonucleotide are
independently activated by means of separate heterobifunctional cross-linking agents.
activated antibody and DNA label

The

are then covalently coupled in a single spontaneous

reaction. Hendrickson ^ ^ report a multi analyte immuno - PCR assay for the simultaneous
detection of human thyroid stimulating hormone (hTSH), human chorionic gonadotropin
(hCG), and P- galactosidase analytes using the sandwich assay format.

Reporter reagents

were prepared for P-Gal, hTSH and hCG analytes by labelling each of the reporter antibodies
with an oligonucleotide 55, 85, and 99 bases in length, respectively. The bound DNA label is
then replicated using PCR.
electrophoresis.

Amplified DNA products are then analysed by agarose gel

PCR generates amplified a DNA product with length and sequence
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characteristic of the original DNA label. Therefore, the amplified DNA is indicative of the
presence and identity of the analyte. The multi analyte immuno - PCR of P-Gal, hCG and
hTSH provide sensitivities of 10'^^, lO'^^, and 10'^^ mol respectively (Hendrickson et al.,
1995).
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1.3.6: Sensitivity
A lot of confusion centres around the meaning of the term sensitivity in relation to
immunoassays. This is mainly due to mathematical theories constructed by two independent
groups which show conflicting concepts of sensitivity.

Briefly, Berson and Yalow define

sensitivity as the slope of the dose response curve relating the fraction of labelled antigen
bound to analyte concentration (Yalow and Berson, 1970). In contrast, Ekins et al defined
sensitivity as the imprecision of measurement of the zero dose this quantity being indicative of,
and essentially equivalent to the lower limit of detection (Ekins et ^., 1970). By neglecting
the error in the measurement of the response variable, the “response curve slope” definition
leads to many obvious defects. For example, plotting conventional RJA data in terms of the
response term

(bound to free ratio) suggests the assay sensitivity is increased by

increasing the antibody concentration in the system, however, the opposite conclusion can be
formed if the same data are plotted in

terms of

(free to bound ratio).

Thereby,

examination of the shape and slope of response curves without detailed error analysis lead to a
defective guide to optimal immunoassay design. This defective guide led Berson and Yalow to
repeatedly report that maximum (RIA) sensitivity is obtained using an antibody concentration
give by VC or by ^

where K is the antibody affinity constant, (Berson and Yalow, 1973)

implying that, in labelled antigen assays fractional binding of labelled antigen at zero dose
approximated to 50% and 33%, respectively.

These precepts have been accepted, for a good

few years, by many workers in the field, and most commercial kits are designed in accordance
with them. However, the assay detection limit is now widely accepted as the only valid
indicator of sensitivity.
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Strategies to improve sensitivity
All of the detection method developments described

have as their principal aim increased

sensitivity of the immunoassay. However, mere amplification of a signal does not increase
sensitivity unless it preferentially amplifies the signal and not the background noise; few if any
of the systems for amplifying solid phase immunoassay possess this property.

Therefore,

background noise reduction must be part of a scheme designed to improve sensitivity.
Background noise in solid phase immunoassay originated from two main sources:
(1) the binding of components of the detection system, or non-ligand compounds which are
recognisable by the detection system, directly to the synthetic solid phase.
(2) the non-specific binding of some components to the antibody on the solid phase.

In solid phase immunoassays, the former is generally prevented by the use of non-ionic
detergents which prevents hydrophobic interaction of protein with the solid phase, while the
latter is prevented by the addition of a “blocking protein” or the use of buffer conditions which
discourage non-specific protein - protein interactions. Background problems are exacerbated
when measuring immunochemical interactions of low affinity because it means that the
reactants must be used at very high concentrations to drive the interaction (Graves, 1988).
This raises the potential for non-specific interactions.

This lead Ekins to develop a system

where the affinity of the interaction or site occupancy (Ekins and Chu, 1991) would be
increased. This system known as the “multispot assay” provides a novel means of increasing
sensitivity.

85

I.3.6.I. Microspot Immunoassay
Basic Concepts
(a) Antibody occupancy principles
This involves the proposition that all immunoassays rely on the determination of the fractional
occupancy by analyte of antibody. When a coating antibody is exposed to an analyte medium,
coating antibody binding sites are occupied by analyte molecules to a fractional extent which is
dependent on the equilibrium constant governing the binding reaction, and the final unbound
or free analyte concentration in the medium. This conclusion follows from the Mass Action
Laws.
k 1

[fAbJ + [fAg]

O

[AbAgJ

k2

[AhAg]
K =

UAhMfAg]

K [fAg]

where K =

[AhAg]
UAh]

the final fractional occupancy of antibody binding sites is given by:

[AhAg]
[Ah]

K[fAg]
1 + K[fAg]

Where [AbAg], [Ab], [fAb] and [fAg] represents the concentrations at equilibrium of bound an
total antibody, and free antibody and antigen respectively, and K represents the equilibrium
constant. The final free analyte concentrations is generally dependent on both total analyte and
antibody concentrations.
Non-competitive assays directly determine occupied sites, competitive assays require
observation of unoccupied sites, this being generally effected by back titration using labelled
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analyte. Though labelled anti-idiotypic antibody (reactive only with unoccupied sited on the
sensor antibody) may likewise be used.

(b) Ambient analyte assay
This term describes assay systems which, unlike conventional methods, measure the analyte
concentration in the medium to which an antibody is exposed, being independent both of
sample volume, and of the amount of antibody present (Ekins ^ M., 1990). The possibility of
developing such assays follow from the Mass Action Laws which lead to the following
equation, representing the fractional occupancy (F) of antibody binding sited by analyte at
equilibrium (Ekins and Chu, 1995).
1

- F

+

[Ag]
[Ah] + 1

.LSI
=0
[Ah]

From this equation it is evident that, for antibody concentrations tending to 0,
F»

K{Ag]

less than

x

Ekins and Chu showed that when sensor antibody binding site no.

10'^ x N, where V = sample vol (mis) and N = Avogadros no., were

exposed to an analyte containing medium the resulting occupancy of antibody binding sites
solely reflects the ambient analyte concentration and is independent of total amount of
antibody (Ekins an Chu, 1992). Analyte binding by antibody causes analyte depletion in the
medium, but because the amount bound is small, reduction in the ambient analyte
concentration is insignificant.

(c) Microspot Assays
These assays are characterised by the use of small amounts of antibody present at high surface
density on the solid phase to form a “microspot” (Ekins, 1992). If the system fiilfils ambient
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analyte conditions, the microspot acts as an analyte “sensor”, its fractional occupancy by
analyte being indicative of the analyte concentrations in the surrounding volume.

(d) Dual label. Ambient Analyte “ratiometric” Binding Assays.
Ratiometric assay involves the idea that fractional occupancy may be determined by labelling
the coating antibody with one label and the second detector antibody with a second label, and
observing the ratio of signals emitted by the two labels (Chu et al, 1997). Thus, following
exposure of the antibody coated microspot to the analyte containing medium the surface is
removed and exposed to a solution containing the “detector” antibody directed either against a
second epitope on the analyte molecule if it is a large analyte, or against unoccupied antibody
binding sites in the case of small analytes. An alternative approach is to use two “detector”
antibodies with different labels, one directed against occupied sites, the other against
unoccupied sited on the unlabelled coating antibody (Fig. 26). The ratio of signals emitted is
in each case, a measure of the analyte concentration. Coating and detector antibodies may be
labelled, for example, with a pair of radioisotopic, enzyme or chemiluminescent labels.
However, fluorescent labels are especially useful because they enable arrays of “microspots”
distributed over a surface (each microspot directed against a different analyte) to be readily
scanned, thereby permitting multianalyte assays to be performed on the same sample. (Chu et
d., 1997).
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Conventional ELISA

‘Rationietric”Binding assay

/ 77 7/T/ / /7/ / /

Measure signal S
S is proportional to analyte cone.

Measure signals S and U
Ratio S:U is proportional to analyte cone.

Figure 26. Schematic representation of a dual label “ratiometric” immunoassay

Instrumentation
A laser scanning confocal fluorescence microscope (Fig. 27) is used to detect the fluorescent
signal.

In laser scanning confocal fluorescence microscopy, a small defined area of the

spec.men is exposed to a focused laser beam, the fluorescence photons from this area are in
turn, focused onto a detector, typically a low current photomultiplier (White et d., 1987).
Sources of background fluorescence include electrons spontaneously being emitted from the
photymultiplier photocathode, and fluorescence being emitted by the opitical components in
the system.

Nevertheless, the laser scaiming confocal microscope can detect fluorescent
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signals with high sensitivity.

One commercially available microscope is claimed to detect

fluorescein at a density of a few FITC - labelled IgG molecules per micrometer^ (Ploen, 1986).

Figure 27. Schematic representation of a confocal fluorescence microscope.

Sensitivity
Theoretical analysis reveals that microspot assays are likely to yield sensitivities higher than
conventional methodologies (Ekins, 1995; Ekins and Chu, 1992).

If we assume that sensor

antibody molecules are attached to the surface of a solid support such that their binding sites
remain exposed to the analyte, and that their affinity for the analyte is unchanged.

Also

assume that the antibody molecules exists as a uniform monolayer of maximal surface density
on the support. Ekins M M, studied the effects of a progressive reduction of the antibody 90

coated surface area from Imm^ (effective antibody concentration /^) through 0.1 mm^

) to 0.0 Imm^

below (Ekins and Chu, 1991). A summary of the results

presented in figure 28 show that as the coated area and the amount of antibody decreases, the
fractional occupancy of binding sites on the surface increases reaching a plateau when the
antibody concentration falls below

-------------------

^^Yf^

Bound analyte (% of total)
Signal to noise ratio(% of total when [ab=0J

Figure 28.

Curves representing signal/noise ratio and antibody bound analyte as functions of antibody

concentrations (modified from Ekins and Chu4992)

If however, a reduction in the antibody coated area were not accompanied by a corresponding
reduction in the detecting instruments field of view, the resulting reduction in “signal” would
not lead to a corresponding decrease in the background generated by non-specifically bound
detector antibodies (Fig. 29). Therefore, although reduction in the coated area would increase
the fractional occupancy of the sensor antibody the signal/noise ratio might either remain
constant or fall.
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Field of view decreases, surface coverage of wtibody deposition decr^B^,_S/B_rises

Field of view constant, surface covera^ of antibody deposition decreases. S/B falls

Field of view constant, surface coverage of antibody deposition decreases. S/B falls
Figure. 29. Captured antibody is assumed coated on circular areas; the field of view of the signal measuring instrument is represented by square unshaded areas (modified from Ekins and Chu,1991)

Thereby, if we accept the signal/noise ratio as indicative of the precision of the measurement
of antibody occupancy these results suggest that it is advantageous to reduce the antibody
coated surface area toward zero. Although little advantage is likely to result from reducing the
area below 0.01 mm^ (Ekins and Chu, 1992). The point at which the reduction in the antibody
coated area causes the detectable signal to be lost sufficiently to affect the precision of the
measurement of antibody occupancy depends clearly on the specific activity of the labelled
antibody used to measure the occupied sites; the higher the specific activity, the smaller the
permissible area (Ekins and Chu, 1992).
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Applications
Chu ^

developed a variety of non-competitive and competitive microspot assay formats,

including sandwich assays, labelled analyte back titration assays for analytes of low molecular
weight and solid phase capture antigen assays for the determination of serum antibodies (Chu
et d., 1997).

These assays have been developed for a wide range of analytes.

Total IgE

assays with a lower detection limit of <0.01 I.U./ml have been developed. While TSH assays
with sensitivities of <0.01 pg/ml and giving good correlation with results yielded by other
conventional analysers have been obtained. Microspot assays for a range of analytes relating
to infectious diseases have been developed and are being evaluated by this group. Chu ^ d,
also successfully developed combined competitive/non-competitive TSH assays using two
labelled detector antibodies as described previously. These assays have been found to extend
the assay working range.
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1.4: Atomic Force Microscopy
1.4.1: Introduction
The atomic force microscope (AFM), was developed by Binnig, Quate and Gerber (Binnig ^
1986). They calculated the force between atoms and found that they could easily make a
spring constant weaker than the equivalent spring between atoms. For example, the vibrational
frequencies (w) of atoms bound in a molecule or in a crystalline solid are typically 10*'^ Hz.
Combining this with the mass of atoms 10'^^ kg gives interatomic spring constant K, given by
w^m, on the order of 10 N/m. For comparison, the spring constant of a piece of household
aluminium foil that is 4mm long and 1mm wide is about 1 N/m. They believed that by sensing
Angstrom size displacements of such a soft lever spring, one could image atomic - scale
topography. Furthermore, the applied force would not be large enough to push the atoms out
of their atomic sites.

1.4.2: Principle
The AFM uses a cantilever mounted tip to sense the surface topography of a specimen. When
the tip is pressed on a surface of a specimen, the tip-surface interactions which can be
attractive or repulsive, depending on the distance causes the cantilever to deflect.

In most

cases the Van der Waals force is dominant when the tip is close enough to the sample.
Usually, laser reflection is used to detect the cantilever deflection. The movement of the tip or
sample is performed by an extremely precise positioning device made from piezoelectric
ceramics. This device, known as a scanner, is capable of sub-Angstrom resolution in the x-, yand z- direction. The z axis is conventionally perpendicular to the sample. A feed-back system
controls the motion of the scanner and the z data.
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1.4.3: Instrumentation
The atomic force microscope has five essential components (Fig.30).
1. A sharp tip attached to a cantilever.
2. A method for sensing cantilever deflection.
3. A mechanical scanning system that moves the sample with respect to the tip.
4. A feedback system to monitor and control the deflection.
5. A display system.

Gonbolkr

Figure 30. Atomic force microscope
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1.4.3.1: A sharp tip attached to a cantilever
A cantilever is a small bar spring usually fabricated, as an integrated tip - cantilever assembly
from silicon or silicon nitride using photolithographic techniques. Cantilevers typically range
from 100 to 200 pm in length, 10 to 40 pm in width and 0.3 to 2pm in thickness (Howland
and Benatar ,1996).

There are two important properties of the AFM cantilever; spring

constant and resonant frequency. The spring constant determines the force between the probe
and the sample when they are in close proximity and is determined by its shape, its dimensions
and the material from which it is fabricated. Thicker and shorter cantilevers tend to be stiffer
and have higher resonant frequencies.

The spring constants of commercially available

cantilevers range over four orders of magnitude, from thousandths of a Newton per metre to
tens of Newton’s per metre (Topometrix,1995; Howland and Benatar, 1996).

When a

cantilever is moved from its equilibrium position and released it will oscillate at a “resonance
frequency” that is determined by the mechanical properties of the cantilever.

The resonant

frequency depends on the material and physical dimensions of the cantilever and the forces that
act on the tip. Commercially available cantilevers have resonant frequencies ranging from a
few kilohertz to hundreds of kilohertz providing high speed response and allowing for noncontact AFM operation (Topometrix,1995: Howland and Benatar, 1996).

The desirable

properties of a cantilever depends on the intended imaging mode and the intended application.
In all situations, the resonant frequency of the cantilever should be high, and the spring
constant selected for the desired experiment. In contact mode, where the tip is in contact with
the sample, soft cantilevers are more suitable because they can deflect without deforming the
surface of the sample. In non-contact, where the tip is brought extremely close to the sample,
stiff cantilevers with high resonant frequencies are preferred.
The cantilever geometry also influences the resonant frequency and spring constant.
simplest geometry is the L-shaped cantilever (Fig. 31a).
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The

These are usually used for non-

contact applications. In non-contact application, there is negligible tangential force to deflect
the cantilever sides. Other cantilever geometry’s were developed to reduce the lateral motion
of the L-shaped cantilever beam. For example the single V geometry, (Fig. 31b) is used in
contact mode imaging. Although, the v-shaped cantilever limits x and y deflection, there is still
some torsion around intersection of the tip and the apex of the v. The double v (Fig. 31c)
configuration truly restricts the motion of the cantilever in the z direction but are harder to
construct than an L-shaped cantilever
( a

)

V

( b

)

( c

)

Figure 31. Common cantilever geometry-

Attached to the cantilever is a tip. The tip is the component of the instrument that interacts
with the sample. Commercial AFM tips are available in three different geometries: pyramidal,
tetrahedral and conical. AFM tips are fabricated form silicon or silicon nitride.
The fabrication process is different for the two materials.
Silicon is often used for imaging modes that require a resonating cantilever. The tips are made
on these cantilevers by etching into silicon around a silicon dioxide cap. They are conical in
shape with a base radius of 3 - 6 pm and a height of 10 - 20 pm (Topometrix, 1995). Tip
radius as small as 50

A

have been reported (Howland and Benatar, 1996). The high aspect

ratio (ratio of tip length to tip width) makes them suitable for imaging deep narrow trenches,
but they may break more easily than the pyramidal or tetrahedral geometry.
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Silicon nitride tips are fabricated by depositing a layer of silicon nitride over an etched pit in a
crystalline silicon surface. This method produces the pyramidal or tetrahedral tip geometry.
The aspect ratio of a silicon nitride tip is thus limited by the crystallographic structure of the
etch pit material. The tips are broader than conical silicon tips (200 - lOOOA) (Topometrix,
1995) making them sturdier but less suitable for imaging deep, narrow features. Silicon nitride
is a harder material than silicon which also makes silicon nitride tips more robust than silicon
tips.
For both contact and non-contact imaging, a tip should be selected that is sharper than the
smallest feature on the sample. If the tip is larger than the surface features, an artefact known
as tip imaging occurs. However, sharper tips are expensive and can be less durable and should
only be used where necessary.
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1.4.3.2: Methods for sensing cantilever deflection
The first AFM employed electron tunnelling to detect cantilever deflection (Binnig et M.,
1986).

This system displayed high sensitivities since the tunnelling current between two

conducting surfaces changes exponentially with distance, typically by a factor of 10 per
Angstrom of displacement.

A second advantage is that in principle one can work with

extremely small cantilevers since the tunnelling probe is confined to a small region. However,
feed-back circuits are required to follow large cantilevers deflections and thermal drift.

In

addition the tunnelling detection method suffers from contamination induced instabilities of the
tunnelling function, which can lead to unreliable imaging, even under vacuum conditions.
Finally, the tunnelling tip exerts extrinsic forces on the cantilever, both Van der Waals and
electrostatic in nature, which can significantly distort actual force measurements.
The need for a more reliable detection method led to the introduction of different optical
techniques, which have a greater measuring range and exert no extraneous force on the
cantilever.

In optical interferometry, a HeNe laser beam is reflected off a cantilever and

interferes with a part of the beam reflected from a reference flat. Despite its simplicity and
high reliability, interferometry suffers from high noise levels at frequencies below 100 Hz due
to the large physical path difference between the reference beam and the light reflected from
the cantilever.

This noise level has been reduced by the use of fibre-optic techniques that

places a reference reflector within microns of the cantilever.
Most AFMs currently on the market detect the position of the cantilever by reflection of a laser
beam (Howland and Benatar, 1996, Topometrix, 1995). In this scheme a laser beam reflects
off the back of the cantilever onto a position-sensitive photodetector (PSPD). (Fig. 32).
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Figure 32. Measurement of cantilever deflection by reflection

As the cantilever bends the position of the laser beam on the detector shifts, the ratio of the
path length between the cantilever and the detector to the length of the cantilever produces an
amplification.

This system can detect sub-Angstrom size displacement of the cantilever

(Howland and Benatar,1996).
Neuber §t d. (1990) used capacitance variation to measure cantilever deflection (Neuber oi
1990).

In capacitance detection, a small metal plate is placed adjacent to the back of the

cantilever beam which forms the other plate of the capacitor. The separation of the plates is
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typically one micron, and the capacitance is a few picofarads.

This method provides high

sensitivity and a high dynamic range while maintaining low noise levels.

However, since a

capacitance transform bridge must be used to measure picofarad capacitance, the overall
sensitivity is limited by a temperature-induced drift of the reference capacitor and by the
roughness of the cantilever.
The deflection of a cantilever fabricated from a piezoresistive material can be detected
electrically. Strain from mechanical deformation causes a change in the electrical resistance of
the cantilever. For piezoresistive detection a laser beam and PSPD are unnecessary.
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1.4.3.3: Mechanical scanning system
A piezoelectric scanner is used as an extremely fine positioning stage to move the tip with
respect to the sample. The AFM electronics drive the scanner in a type of raster pattern. (Fig.
33).

Finish

Start

H

h

Step
Size
fast- scan direction

Figure 33. Scanner motion

Piezoelectric ceramics are members of a family of materials that change dimensions when an
electric potential is applied.

They are usually fabricated from lead zirconium titanate.

The

scanner can be designed to move in the x, y and z direction by expanding in some directions
and contracting in others. Several types of scanners have been developed. The most common
types in commercial AFM instruments are the tripod and tube scanner. A tripod scanner is
made of linear, stacked ceramics in a tripod configuration, while the tube scanner has
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electrodes attached to the outside of a hollow tube, segmenting it electrically into vertical
quarters, +x, +y, -x and -y travel. (Fig. 34).

Figure 34. Tube scanner

When alternating voltages are applied to the +x and -x electrodes, for example, the induced
strain of the tube causes it to bend back and forth in the x direction.

Movement in the z

direction is generated by energising the electrode in the centre of the tube. This lengthens the
entire tube, and is proportional to the nominal length of the tube and the applied voltage.
In the ideal case the piezoelectric ceramic will deform in a linear fashion. However, in practice
linearity is not obeyed due to intrinsic non-linearity, hysteresis creep and ageing.

Intrinsic non-linearity
The piezoelectric ceramic does not produce a linear response with applied voltage. If we plot
the extension of the ceramic as a function of applied voltage an S-shaped curve is attained (Fig.
35). This non-linearity causes error in the height measurement.
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Figure 35. Intrinsic non-linearity

Hysteresis
Refers to the different response paths attained on increasing and decreasing the voltage. If we
start at a low voltage and increase the voltage very slowly to some finite value and then return
slowly to zero. On constructing a plot of extension versus voltage, the descending curve does
not retrace the ascending curve. AFM data are usually only collected in one direction to
minimise registration errors caused by scanner hysteresis . (Fig. 36)
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Creep
When a large change in voltage is applied, the piezoelectric material does not change
dimensions at once.

The dimensional change occurs as a two-step process.

The first step

takes place in less than a millisecond, the second occurs over a much longer time scale. The
second step is know as creep.

As a result, two scans taken at different scan speeds show

slightly different length scales.

Ageing
This term refers to the change in scanner response over time and is dependant on the work.
When a scanner is not used, the deflection achieved for a given voltage decreases. When a
scanner is used regularly, the deflection achieved for a given voltage increases slowly with
time.
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There are several ways that non-linear behaviour of piezoelectric ceramics can be removed
from AFM.

These techniques can be divided into open loop techniques and closed loop

technique.

Open loop techniques
These involve the development of software correction systems which can compensate for non
linearity while collecting data by adjusting the applied voltage to the scanner.
techniques are relatively simple and inexpensive.

These

Their main disadvantage is that they only

panially compensate for scanner non-linearities.

Closed loop techniques
This method uses a sensing device to measure the actual scanner motion and drive the ceramic
to produce linear scanner displacement.

The signal read from the sensor for each axis is

compared to a signal that represents the intended scanner position along that particular axis. A
feed-back system applies voltage to the scanner to drive it to the desired position.
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1.4.3.4: Feed-back system
The AFM feed-back circuit directs the motion of the z piezoelectric ceramic and the z data
acquisition. There are two basic AFM feed-back techniques, depending on whether or not the
cantilever is being modulated.

Non Modulated method
In conventional AFM, a laser light is reflected from the back of the AFM cantilever, and
detected in a multiple stage photodetector.

Changes in phototdetector output are used to

adjust the z-piezoelectric ceramic and generate the z data points.

Modulation Method
In these techniques, the cantilever is modulated, generally by mounting the base of the
cantilever on a piezoelectric ceramic.

The piezoelectric ceramic is driven by an alternating

voltage which causes it to oscillate. The relationship between the input oscillation and the
oscillation of the tip depends on the resonant frequency of the cantilever. Below the resonant
frequency, the motion of the tip is the same as the input oscillation. As the frequency comes
close to the resonant frequency, the tip moves up and down at a higher amplitude for a given
driving voltage. The oscillation also lags the input signal.

The lag in the probe oscillation

compared to the input oscillation is referred to as the “phase shift”. When a tip is moved close
to the sample, it acts as though a weight were placed at the end of the cantilever, the resonance
frequency is shifted. The change in phase or amplitude associated with an oscillating tip near a
sample can be used to control the feed-back loop.

This is achieved by comparing input

oscillation and oscillating photodetector output, through a phase lock loop.

The output is

proportional to either the change in amplitude or the phase shift which is used to control the
feed-back in the z-piezoelectric ceramic and to generate the z data points.
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1.4.3.5: Display system
A computer is used for displaying the images. The x, y and z data points are processed by the
computer to form an image of the sample. Many software features are available for powerful
enhancement of data.

The commonly used software features of the TopoMetrix Explorer

(Section 2) can be outlined as follows.
• Image display format; planar or 3 dimensional view.
• Line analysis: details the line profile of the surface and is accompanied by the
following roughness parameters.
Ra. the arithmetic mean of the deviations in height from the profile mean value.
Rrms: the root mean square determination of the height from the profile mean
Rf). the peak to mean height.
Rpm; the mean of Rp
Rt. the peak to valley height.
Rtm . the mean of Rt
• Roughness analysis; details the roughness characteristics of a defined area
Area Ra. the arithmetic mean of the deviations in height from the profile mean value for
defined area.
Area Rrms. the root mean square determination of the height from the profile mean for
the defined area.
A vg. Height, the mean of the peak to mean height for the defined area.
Max. Range. The maximum peak to valley height for the defined area.

Data enhancement techniques, such as Fourier filtering, shading and three-dimensional display
may be used to provide better resolution of the scanned image.
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1.4.4: Imaging Modes
Several forces typically contribute to the deflection of an AFM cantilever.

The force most

commonly associated with atomic force microscopy is the Van der Waals force. The Van der
Waals force is highly dependant upon the distance between the tip and sample. As the tip is
brought close to the sample, in the order of tens to hundreds of Angstroms, it is first attracted
to the sample surface.

When the tip gets to within a few Angstroms of the surface, the

electron orbitals of atoms on the surface of the probe and sample start to repel each other. On
further decreasing the distance, the repulsive forces neutralise the attractive forces and then
become dominant.

1.4.4.1: Contact AFM
In this imaging mode the cantilever is curved away from the surface of the sample. As the
scanner moves the tip with respect to the sample the contact forces cause the cantilever to
bend in relation to the topography of the surface. The forces involved include, the Van der
Waals force, a capillary force exerted by the water layer and the force exerted by the
cantilever. The strength of the capillary force depends upon the tip to sample separation.
While the magnitude and sign of the cantilever force depends upon the deflection of the
cantilever and upon its spring constant.

The variable force in contact AFM is the force

exerted by the cantilever. The magnitude of the total force exerted on the sample (capillary
and cantilever) are typically in the order of 10'^ - 10'^ N.
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1.4.4.2: Non-contact AFM
In the non-contact AFM imaging mode, the AFM cantilever is curved toward the sample, due
to the attractive Van der Waals forces. The force between the tip and the sample in the noncontact region is low, generally about 10'^^ N. The low force values and greater stiffness of
the cantilever used are both factors that make the signal small and difficult to measure. The
low force is advantageous for studying soft or elastic samples. Also, this imaging mode does
not suffer from tip or sample degradation effects. However, if a layer of moisture is present
on the surface of a rigid sample the AFM operating in the non-contact mode will fail to
penetrate the liquid and will thereby image the surface of the liquid layer.

1.4.4.3: Tapping Mode
The tapping mode is similar to the non-contact mode.

In the tapping mode the vibrating

cantilever is positioned relative to the sample so that at the bottom of its oscillation the tip
just slightly “taps” the sample. This mode of imaging is less likely to damage the sample than
contact AFM because it eliminates the friction between the tip and sample. In general it has
been found that the tapping mode is more effective than the non-contact mode for imaging
larger scan sizes that may involve greater variation in surface topography.
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1.4.5: Biological Applications of AFM
We can broadly divide biological applications of AFM in to 2 groups:
(1) . Imaging
(2) . Manipulation

1.4.5.1: Imaging
The AFM can image three-dimensional surface structures of biological specimens. The great
advantage of the AFM for biologists is that it can image samples in a fluid environment. This
provides the opportunity of observing biochemical and physiological processes in real-time at
m_olecular resolution.

Cells and Cell Processes
It is possible with the AFM to image cellular and subcellular structures under physiological
conditions with resolution far greater than that of the optical microscope. A variety of fixed
and dried cells have now been imaged by AFM. Erythrocytes and bacteria dried onto a glass
cover slip were some of the first cells to be examined (Butt ^ d., 1990a). However, little
information was obtained about the extracellular or intracellular structures.

Ushiki et ^

(1995) reported a favourable AFM sample of mice tissue with embedment-free sections
prepared according to the polyethylene glycol (PEG) embedding and subsequent de
embedding method. AFM images show the cut surfaces of cytoplasmic organelles such as
rough endoplasmic reticulum and mitochondria even at low magnification.
There is significant interest in developing imaging conditions for live cells. Henderson et ^
(1992) imaged glial cells and showed F actin under the surface of the plasma membrane. The
actin was identified by comparison with fluorescent cell images labelled with anti-actin and
anti-tubulin antibodies (Henderson et d.,1992). Barbee M
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(1994) imaged cultured bovine

aortic endothelial cells which were subjected to a flow induced shear stress (Barbee ^
^.,1994).

The resulting cells show a significant reorganisation of cell morphology and

cytoarchitecture. Horber et ^ (1992) imaged monkey kidney cells at a resolution of 10 nm
(Horber et ^.,1992). When these cells were transfected with vaccinia virus, the cell surface
morphology changed and real-time extrusions of proteins (10 - 100 nm) and viruses were
observed.
While working with live cells is of more interest, the ability to image surfaces of dried and
fixed cells easily and quickly at high resolution may be useful for the rapid detection and
diagnosis of pathological conditions in cells. A limitation of the AFM, as a diagnostic tool is
the difficulty in identifying specific structures at the surface of the cell.

One particular

method developed to improve resolution is low temperature atomic force microscopy (Prater
^ d., 1991). Zhang ^

(1996) imaged red blood cells by both SEM and cryo - AFM.

Although both methods were well suited to resolving the shape of the red blood cells, the
resolution of cryo - AFM on the cell surface is much higher (Zhang et d., 1996).

Isolated Macromolecules
Nucleic acids
The original aim was to accurately image the individual bases so that the sequences of along
nucleic acid polymer could be read directly. (Jing ^ d., 1993). This is now recognised to be
beyond the scope of this technique , since the resolution required to distinguished the DNA
or RNA bases is higher than that which may be achieved reliably by the AFM. In addition
even single stranded DNA adopts a complicated spatial structure in solution such that the
bases may not be directly accessible and their orientation uncontrollable. One of the current
aims is to image DNA and DNA - Protein complexes in physiological buffers, in order to
study the processes involved in the regulation of transcription.
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Mica has been the favourite material as the AFM substrate since it can be easily cleaved to
obtain a clean and atomically flat surface. However, the mica surface is negatively charged in
solution for the entire pH range, this may effect the adsorption of acidic DNA to the
substrate. Bustamante et

(1992) overcame this problem by treating the mica surface with

magnesium acetate (Bustamante et d.,

1992).

Afterwards a droplet of DNA solution

(100jj,g/ml in lOmM-Tris, ImM-EDTA, pH 7.6) was deposited on the surface. With such
specimens a spatial resolution of about lOnm was obtained when imaged in air.
much broader than naked DNA (approx. 2nm).
finite tip size (Bustamante

Which is

This broading has been attributed to the

d. 1992). DNA protein complexes were also imaged at low

protein to DNA ratios, however the resolution was poor, the bound proteins appearing as
blobs without any detail (Rees ^ M ,1993).
Yang et d. (1992) introduced a modified Kleinschmidt method for DNA imaging in air or
organic solvent (Yang et ^.,1992).

A thin coating of a carbon film was applied to a bare

mica surface to render it hydrophobic.

A droplet of DNA containing cytochrome C

(lOOpg/ml cytochrome c, approx. 2|j.g/ml DNA) is believed to denature at the surface due to
osmotic pressure shock and forms a protein monolayer with bound DNA. The film is then
picked up on the carbon coated mica and dried in air, with this preparation, a resolution of 46nm was obtained in air with commercial Si3N4 pyramidal tips (Yang et ^.,1992).
In order to improve the stability of DNA adsorption the substrate surface can first be
functionalised by introducing active chemical groups such as amines (Lyubchenko M
d.,1993).

Lyubchenko

^

d.

aminopropylytriethoxysilane (APTES),

(1993)

treated

the

the

followed by vacuum drying.

mica

surface

with

They incubated the

treated mica with DNA solution (0. Ipg/ml) for l-2hrs and imaged the DNA in air, water and
propanol. However, the lateral resolution they could achieve was only 60nm in air and 30nm
in water and propanol, lower than that obtained in other methods.
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Fritz et

(1997) immobilised 5Kb ssRNA (single stranded RNA) fragments to silanised

mica and imaged them in air (Fritz ^ d., 1997). Its contour length was determined to be
about 1300nm, indicating 0.26nm per base. The self affinity of the ss RNA in water induces a
more or less globular structure. Therefore, to observe their chain like structure, denaturation
of the ssRNA fragments with formamide is necessary prior to adsorption.

Soluble Proteins
Unlike DNA, the aim in the case of proteins was to image the macromolecules in solution
(Lin ^ d.,1990, Weisenhom et

1990) however in order to do so macromolecules must

be adsorbed to a substrate with sufficient strength, so that neither the AFM probe nor the salt
in the buffer solution can remove the molecules from the substrate. This seemingly simple
task is in reality quite difficult.
Karrash et M (1993) improved the functionalised surface technique adopted by Lyubchenko

et al- (1993) used to fix DNA (as outlined in previous section) to mica (Karrash ^ d.,1993).
In this technique, the surface of a coverslip was first silanised with APTES (5% in 95%
acetone), followed by washing and baking at 110°C (Karrash et d.,1993).

The NH2 group at

the end of the hydrocarbon chain was reacted with the succinimide ester group of the photo
crosslinker N-5-azido-2-nitrobenzoyloxysuccinimide. After washing off excess reagent, the
azide groups on the surface are readily activated by u.v. light to cross link macromolecules to
the substrate. Using this method a number of protein specimens have been imaged in buffer
solutions with excellent reproducibility. Karrash ^ d. (1993) showed that for bacteriophage
T4 polyheads, on direct adsorption to mica the phage head could not be stablely adsorbed to
the surface. However, with adsorption on to the functionalised surface, the phage polyheads
could sustain repeated scans, and, at high resolution, the characteristic gp 23 hexamer at the
surface was resolved. For the reconstituted intermediate filaments, stable adhesion became
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possible with this technique, but with a much lower resolution (approx. 40nm). For the two
dimensional crystalline HPI layer of the bacterium Deinococcus radiodurans. the resolution
was better. In particular, in the diffraction pattern, spots down to 1.6nm were resolved.
Simple amphillic molecules can provide a good substrate for soluble proteins which may even
form 2-D crystals.

This area was first tried by Ohnishi el

(1993) who performed a

monolayer of poly - I -benzyl - L histidine on a Langmuir trough (Ohnishi ^ d.,1993).
Ferritin molecules in the subphase were found to order themselves against this monolayer at
pH 5. They showed that, with the horizontal transfer of the monolayer to the silicon wafer
surface, which was silanised to render it hydrophobic, ferritin molecules adsorbed to the
monolayer could be seen by the AFM in water. The resolution achieved was about lOnm,
which was not quite sufficient to resolve each subunit.
Another approach is to introduce binding sites on the protein that can bind to specific groups
present on the surface. Ill ^ d. (1993) incorporated a metal chelating His - Trp dipeptide at
the carboxyl terminus of the heavy chains of immunoglobulin G (IgG) this modification
causes the protein to bind to nickel ions (Ill et d. 1993). When the IgG chelating protein in
solution was incubated with the nickel treated mica; particulate structures were found to bind
to the surface strongly and could withstand probe forces up to lOOnN.

However, it is

difficult to ascertain these were indeed IgG molecules because the resolution achieved
(approx. 20nm) is not sufficient to show the characteristic Y shape of the IgG molecule.
Other attempts at imaging immunoglobulins by AFM in solution or in air have also been
rather unsuccessful (Yang ^ d., 1994, Roberts ^ d., 1995)

The best images to date

revealed particulate structures on the substrate surface with much larger dimensions than the
known values (Roberts et

1995). When the immunoglobulins were imaged with an AFM

operated in liquid nitrogen vapour (cryo-AFM) much higher quality images were obtained
(Zhang ^ d.,1996).

They showed the well resolved characteristic Y shape.
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Direct

measurement shows that the overall lateral dimension is 15 - 16nm, in good agreement with
the known values from electron microscopy and X-ray diffraction (Poljak,1975). However,
the height of the IgGl is only 2.5nm, lower than what would be expected (4nm) in the Y
conformation. They thought a possible reason for this lower height is the collapse of the
molecule during the removal of the solution due to the surface tension of water.

Membrane and Membrane Proteins
AFM imaging of unsupported membranes such as the plasma membrane of an intact cell,
does not appear very' promising with only ~ 20riM resolution demonstrated to date (Butt ^
d., 1990 a; Fritz ^ d., 1994). This is primarily due to the extreme flexibility of the hydrated
membranes. When such membranes are placed on a solid support, such as mica or glass
coverslips much higher resolution has been reported (Butt ^ M , 1990 b; Mou ^ ^., 1995).
The easiest method for preparing high quality phospholipid bilayers on a hydrophilic substrate
is the direct fusion of small unilamellar membranes on freshly cleaved mica.

So far this

method has been applied to prepare various phospholipid bilayers from saturated to
unsaturated, including all types of head groups. Direct fusion has the most natural lateral
pressure in the bi-layer compared with the Langmuir trough method. However, the content
in each leaflet cannot be controlled, and sometimes such asymmetric bilayers are required.
The method of using the Langmuir trough to prepare supported membranes of biological
interest is well established (Roberts, 1990). Using this method, the content in each leaflet is
easily controlled, and the transfer pressure can be a desirable value. Details of this method
for the preparation of biologically relevant model membranes can be found in numerous
publications (Tamm 1988; Yang ^ ^., 1993 a; Yang ^ d.,

1993 b).

For unilamellar

bilayers, cleaved mica is again found to be a good substrate for reproducible results. Yang et
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(1993 a) have used the Langmuir trough to prepare bilayers of different phospholipids with
reliable results (Yang ot

1993a).

Where a membrane of appropriate composition is made on a mica surface, peripheral
membrane proteins can be easily added to the buffer to allow binding to the membrane. This
is shown in the case of cholera toxin bound to supported bi-layers (Yang ^
^

1993 b, Mou

1995). The cholera toxin and its B-oligomer were readily bound to support bilayers of

a variety of phospholipids containing the cholera toxin receptor, ganglioside GM.

For

integral membrane proteins, reconstitution into such planar membranes has not been
demonstrated.

To date, the only success with integral membrane proteins are those with

purified fragments. Hoh

d- (1991) demonstrated that gap junction plaques purified from

rat liver can be adsorbed quite well to the glass surface (Hoh ^ ^., 1991). In a later study,
the resolution was improved to allow visualisation of the pores directly (Hoh et ^., 1993).
Other examples include the Purple membrane (Butt Gt ^., 1990 b, Muller ^ ^., 1995) and
nuclear pores (Goldie M

1994). The advantage over reconstitution is that the membrane

is in its native state, which eliminates some of the potential artefacts in a reconstituted
system.
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Dynamic Processes
One major difference between the AFM and electron microscope (EM) and other molecular
imaging systems is that the images can be obtained in an aqueous environment.

This

characteristic confers on the AFM the ability to follow processes in real time.
Drake ^ al. (1989) studied the real-time polymerisation of the blood clotting factor fibrin.
They showed that the growth of the polymer chain is by fusion of many short chains rather
than by a successive addition of monomers to a few long chains (Drake ^

1989).

Edstrom ^ ai. (1990) studied the possibility of directly viewing enzyme substrate complexes
of phosphorylase kinase and phosphorylase b.

Complexes between the enzymes were

prepared by mixing 1:5 molar ratios of phosphorylase kinase and phosphorylase b to give a
final protein concentration of 0.1 mg/ml.

Comparison of the AFM and STM images of

phosphorylase kinase in the isolated and complexed state shows that this molecule undergoes
significant change in its size and shape on binding to its substrate, phosphorylase b (Edstrom
et al-, 1990).
Weisenhom ^

(1990) studied the antibody - antigen reaction as a real time process. They

used Langmuir Blodgett (LB) films of lipids for antigen presentation in antigen-antibody
reactions. Four per cent of the lipids were replaced by hapten lipids, having an ®itigen site in
the headgroup. These hapten lipids could not be resolved due to the roughness of the glass
(0.3nm) used as a substrate, in spite of the roughness they reported antibodies at 40 min
after a 1 tig/ml solution was introduced into the AFM. The apparent size of the antibodies is
between 25nm x 8nm and 35nm x 12nm. The height is roughly half a nanometer.

These

observed dimensions are again too big; the total length of an antibody is about 16nm and the
thickness at the base is about 3-4nm. They also reported circles of depression of about 50nm
radius, about 15 min after introducing the antibody.
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It is not known if this is something

specific to this reaction or due to the fact that glass was used as a substrate (Weisenhom et
M.,1990).
Horber et

(1992) visualised real time surface processes on virus infected cells. In monkey

kidney cells that were infected with vaccinia virus. Pox viridae , real time changes in surface
morphology and exocytosis of enveloped virus and proteins (10 -lOOnm) were observed over
a period of approx. 12 min, 19hrs after the transfection. In contrast, cells not infected with
the virus did not show any appreciable change in surface morphology (Horber et M-,1992).
While imaging in the tapping mode Benzanilla et d. (1994) showed that DNA degradation by
the enz>'me DNAase 1 (Benzanille ^ d., 1994).
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1.4.5.2: Nanomanipulation
Imaging is the most obvious use of the AFM. However, there are other applications that are
important to the biologist, particularly nanomanipulation. The precise positional control and
small size of the AFM tip makes it useful for nanomanipulation of molecules and structures
The AFM tip has been used to dissect away one bilayer of isolated gap junctions leaving the
extracellular region of the remaining bilayer accessible for experimental manipulation (Hoh ^
^.,1991). Plasmid DNA has been manipulated such that 100-150nm pieces have been cut off
(Hansma et d.,1992). When this technique is combined with the recent labelling of DNA
with dUTP and gold particles, it may be possible to use probes labelled with gold to locate
genes on chromosomes and dissect them or use them to map regions of DNA. Such images
of DNA have already been generated by DeGrooth and Putman and compared well with the
banding observed by light microscopy (DeGrooth; Putman, 1992). Thalhamer ^

(1997)

used the AFM to dissect regions of the chromosomes and carryout nanoextraction of DNA.
They amplified the minute amounts of DN A extracted, by only single cuts (one AFM line
scan in contact mode at high force), by the polymerase chain reaction (PCR). This opens the
unique possibility of developing specific genetic probes from any distinct region. (Thalhamer
^ ^,1997)
Muller M d. (1996) combined the imaging and manipulation properties of the AFM to
distinguish the cytoplasmic and extracellular surface of purple membrane.

They used

antibodies directed against C - terminus of bacteriorhodopsin to distinguish the surfaces of
purple membrane. At forces > 0.8nN the antibodies were removed by the AFM probe and
the unveiled cytoplasmic membrane revealed doughnut shaped trimers, agreeing with
previous studies (Muller, 1996).
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1.4.5.3: AFM and Immunoassays
The studies carried out to date in the role AFM can play in immunoassays can be divided into
three different sections;
1. Measurement of binding strengths of biomolecular interaction.
2. Quantitation of immune complexes.
3. Molecular mapping of biosurfaces.

1.

Measurement of binding strengths of biomolecular interaction.

The ability of the AFM to measure forces of 1 OpN or less has been exploited by a number of
investigators to measure the forces required to separate specific biomolecular interactions
involved in immunoassays (Lee ^ d., 1994; Dammer ^

1996; Hinterdorfer ^

1996,

Allen et af ., 1996). In this type of investigation the complementary biomolecules are attached
to the AFM tip and the opposing substrate surface. The tip is subsequently moved towards
the surface at a constant velocity until it is brought into contact with the sample. The tip is
compressed into the sample surface until a point of maximum load is reached. The direction
of motion is then reversed and the probe is withdrawn from the sample surface.

The

maximum cantilever deflection during the retraction phase of the force measurement is
related directly to the magnitude of the force required to break the biomolecular interaction.
Dammer et

M

(1996) measured the specific interaction between biotin antibody and

biotinylated bovine serum albumin by the above method. They showed that only very few
antibiotin/biotin complexes are formed and subsequently broken in an approach experiment.
They concluded that typical antibody - antigen interactions require a separation force of 35 135 pN (Dammer et d., 1996). In another study of antibody - antigen interaction polyclonal
antihuman serum albumin antibodies were attached to a tip by means of a spacer group. This
sensor allowed the detection of single antibody - antigen recognition events by force signals
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with an unbinding force of 244 plus or minus 22pN (Hinterdorfer ^ d., 1996). Allen ^
(1996) showed that adhesive force between a single ferritin molecule and anti-ferritin to be of
the order of 49 ± lOpN (Allen et d., 1996)

The binding force of the streptavidin - biotin

system has also been measured by the AFM and found to be of the order of 30nN (Lee et
1994).

2.

Molecular mapping of bio surfaces.

Hinterdorfer et d. (1996) covalently coupled ligands to a tip via a long flexible spacer
molecule at a sufficiently low ligand concentration so that about one ligand is expected to have
access to surface bound receptors. They reported the detection and characterisation of single
antibody - antigen recognition events and the localisation of antigenic sites (Hinterdorfer ^
1996). Thus, by combining the molecular recognition of ligands with the structural resolution
of the tip a system for molecular mapping the topography of biosurfaces becomes available.

3. Quantitation of immunocomplexes
McDonnell ^

(1992) proposed the development of an immunoassay whereby the

immunocomplex formation be detected using atomic force microscopy. They anticipated that
the detection limit of the AFM immunoassay could be lower than the conventional assays, such
as RIA or EIA (McDonnell ^ d., 1992). While Davies et d. (1994) demonstrated the anti
ferritin-ferritin interaction using AFM with surface plasmon resonance as a correlative
technique. These authors were able to differentiate between molecular dimensions of ferritin
and antibodies and hence, to count the number of ferritin molecules per unit area (Davies ^ M ,
1994). The ferritin - anti-ferritin model was also studied by Perrin ^ d. (1997) who related
the amount of ferritin bound after immunocomplex formation to their initial bulk concentration.
The antibody - antigen complex formation was related to the increase in the square root of the
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mean square roughness (Rrms). However, while a standard curve was attained (0.12-4 gg/ml
), the sensitivity was 50 fold less than that obtained for the conventional ELISA (Perrin et
1997)
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1.5. Objectives

The objectives of the experimental investigation can be divided into five parts.

1. To optimise the adsorption conditions of a range of proteins, including a number of
different monoclonal antibodies, to two different sorbent surfaces namely
polystyrene and silanised silicon. The purpose of this approach is two fold.
(a).

The optimised conditions can be used in subsequent experiments to

produce an optimised AFM immunosensor surface.
b). The results attained for the different proteins and different sorbent surfaces
can be spooled together to produce a “database” of information from which an
informed decision can be made on the optimum conditions of other proteins.

2. To estimate the surface coverage of anti ferritin on silanised silicon. If we assume a
packed monolayer of antibodies this surface coverage gives us an indication of the
orientation of the antibody molecules on the sorbent surface.

Also the maximum

“signal generating concentration” gives an alternative approach to the determination
of the optimum coating concentration of the protein.

3. To detect the presence of three different proteins, ranging in molecular weight from
22kDa to 450kDa, on their specific antibody-coated silicon surface using the AFM.

4. To develop and evaluate a ferritin ELISA on the silanised silicon surface which
utilises a sample volume of 6[i\ and a reaction time of 10 minutes.
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5. To develop a quantitative ferritin immunoassay on a silicon surface, which involves
the direct quantitation of the number of binding events per unit area, using the AFM
(Fig. 37) The proposed assay offers unique possibilities of increased sensitivities.

(a)
■ ■ ►

Line scan

AFM tip

YYTYYY

“Smooth surface”
Antibody
surface

/ / / / / } / / / /T 7~y

CD^P
Analyte

(b)

Line scan
‘Rough surface"

Figure 37. Schematic representation of the proposed AFM Immunosensor. The AFM
probe profiles (a) the topography of the anti-ferritin antibody coated-surface; (b) the
topography of the anti-ferritin antibody surface following incubation with varying
concentrations of the ferritin antigen. Surface roughness comparisons of the different
surfaces are related to ferritin concentrations

The proposed assay offers unique possibilities of increased sensitivities.
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Materials and Methods

2.1: Materials

2.1.1: Apparatus
1. pH meter
Orion-benchtop pH/ISE meter, model 420A is a microprocessor-controlled instrument
which features pH Autocalibration.

2. Microplate reader - Dynatech Laboratories MR 7000. Dynatech Laboratories Ltd. Daux
Rd, West Sussex, RH14 9SJ. This microprocessor controlled photometer is designed to
measure the absorbance of sample in microtitre plates. It is suited to colorimetric
applications. It offers high reading rates for 96 well microtitreplates (1.7 seconds in single
wavelength modes). Such rapid operation facilitates accurate and reliable determination of
kinetic functions and end points. Advanced software enables data to be presented
graphically or as optical density matrices via an Epson-compatible printer.

3. Balance - Kern 820/23 - for amounts >10mg
Mettler AE 200 - for amounts < lOmg

4. Safety Cabinet - Lab-Flex laboratory engineering.

5. Plate washer - BIO-TEK instruments automicroplate washer-EL 403.
BIO-TEK Instruments, Inc.
Highland Park, Box 998
Winooski, VT 05404-0998 USA.
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The model EL403 is designed to automatically remove unbound reagents in 96 well
microplates in immunological assays such as Enzyme-Linked Immunosorbent Assays
(ELISA).
6. Silicon wafers
Source-Nanosensors
Dopant-B
Resisitivity - 4 - bflcm
Orientation - 111
Thickness - 500 -^ /-20|J.m

8. Microtitreplate - Nunc-lmmuno Plate MaxiSorp.

9. Millipore Wafer Purification System. The Millipore-milli-u 10 purification system
produces Grade 2 (according to ISO 3696/B53978) purified water directly from
deionisation using a mixed-bed ion exchange resin. The resulting product water is low in
inorganic ions, dissolved organic compounds, bacteria and colloidal matter.

10. AFM. - The TMX 2000 Explorer is a multipurpose scanning probe microscope capable of
operating in the following capacities:
• As a high performance free standing AFM capable of imaging samples of any size
or shape
• A biological imaging tool for use in combination with an inverted microscope.

• An integral component in a dedicated wafer analysis system.
This instrument facilitates imaging in ambient conditions or within the meniscus
layer of a liquid. 130micron scanners control the motion in the x and y direction
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while a 12micron scanner controls the motion in the z direction

With external

vibration isolation , the explorer SPM has been demonstrated to resolve features at
the atomic level. To achieve this vibration isolation the Explorer used in this
investigation is placed on a marble stage mounted on 10 metres of concrete.

11. AFM cantilevers and tips- Two types of cantilever integrated tip systems where used in
this investigation.
Type 1-

Non contact ultrasharp silicon cantilevers
Zelenograd Research Institute of Physical Problems
103460,
Moscow,
Russia.
Cantilever characteristics.

Length (pm)- 200
Width (pm)- 40
Thickness(pm) - 2.0 +/- 0.1
Resonant frequency (kHz) - 40 +/- 6

Tip characteristics.

Radius of curvature - < 20nm
Tip height - 7 pm
Tip and cantilever side of chip are highly doped
with B (specific resistance = 0.0020hm/cm).
Tip and cantilever side of chip are coated with
W2C (specific resistance of film = 30pOhm/cm^)
Reflective side of cantilever is coated with Al.

Type 2.

Point probes
Nanosensors
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Germany.
Cantilever characteristics: Length (|im)- 219
Width

36-37

Thickness(iim) - 6.6 - 7.1
Resonant frequency (kHz) - 187 - 201

Tip characteristics;

Radius of curvature - 30nm
Height - 9}im

12. Filters

-

0.2pm cellulose nitrate membrane filters
Whatman International Ltd.
Maidstone,
England.
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2.1.2: Chemicals

Sigma Chemical Co.,

The following chemicals were obtained from

St Louis,
M063178,
USA
Acetone (hplc grade)
Hydrogen peroxide (H2O2)
Sodium acetate (NaC2H302)
Citric acid
Toluene
Polyoxyethylene sorbitan monolaurate (Tween 20)

BDH Chemicals Ltd.,

The following chemicals were obtained from

Poole,
England.
Potassium dichromate (K2Cr207)
Sulphuric acid (H2SO4)
Sodium hydroxide (NaOH)
Sodium carbonate (Na2C03)
Sodium bicarbonate (NaHC03)
Sodium dihydrogen orthophosphate (NaH2P04)
Disodium hydrogen phosphate (Na2HP04)
Hydrochloric acid (HCl)
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Magnesium chloride (MgCU)
BOC Gases Ireland Ltd.,

Nitrogen gas (N2) -

Little Island, Cork.

Boehringer Mannheim UK,

p-Nitrophenylphosphate -

Diagnostics and Biochemicals Ltd.
Bell Lane, Lewes,
East Sussex Bn7 ILG,

ABCR.,

n-Octadecyldimethylmethoxysilane

Karlsruhe,

(ODDMMS)

Scoomperlenstrasses.
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2.1.3: Buffers
(1) 0.05M phosphate buffered saline (PBS) buffer, pH 7.4. Dissolve 1.19g NaH2P04, 5.67g
Na2HP04 and 8.76g of NaCl. Make up to 1 litre. Adjust pH with 6M HCl/NaOH.

(2) O.OIM PBS buffer, pH 7.4. Dissolve 0.24g NaH2P04, 1.12g Na2HP04 and 8.76g of NaCl.
Make up to 1 litre. Adjust pH using 6M HCl/NaOH.

(3) 0.1M PBS buffer, pH 7.4. Dissolve 2.38g NaH2P04, 11.34g Na2HP04 and 8.76g of NaCl.
Make up to 1 litre. Adjust pH using 6M HCl/NaOH.

(4) 0. IM citrate acetate buffer, pH 5. Dissolve 6.8Ig citric acid and 5.29g sodium acetate.
Make up to 1 litre with dH20. Adjust pH using 6M HCl/NaOH.

(5) 0.2M citrate acetate buffer, pH 5. Dissolve 13.62g citric acid and 10.59g sodium acetate.
Make up to 1 litre with dH20. Adjust pH using 6M HCl/NaOH.

(6) 0.4M citrate acetate buffer, pH 5. Dissolve 27.24g citric acid and 21.18g sodium acetate.
Make up to 1 litre with dH20. Adjust pH with 6M HCl/NaOH.

(7) O.OIM sodium bicarbonate buffer, pH 9.6. Dissolve 0.672g NaHCOs and 0.21 g Na2C03.
Make up to 1 litre with dH20. Adjust pH with 6M HCl/NaOH.
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(8) 0.05M sodium bicarbonate buffer, pH 9.6. Dissolve 3.36g NaHCOs and 1.06g Na2C03.
Make up to 1 litre with dH20. Adjust pH with 6M HCl/NaOH.

(9) 0.IM sodium bicarbonate buffer pH 9.6. Dissolve 6.72g NaHCOs and 2.12g Na2C03.
Make up to 1 litre with dH20. Adjust pH with 6M HCl/NaOH.

(10) Substrate buffer. 0.05M sodium bicarbonate buffer pH 9.8 containing ImM MgCb.
Dissolve 3.1 Ig NaHCOs, 1.37g Na2C03 and 0.2g MgCb. Make up to 1 litre. Adjust
pH using 6M HCl/NaOH.

Wash solution/Phosphate buffered saline (0.1% v/v Tween 20) PBST
0.05M PBS buffer containing 0.1% Tween 20, pH 7.4. Dissolve 1.19g NaH2P04, 5.67g
Na2HP04and 8.76g of NaCl. Add 1ml of Tween 20. Make up to 1 litre dH20. Adjust pH
with 6M HCl/NaOH
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2.1.4: Immunoglobulins
Alkaline phosphatase conjugated goat anti-mouse
antibody

Sigma Chemical Co.,
St Louis,
M063178,
USA.

Biomerieux,

The following antibodies were supplied by

Lyon,
France.

monoclonal anti-hCG a + P, lot no. 19105196
monoclonal anti-hCG P alk. phos. conjugated, lot no. 364733
monoclonal anti-alpha-fetoprotein, lot no. 306654
monoclonal anti-alpha-fetoprotein alk. phos. conjugated lot no. 166304
monoclonal anti-ferritin lot no. 193326
monoclonal anti-ferritin alk. phos. conjugated, lot no. 4A511139

2.1.4: Antigens
Calbiochem Novabiochem U.K. Ltd.,

Human liver ferritin. Lot no. 405864

Boulevard Indl. Park,
Beston,
Nottingham NGS2Jk,
United Kingdom.
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Human alpha-fetoprotein . Lot no. 042125D

Behringwerke AG,
Marburg,
France.

Human chorionic gonadotrophin (hCG).

Sigma Chemical Co.
St Louis,
M063178,
USA
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2.2: Methods

2.2.1: Optimisation of the conditions for the adsorption of immunoreactants to
polystyrene and silicon
2.2.1.1: Biochemical detection of antibody on polystyrene surfaces
1. The wells of a microtitre plate were coated with lOOpl of antibody diluted in the selected
buffer*.
2. The microtitre plate was then washed 3 times with wash solution in an automated plate
washer.
3. The washed wells were incubated with lOOpl of the appropriate antigen serially diluted (1
in 2) in PBS for 1 hr. @ 37°C.
4

The wells were then washed with wash solution as described previously.

5.

lOOpl of Ipg of the appropriate alk. phos.-labelled anti-antigen per ml of PBST was then
added to each well. The plate was then incubated for Ihr. @ 37°C.

6. The microtitre plate was then washed 5 times with wash solution
7.

lOOpl of substrate buffer containing 2mg/ml of pNPP was pipetted into each well and the
plate was incubated for 30 mins. @ 37°C.

8. The absorbance of each well was read (5) 405nm.

''The antibody concentration, buffer composition and time and temperature of incubation are
defined under assay layout for each experiment in Section 3.

136

2.2.1.2: Biochemical detection of antigen on polystyrene surface
1. The wells of a microtitre plate were coated with antigen serially diluted 1 in 2 in the
selected buffer *
2. The microtitre plate was washed 3 times with wash solution in an automated plate washer.
3.

lOOpl of 0.5 pg of the appropriate alk. phos.-labelled antibody per ml of PBST was
pipetted into each well. The plate incubated for Ihr. @ 37°C.

4. The wells were then washed 5 times in wash solution.
5.

lOOpl of substrate buffer containing 2mg/ml of pNPP was pipetted into each well and the
plate incubated for 30 mins. @ 37°C.

6. The absorbance of each well was read (a), 405nm..

'’The antigen concentration, buffer composition and time and temperature of incubation are
defined under assay layout for each experiment in Section 3.

137

2.2.1.3: Sulfochromic acid cleaning of silicon wafers
This cleaning procedure was developed by Biomerieux, ENS, Lyon, France (Brite Euram 2,
project 8126)* and used in this investigation for cleaning silicon wafers prior to protein
adsorption. The cleaning solution was prepared by dissolving 2.8g of potassium dichromate
(K2Cr207) in lOOmls of distilled water (dH20). 58ml of sulphuric acid was slowly added to
the dissolved K2Cr207 in an ice bath. The wafers were then incubated in solution for 2 hours
at 120°C. Following incubation the cleaned wafers were washed thoroughly with dH20,
rinsed in acetone and dried under nitrogen gas (N2). This method allows the removal of the
organic contamination on the surface without damaging the oxide layer, this results in a slight
decrease in surface roughness. It leads to hydrophilic surfaces as it creates hydroxyl groups
on silica by opening siloxane bonds. Using surface analysis methods, i.e. ESC A, it has been
verified that the silica was not contaminated by chromium after sulfochromic acid treatment
and that carbon contamination was very low (5% atomic ratio)
* Coordinated by CIT Biophysics group.

2.2.1.4: Silanisation of silicon wafers
Following a sulfochromic acid wash (Section 2.2.3) cleaned silicon wafers were placed in 2%
(v/v) ODDMMS in toluene and incubated for 3 hours at room temperature. The wafers are
then removed from toluene and washed thoroughly in acetone, to remove weakly bound silane
molecules, before being dried under N2 gas.
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2.2.1.5: Biochemical detection of antibody on silanized silicon surface
1. Silanised silicon wafers (16mm x 16mm) were placed in a petri dish polished side faced
upwards in a moist environment.
2. 200|il of the antibody diluted in the selected buffer was pipetted onto the surface of each
wafer*.
3. Following antibody coating the silicon wafers were washed several times with wash
solution.
4.

ISOpl of alk. phos.-labelled anti-antibody (Ipg/ml) diluted in PBST was pipetted onto the
surface of each silicon wafer and the wafers incubated for 1 hour @ 37°C.

5. The silicon wafers were again washed several times with wash solution.
6. Following washing, the wafers are placed in 3 mis of substrate buffer containing 2mg/ml of
p-nitrophenylphosphate @ 37°C for 30 mins..
7. The wafers were then removed from the tubes. The contents of each tube was mixed
before transferring a 200p,l volume from each tube to a well of a microtitre plate.
8. The absorbance of each well was read @ 405nm.

'=The antibody concentration, buffer composition and time and temperature of incubation are
defined under assay layout for each experiment in Section 3.
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2.2.1.6: Biochemical detection of antigen on silanized silicon surface
1. Silanized silicon wafers (16mm x 16mm) were placed in a petri dish, polished side faced
upwards in a moist environment.
2. 200|il of the antigen appropriately diluted in the selected buffer was pipetted onto the
surface of each wafer*.
3. Following antigen coating the silicon wafers were washed several times with wash
solution.
4

ISOjil of the alk. phos.-labelled anti-antigen (Ipg/ml) diluted in PBST containing 10%
(v/v) horse serum was pipetted onto the surface of each silicon wafer and the wafers
incubated @ 37°C for 1 hour.

5. The silicon wafers were again washed several times with wash solution.
6. Following washing the wafers are placed in 3 mis of substrate buffer containing 2mg/ml of
p -nitrophenylphosphate @ 37°C for 30mins..
7. The wafers were then removed from the substrate buffer. The contents of each tube was
mixed before transferring a 200|il volume from each tube to a well of a microtitre plate.
8. The absorbance of each well was read @ 405nm.

'^The antigen concentration, buffer composition and time and temperature of incubation are
defined under assay layout for each experiment in Section 3.
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2.2.1.7: Experimental Strategy
The optimum conditions for the adsorption of the immunoreactants was determined for both
the silicon and polystyrene surfaces, by carrying each immunoreactant through a series of five
experiments for each surface. The optimum or selected condition for each step is carried
onto the proceeding step.

Step 1

Selection of a suitable immunoreactant concentration for adsorption to the
surface

Step 2

Optimisation of the time and temperature condition for immunoreactant
adsorption to the surface

Step 3

Optimisation of the buffer pH for adsorption to the surface

Step 4

Optimisation of the molarity of the buffer for immunoreactant adsorption to the
surface

4
Step 5

Optimisation of the ionic strength of the buffer for immunoreactant adsorption
to the surface

141

2.2.2: Estimation of anti-ferritin antibody coverage on silanised silicon wafers
Two parallel experiments with different coating versions (a and b) were performed for the
ferritin/antiferritin system.
1 a

The first series of cleaned, silanised silicon wafers were coated with 6p,l of a 2 fold
dilution series of lOOp-g anti-ferritin antibody per ml of 0.4M citrate acetate buffer.
The wafers were incubated @ 37°C for 1 hour.

1b

Another set of cleaned, silanised silicon wafers are coated with bpl of a 2 fold
dilution series of lOOpg anti-ferritin antibody per ml of 0.4M citrate acetate buffer
added with anti-alpha-fetoprotein antibody to a constant total of lOOpg/ml. The
wafers were incubated @ 37°C for 1 hour.

2

Both sets of wafers are washed with wash solution according to the following
protocol. 150pl of wash solution was pipetted into each well. The wash solution
was then aspirated from each well. This procedure was repeated twice before
transferring the washed wafers into a fresh set of microtitre wells.

3

bpl of a 1 pg ferritin standard per ml of 0.05M PBS, pH 7.4 was pipetted on to the
centre of all wafers. The wafers were incubated @ 37°C for 10 minutes.

4

The wafers were washed as described previously and transferred to a new set of
microwells

5

6pl of a 2.5pg anti-ferritin alk. phos. conjugated antibody per ml of 0.05M PBST
containing 10% horse serum was pipetted onto the centre of all wafers. The wafers
were incubated @ 37°C for 10 minutes.

6

The wafers were then washed 5 times as described in section 2.2.2.1. and transferred
to a new set of microwells.
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200|il of substrate buffer containing 2mg/ml of pNPP was pipetted into each of the
wells containing wafers. The plate was incubated for 2 hours @ 37°C. The wafers
were then removed from the microtitre wells, the contents of the wells were mixed
carefully before reading the absorbance @ 405nm.
Both antibody dilution series are plotted against absorbance @ 405nm on a single
chart . The antibody surface coverage can be calculated from the following formula.

Q(ng/cm^) = 10^ .

C.

Yb

■

Vf

(Esser,1988)

where Q = surface coverage of specific antibody (ng/cm^)
A = virtual concentration of specific antibody just large enough to give
maximum signal
— = ratio between the specific and the total concentration of antibodies
resulting in a surface density of specific antibodies just large enough to
give maximum signal.
V = volume of coating material (cm'^)
F = surface area of coated solid phase (cm^)
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2.2.3: Development and evaluation of a ferritin millispot ELISA
2.2.3.1: Millispot ELISA
1. 4x4 mm cleaned silanised silicon wafers were placed in the wells of a microtitre plate
with the polished side faced upwards.
2. 6pl of 7|ig anti-ferritin antibody per ml of 0.4M citrate acetate buffer, pH 5, was pipetted
onto the centre of the silicon wafer. The microtitre plate was then sealed with a self
adhesive sheet and incubated @ 37^C for 1 hour.
3. The silicon wafers were washed with wash solution as outlined in method 2.2.2 before
transferring the washed wafers into a fresh set of microtitre wells.
4. 6pl of the appropriated ferritin concentration, diluted in 0.05M PBS, was pipetted onto
the centre of the silicon wafer according to the scheme represented in figure 38. The
microtitre plate was then sealed and incubated for 10 mins. @ 37°C.
10
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Figure 38. Pipetting scheme. Pipette 6pl of the 500ng/ml calibrant on to the centre of wafers present in wells A1,A2&A3.
Pipette 6pl of the 2S0ng/ml calibrant on to wells B1,B2&B3. Continue the sequence adding 6pl of the 0 calibrant to wells
H1,H2&H3. Columns 4-12 inclusive represent vacant wells.
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5. The silicon wafers were washed as described previously and transferred to a fresh set of
microtitre wells.
6. 6}il of l.Opg/ml of anti-ferritin alk. phos. conjugated antibody diluted in PBST containing
10% horse serum was pipetted onto the centre of the silicon wafer. The microtitre plate
was then sealed and incubated for 10 mins. @ 37°C.
7. Following incubation the silicon wafers were washed as described previously increasing
the cycle number to 5. The washed wafers were transferred to a fresh set of wells.
8. 200jil of substrate buffer containing 2mg/ml of pNPP was pipetted into each of the wells
containing wafers. The plate was incubated for 2 hours @ 37°C. The wafers were then
removed from microtitre wells, the contents of the wells were mixed carefully before
reading the absorbance @ 405nm.
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2.2.3.2: Precision study
Within run precision
0.05M PBS, pH 7.4 was spiked with ferritin standard to give final ferritin concentrations of
250, 100 &17ng/ml. Each of these three samples were assayed 10 times according to method
2 2.3.1. The concentration of each replicate was determined from a calibration curve set up in
triplicate, as outlined in fig. 38, as part of the experiment. The mean concentration, standard
deviation (S.D.) and co-efficient of variation (C .V.%) was calculated for each of the three
samples and the results tabulated.

Precision profile
A ferritin calibration curve (7.8 - 500ng/ml) as outlined in fig. 38 was set up in replicate (n =
10). The mean absorbance, S.D. and C.V.% was calculated for each of the calibrants. The
results are plotted in graphical form consisting of plots of S.D. Vs ferritin cone, (ng/ml) and
C.V.% Vs ferritin cone, (ng/ml).
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2.2.3.3: Accuracy study
Recovery
A horse serum matrix was spiked with a constant minimum volume of ferritin standard to give
sample with a final ferritin concentration of 380, 150, 80 and 20 ng/ml. Each of these four
samples and an unspiked horse serum sample were assayed according to method 2.2.3.1. The
mean ferritin concentration of each sample was determined from a calibration curve (fig. 3 8)
set up in triplicate as part of the experiment. The % recovery was calculated for each sample
using the following equation.

[C] -

[A]

[^]

X

100

=

% recovery.

where [C] = measured ferritin concentration of spiked sample (ng/ml)
[B] = measured ferritin concentration of unspiked sample (ng/ml)
[A] = ferritin concentration added to spiked sample (ng/ml)

The results are presented in a table format.

Linearity and Parallelism
Patient samples with ferritin concentrations of 300, 180 and 58 ng/ml are diluted 1 in 2 in
horse serum. These dilution series are assayed in parallel with a ferritin calibration curve
(7.8ng - 500 ng/ml in 0.05M PBS, pH 7.4) (fig. 39) according to method 2.2.3.1.
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These dilution series are plotted on the same graph as calibration curve and we observe for
parallelism. The ferritin concentration of each of the dilution steps are determined from the
calibration curve (observed values). These observed values for each series subsequently
plotted against the expected ferritin concentrations in an x - y scatter plot and we observe for
linearity. The correlation coefficient for each dilution series is calculated.

2.2.3.4: Correlation study
37 patient samples are selected and the concentrations determined by both the millispot
ELISA and Fluorescent Immunoassay (used routinely in Cork University Hospital for the
determination of ferritin concentrations in serum samples). The results obtained by both
methods for each sample are paired and plotted on an x - y scatter plot.
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2,2.3.5: Sensitivity
A ferritin calibration curve was set up in replicate (n = 10). The mean absorbance of each of
the calibrants was plotted against the calibrant concentration. The S.D. of the absorbance
readings for the zero calibrant was calculated. The sensitivity of the assay was determined as
the concentration corresponding to an absorbance reading equal to the mean absorbance of the
zero calibrant plus 2.5 S.D. of the zero calibrant.
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2.2.4.I.: AFM Imaging.
The silicon wafers for imaging were attached to the sample stage with double sided adhesive
tape using a dedicated forceps. The AFM head was then placed over the sample stage. The
tip-cantilever system was manually lowered towards the surface of the sample using the
precision screws of the instrument. The resonant frequency of the cantilever was selected at
this point. The tip was subsequently allowed to approach the surface using the software of the
instrument. This software allows the tip to be lowered to a point were there is interactive
forces between the sample and tip surfaces without actually making physical contact, this
mode of imaging is known as non contact imaging. Non-contact imaging in ambient
conditions was used to acquire all the images presented in this investigation. The following
imaging parameters were selected to acquire the images:
Scanning speed - 13 pm/sec
Scan area - either 2.4 or 5pm^ (the scan area is given for each image in section 3)
Drive amplitude - 0.06 - O.OVvolts
Resolution - 300 points per line
The proportional, integral and derivative was adjusted and set to acquire stable
imaging.
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2.2.4.2: Preparation of Immunoreactant coated silicon wafers for AFM imaging
All glassware used in this method were pre-rinsed with h.p.l.c. grade acetone.
1. Silicon wafers (4 x 4mm) were cleaned in sulfochromic acid and silanised according to
method 2.2.1.3 and 2.2.1.4, respectively. The only modification being that the distilled
water, used to wash off the sulfochromic acid, was passed through a disposable 0.2nm
cellulose acetate filter.
2. The selected immunoreactant concentration was prepared in 0.2p.m filtered buffer. The
selected concentration, optimum time and temperature of incubation and optimum buffer
conditions are outlined for each immunoreactant in Table 7.
3. A 6pl volume of the diluted immunoreactant is pipetted onto silanised silicon wafers under
the optimum coating condition.
4. The coated wafers were then washed thoroughly with 0.2|j.m filtered PBST, rinsed in
0.2pm filtered dH20 and dried under N2.
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2.2.4.3: Detection of antigen on antibody coated silicon

1. Following antibody immobilisation on the silicon surface as described in section 2.2.4.1. a
preparation of the appropriated antigen is diluted in 0.2pm filtered, 0.05M PBS, pH 7.4.
2. A 6pl volume of the diluted antigen is pipetted onto the centre of the coated silicon wafer.
The wafers were incubated @ 37°C for 10 mins.
3. Wafers were then washed thoroughly with 0.2pm filtered PBST, rinsed in 0.2pm filtered
dH20 and dried under N2.

2.2.4.4: Optimization of anti-ferritin antibody coating concentration for adsorption to
silicon with a view to an AFM Immunoassay

1. A range of anti-ferritin antibody concentrations, 3.5 - 40pg per ml of 0.2pm filtered 0.4M
citrate acetate buffer, pH 5, was coated to cleaned silanised silicon wafers as described in
section 2.2.4.1.
2. Several 5pm^ areas of the silicon were imaged in non-contact mode. The optimum coating
concentration was determined on a combined morphological and surface roughness study of
the acquired images.
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2.2.4.5: Construction of a standard curve of ferritin concentration versus the number of
binding events
1. A 6}j,l volume of 14|ig/ml anti-ferritin antibody per ml of 0.2|im filtered, 0.4M citrate
acetate buffer, pH 5.0 was coated to silicon wafers as described in section 2.2.4.2.
2. The coated wafers were then washed thoroughly in 0.2|im filtered PBST, rinsed in 0.2|im
filtered dH20 and dried under N2.
3. A range of ferritin calibrants (7.8 - 500ng/ml) were prepared in 0.2|im filtered 0.05M PBS,
pH 7.4.
4. The silicon wafers were then placed into wells of microtitre plate. A 275 pi volume of the
ferritin calibrants is then added to each wafer containing microwell. The wafers were
incubated @ 37°C for 10 minutes.
5. The wafers are then washed thoroughly in 0.2pm filtered wash solution, rinsed in 0.2pm
filtered dH20 and dried under N2.
6. Each wafer was then imaged by the AFM as described in section 2 2.4.1.
7. The number of binding events per unit area is then plotted against ferritin concentration.
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Results

3.1. Optimisation of the conditions for the adsorption of immunoreactants to
polystyrene and silanised silicon surfaces.

Section 3.1 represents the results attained for the adsorption of the different
immunoreactants to both the polystyrene and silanised silicon surfaces. The optimum
conditions were attained in each case by carrying the protein through an experimental
setup which involved five steps.

Step 1

Selection of a suitable immunoreactant concentration for adsorption to
the surface.

Step 2

Optimisation of the time and temperature condition for immunoreactant
adsorption to the surface.

Step 3

Optimisation of the buffer pH for adsorption to the surface.

4
Step 4

Optimisation of the molarity of the buffer for immunoreactant
adsorption to the surface.

4
Step 5

Optimisation of the ionic strength of the buffer for immunoreactant
adsorption to the surface.

The selected/optimum conditions at each step was carried forward to the next step. A
precision study was then performed for each protein under the optimum conditions.
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3.1.1: Optimisation of anti-ferritin antibody adsorption to polystyrene.
3.1.1.1: Selection of suitable anti-ferritin antibody concentration for adsorption to
polystyrene.
Assay layout
1. Range of anti-ferritin antibody concentrations: 20, 10 and 5|j.g/ml (n=3)
2. Ferritin (500ng/ml) serially diluted 1 in 2 on plate
3. Anti-ferritin antibody alk.phos. conjugate 1/1000 dilution for Ihr @ 37°C.

- 2(X^ni; —lOi^rri;

Sug'rri

Figure 40. Selection of a suitable anti-ferritin antibody concentration for adsorption to polystyrene.

Interpretation: A ferritin antibody concentration of lOpg/ml is considered suitable.
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3.1.1.2: Optimisation of the time and tempetature condition for anti-ferritin antibody
adsorption to polystyrene.
Assay layout
1) Anti-ferritin antibody lOpg/ml is coated to the wells of a microtitre plate at:
(a) 2 different time periods: 2 & 16hrs, (n=3).
(b) 2 different temperatures: 4 & 37°C, (n=3).

-4°C10ts! -♦-4C2hrsi

-k-37°C2ts

Figure 41. Optimisation of the time and temperature condition for ferritin antibody adsorption to
polystyrene

Interpretation: An incubation condition of 4®C for 2 hours is considered optimum.
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3.1.1.3: Optimisation of pH for anti-ferritin antibody adsorption to polystyrene
Assay layout
Anti ferritin antibody (lOpg/ml) is coated @4°C for 2hrs to wells of a microtitre plate in 3
different buffers:
(1) 0.20M citrate acetate, pH 5, (n=4).
(2) 0.05M phosphate buffered saline (PBS), pH 7.4, (n=4)
(3) 0.05M sodium bicarbonate, pH 9.6, (n=4).

pH5; -«-pH7.4; -:*-pH9.6

Figure 42. Optimisation of pH for anti-ferritin antibody adsorption to polystyrene.

Interpretation: A pH of 5 is considered optimum.
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3.1.1.4: Optimisation of the buffer for anti-ferritin antibody adsorption to polystyrene
Assay layout
Anti-ferritin antibody (1 Opg/ml) coated to wells @ 4°C for 2hrs in 3 different buffer systems:
(a) O.IM citrate acetate, (n=4).
(b) 0.2M citrate acetate, (n=4).
(c) 0.4M citrate acetate, (n=4).

■0.1M;-»-0.2M;-4-0.4M
25 T

2-

c 15
lO

o

(A

n

<

1

0.5-

100

10

Ferritin cone, (ng/ml)

Figure 43. Optimisation of the buffer for anti-ferritin antibody adsorption to polystyrene.

Interpretation: A 0.4M citrate acetate buffer is considered optimum.
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1000

3.1.1.5: Optimisation of the ionic strength for the adsorption of anti-ferritin antibody to
polystyrene
Assay layout
Anti-ferritin antibody (lOfig/ml) coated for 2hrs @ 4°C in 4 different systems:
(a) 0.4M citrate acetate, (n=3)
(b) 0.4M citrate acetate (containing O.IM NaCl), (n=3).
(c) 0.4M citrate acetate (containing 0.5M NaCl), (n==3).
(d) 0.4M citrate acetate (containing l.OMNaCl), (n=3).

|-»-0M NaCl -*-0.1M NaCl -*-0. 5M NaCl -x-1. OM NaCl

Figure 44. Optimisation of the ionic strength for anti-ferritin antibody adsorption to polystyrene

Interpretation: A 0.4M citrate acetate buffer containing OM NaCl was selected.
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3.1.1.6: Precision study.
Assay layout
Ferritin antibody is coated to polystyrene in 0.4M citrate acetate buffer for 2hrs @ 4°C, (n=10).

Figure 45. Precision profile.
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3.1.2: Optimisation of anti-alpha-fetoprotein antibody adsorption to
polystyrene
3.1.2.1: Selection of suitable anti-alpha-fetoprotein antibody concentration for adsorption
to polystyrene
Assay layout
1. Range of anti-alpha-fetoprotein antibody concentrations: 10, 2.5 and 1.25p.g/ml (n=3)
2. Alpha-fetoprotein (640ng/ml) serially diluted 1 in 2 on plate
3. anti-alpha-fetoprotein alk.phos. conjugate 1/10000 dilution for Ihr @ 37°C.

10ug/ml; -•-2.5ug/ml; -^1.25ug/mll

Figure 46. Selection of suitable alpha-fetoprotein antibody concentration for adsorption to polysty rene.

Interpretation: An anti-alpha-fetoprotein concentration of 1.25|j,g/ml is considered suitable.
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3.1.2.2: Optimisation of the time and tempetature condition for anti-alpha-fetoprotein
antibody adsorption to polystyrene
Assay layout
1) Anti-alpha-fetoprotein antibody (1.25|j.g/ml) is coated to the wells of a microtitre plate
at;
(a) 2 different time periods; 2 & 16hrs, (n=3)
(b) 2 different temperatures; 4 & 37°C, (n=3)

-4°C16hrs; -^-4°C2hrs; -*-37°C16hrs; -»<-37°C2hrs

Figure 47. Optimisation of the time and temperature condition for anti-alpha-fetoprotein antibody
adsorption to polystyrene.

Interpretation: An incubation condition of 4^C for 2hours was selected.

163

3.1.2.3: Optimisation of pH for anti-alpha-fetoprotein antibody adsorption to polystyrene
Assay layout
Anti-alpha-fetoprotein antibody (1.25jj.g/ml) is coated @ 4°C for 2hrs to wells of a microtitre
plate in 3 different buffers:
(1) 0.20M citrate acetate, pH 5, (n=4)
(2) 0.05M Phosphate Buffered Saline (PBS), pH 7.4, (n=4)
(3) 0.05M sodium bicarbonate, pH 9.6,(n=4)

pH5: -»-pH74; -^pH9.6

Figure 48. Optimisation of pH for anti-alpha-fetoprotein antibody adsorption to polystyrene.

Interpretation: A buffer pH of 5 is considered an optimum
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3.1.2.4: Optimisation of the molarity of buffer for anti-alpha-fetoprotein antibody
adsorption to polystyrene.
Assay layout
Anti-alpha-fetoprotein antibody (1.25|j,g/ml) coated to wells @ 4°C for 2hrs in 3 different buffer
systems:
(a) O.IM citrate acetate, (n=4).
(b) 0.2M citrate acetate, (n=4).
(c) 0.4M citrate acetate, (n=4).

-0.1I\/I;-»-0.2M;-a-0.4I\^

Figure 49. Optimisation of the molarity of buffer for anti-alpha fetoprotein antibody adsorption to
polystyrene.

Interpretation: : A O.IM citrate acetate buffer was selected.
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3.1.2.5: Optimisation of the ionic strength for the adsorption of anti-alpha-fetoprotein
antibody to polystyrene.
Assay layout
Anti-alpha-fetoprotein antibody (1.25fj,g/nil) coated for 2hrs @ 4°C in 4 different systems:
(a) 0. IM citrate acetate (n=3).
(b) O.IM citrate acetate (containing O.IM NaCl); (n=3).
(c) 0. IM citrate acetate (containing 0.5M NaCl); (n=3).
(d) 0. IM citrate acetate (containing 1 OM NaCl); (n=3).

-OM NaCl; -*-0.1 M NaCl; -^0.5M NaCl; -k-1 .OM NaCl

Figure 50. Optimisation of the ionic strength for alpha-fetoprotein antibody adsorption to polystyrene

Interpretation: A 0. IM citrate acetate buffer containing OM NaCl is considered optimum.
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3.1.2.6: Precision study
Assay layout
Anti-alpha-fetoprotein antibody is coated to polystyrene in 0. IM citrate acetate buffer for 2hrs
4°C (n=10).

Figure 51. Precision profile
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3.1.3:

Optimisation of anti-hCG antibody adsorption to polystyrene

3.1.3.1: Selection of suitable anti-hCG antibody concentration for adsorption to
polystyrene
Assay layout
1

Range of anti-hCG antibody concentrations: 10, 1 and 0.5pg/ml;(n = 3).

2. hCG standard serially diluted 1 in 2 on plate.
3. anti-hCG alk. Phos. conjugate (1/10000 dilution) incubated for Ihr @ 37 C.

1(XQ/rT^;

1 ug/ml;

06ug/ni

2 ---1.8-

1.6-

1.4-

£1.2-^

o

@)

1

A

< 0.8

0.6

0.4

0.2

10

100

1000

hCG cone, (ng/ml)

Figure 52. Selection of suitable anti-hCG antibody concentration for adsorption to polysty rene

Interpretation: An anti -hCG concentration of Ipg/ml is considered suitable.
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3.1.3.2: Optimisation of the time and temperature conditions for anti-hCG antibody
adsorption to polystyrene
Assay layout
1) anti-hCG antibody (1 pg/ml) is coated to the wells of the microtitre plate at . (a) 2 different time periods: 2 & 16hrs; (n=3)
(b) 2 different temperatures: 4 & 37°C; (n=3)

-4° C16hrs: -i-4°C2hrs; -^37°C 16hrs; -^37°C2t^

Figure 53. Optimisation of the time and temperature conditions anti-hCG antibody adsorption.

Interpretation: An incubation condition of 4^C for Ibhours is the optimum.
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3.1.3.3: Optimisation of pH for hCG antibody adsorption to polystyrene
Assay layout
Anti-hCG antibody (1 |ag/nil) is coated @ 4°C for 16hrs to wells of the microtitre plates in 3
different buffers:
(1) 0.20M citrate acetate, pH 5; (n=4)
(2) 0.05M Phosphate Buffered Saline (PBS), pH 7.4; (n=4)
(3) 0.05M sodium bicarbonate, pH 9.6, (n=4)

■pH5i -^-pH 7.4;-A-pH 9.6

Figure 54. Optimisation of pH for anti-hCG antibody adsorption to polystyrene.

Interpretation: A pH of 9.6 is considered the optimum.
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3.1.3.4: Optimisation of the molarity of buffer for anti-hCG antibody adsorption to silicon
Assay layout
Anti-hCG antibody (l|ig/ml) coated to wells @ 4°C for 16hrs in 3 different buffer systems;
(a) 0.02M sodium bicarbonate buffer, (n=4).
(b) 0.05M sodium bicarbonate buffer, (n=4).
(c) 0. lOM sodium bicarbonate buffer, (n=4).

-0.02M;-»-0.05M:

0.1M|

Figure 55. Optimisation of molarity of buffer for hCG antibody adsorption to polysty rene

Interpretation: : A 0.05M sodium bicarbonate buffer is considered suitable.
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3.1.3.5: Optimisation of the ionic strength for the adsorption of anti-hCG antibody to
polystyrene.
Assay layout
Anti-hCG antibody (Ipg/ml) coated for 16hrs @ 4°C in 4 different systems:
(a) 0.05M sodium bicarbonate, (n=3).
(b) 0.05M sodium bicarbonate (containing O.IM NaCl), (n=3).
(c) 0.05M sodium bicarbonate (containing 0.5M NaCl), (n=3).
(d) 0.05M sodium bicarbonate (containing l.OM NaCl), (n=3).

'OM NaCl; -»-0.1 M NaCl; -*-0.5M NaCl; -x-1 OM NaCl

Figure 56. Optimisation of the ionic strength for anti-hCG antibody adsorption to polystyrene.

Interpretation: A 0.05M sodium bicarbonate buffer containing OM NaCl was selected.
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3.1.3.6: Precision study
Assay layout
Anti-hCG antibody is coated to polystyrene in 0,05M sodium bicarbonate buffer for 16hrs @ rC
(n=10)

Figure 57. Precision profile
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3.1.4: Optimisation of the conditions for the adsorption of ferritin to
polystyrene.
3.1.4.1: Selection of suitable concentration for ferritin adsorption to polystyrene
Assay layout
(a) Range of ferritin concentrations - 1, 0.5, 0.4 & 0.25 ^ig/ml (n = 3). Each was serially diluted
1 in 2 on the microtitre plate.
(b) Anti-ferritin antibody alk.phos. conjugate (1/1000 dilution).

1 OOOng/ml;500ng/ml

400ng/ml; -^250ng/ml

Figure 58. Selection of suitable ferritin concentration for adsorption to polystyrene

Interpretation: A ferritin concentration of 500ng/ml is considered suitable
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3.1.4.2: Optimisation of the time and temperature condition for ferritin adsorption to
polystyrene.
Assay layout
(a) Ferritin (500ng/ml) was serially diluted 1 in 2 on microtitre plate
(b) Incubate at (1) 2 different time periods; 2 & 16hrs, (n=3).
(2) 2 different temperature; 4 & 37°C,(n=3).

-4°C16hrs; HK-4‘’C2hrs; -a-37°C 16hrs; ->(-37°C2hrs|

Figure 59. Optimisation of the time and temperature eondition for ferritin adsorption to polystyrene

Interpretation! An incubation condition of 37 C for 16hours is considered the optimum
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3.1.4.3: Optimisation of the pH for ferritin adsorption to polystyrene.
Assay layout
Ferritin is adsorbed to polystyrene @ 37°C for 16hrs in 3 different buffer systems
(a) 0.2M citrate acetate, pH 5, (n=4).
(b) 0.05M Phosphate Buffered Saline (PBS), pH 7.4, (n=4).
(c) 0.05M sodium bicarbonate, pH 9.6, (n=4).

■pH 5; -•-pH7.4; -4-pH 9.6

Figure 60. Optimisation of the pH for ferritin adsorption to polystyrene.

Interpretation: A pH of 7.4 is considered the optimum.
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3.1.4.4: Optimisation of the molarity of the buffer for the adsorption of ferritin to
polystyrene
Assay layout
Ferritin (500ng/ml) serially diluted was adsorbed to polystyrene @ 37°C for 16hrs in 3 different
buffer systems:
(a) O.OIMPBS, (n=4).
(b) 0.05M PBS, (n=4).
(c) O.IOM PBS, (n=4).

-0. 01M; -►-O 05M; -a-0. 10M

Figure 61. Optimisation of the molarity of buffer for ferritin adsorption to polystyrene

Interpretation: : A 0.05M phoshate buffered saline buffer, pH 7.4, is considered optimum.
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3.1.4.5: Optimisation of ionic strength for ferritin adsorption to polystyrene
Assay layout
Ferritin 500ng/ml serially diluted was adsorbed to polystyrene @ 37°C for 16hrs in 4 different
buffer systems:
(a) 0.05M PBS, (n=3)
(b) 0.05M PBS containing O.IM NaCl, (n=3).
(c) 0.05M PBS containing 0.5M NaCl, (n=3).
(d) 0.05M PBS containing l .OM NaCl, (n=3).

-OM NaCl: -i-0.1M NaCl: -A-0.5M NaCl: -x-1 OM NaCl

Figure 62. Optimisation of the ionic strength for ferritin adsorption to polystyrene

Interpretation: A 0.05M phosphate buffered saline containing 1 OM NaCl is considered
suitable.
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3.1.4.6: Precision study
Assay layout
Ferritin (500ng/ml) serially diluted was adsorbed to polystyrene @ 37°C for 16hrs in 0.05M PBS
containing IMNaCl

Figure 63. Precision profile
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3.1.5: Optimisation of the adsorption of alpha-fetoprotein to polystyrene.
3.1.5.1: Selection of a suitable concentration for alpha-fetoprotein adsorption to
polystyrene.
Assay layout
(a) Range of alpha-fetoprotein concentration - 1280, 640, 320 & 160 ng/ml (n = 3). Each was
serially diluted 1 in 2 microtitre plate.
(b) Anti-alpha-fetoprotein alk. Phos. conjugate (1/1000 dilution).

1.280 ng/ml aFP; -■-640 ng/ml aFP;

10

320 ng/ml aFP; -^1 60 ng/ml aFP

100

1000

10000

Alpha-fetoprotein cone, (ng/ml)

Figure 64. Selection of suitable alpha-fetoprotein concentration for adsorption to polystyrene.

Interpretation: An alpha fetoprotein concentration of 640ng/ml is considered suitable.
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3.1.5.2: Optimisation of the time and temperature condition for alpha-fetoprotein
adsorption to polystyrene.
Assay layout
(a) Alpha-fetoprotein (640ng/ml) is serially diluted 1 in 2 on the microtitre plate.
(b) Incubate at (1) 2 different time periods; 2 & 16hrs, (n=3).
(2) 2 different temperatures: 4 & 37°C, (n=3).

■4°C 16hrs; -*-4°C2hrs; -^37‘’C 16hrs; -)t-37°C2hrs

Figure 65. Optimisation of the time and temperature condition for alpha-fetoprotein adsorption to
polystyrene.

Interpretation: An incubation condition of 37®C for Ibhours is considered an optimum.
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3.1.5.3: Optimisation of the pH for alpha-fetoprotein adsorption to polystyrene.
Assay layout
Alpha-fetoprotein is adsorbed to polystyrene @ 37°C for 16hrs in 3 different buffer systems:
(a) 0.2M citrate acetate, pH 5, (n=4).
(b) 0.05M sodium bicarbonate, pH9.6, (n=4).
(c) 0.05M phosphate buffered saline, pH 7.4, (n=4).

■pH5;-i-pH7.4:-4-pH9.6

Figure 66. Optimisation of the pH for alpha-fetoprotein adsorption to polystyrene.

Interpretation: A pH of 5 is considered optimum.
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3.1.5.4: Optimisation of the molarity of the buffer for the adsorption of alpha-fetoprotein
to polystyrene.
Assay layout
Alpha-fetoprotein (640ng/ml) serially diluted was adsorbed to polystyrene @ 4°C for 16hrs in 3
different buffer systems;
(a) 0. IM citrate acetate, (n=4).
(b) 0.2M citrate acetate, (n=4).
(c) 0.4M citrate acetate, (n=4).

Figure 67. Optimisation of the molarity of the buffer for alpha-fetoprotein adsorption to polystyrene.

Interpretation: : A 0.4M citrate acetate buffer, pH 5, is considered optimum.
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3.1.5.5: Optimisation of ionic strength for alpha-fetoprotein adsorption to polystyrene
Assay layout
Alpha-fetoprotein (640ng/ml) serially diluted was adsorbed to polystyrene @ 4°C for 16hrs in 4
different buffer systems:
(a) 0.4M citrate acetate, (n=3).
(b) 0.4M citrate acetate containing O.IM NaCl, (n=3).
(c) 0.4M citrate acetate containing 0.5M NaCl, (n=3).
(d) 0.4M citrate acetate containing 1 OM NaCl, (n=3).

-OM NaCl

0.1M NaCl;0.5M NaCl;-X-1. OM NaCi

Figure 68. Optimisation of the ionic strength for alpha-fetoprotein adsorption to polystyrene

Interpretation: A 0.4M citrate acetate buffer containing OM NaCl is considered suitable.
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3.1.5.6:Precision study.
Assay layout
Alpha-fetoprotein (640ng/nil) is adsorbed to polystyrene @ 4°C for 16hrs in 0.4M citrate acetate.

Figure 69. Precision profile.
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3.1.6: Optimisation of the adsorption of hCG to polystyrene.
3.1.6.1: Selection of a suitable concentration for hCG adsorption to polystyrene.
Assay layout
(a) Range of hCG concentrations 2000 1000, 500 & 250 ng/ml (n = 3). Each was serially
diluted 1 in 2 on microtitre plate.
(b) Anti-hCG antibody alk. Phos. conjugate 1/1000 dilution

2,000 ng/ml;

1,000ng/ml;

500 ng/ml; -^250 ng/ml

Figure 70. Selection of a suitable hCG concentration for adsorption to polystyrene.

Interpretation: A hCG concentration of Igg/ml is considered suitable.
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3.1.6.2; Optimisation of the time and temperature condition for hCG adsorption to
polystyrene.
Assay layout
(a) hCG (Ijig/ml) is serially diluted 1 in 2 on microtitre plate.
(b) Incubate at (1) 2 different time periods: 2 & 16hrs, (n=3).
(2) 2 different temperature: 4 & 37°C, (n=3).

4°C 16hrs: -i-4°C2hrs: -k-37°C 16hrs: ^(-37°C2hrs

Figure 71. Optimisation of the time and temperature condition for hCG adsorption to polystyrene

Interpretation: An incubation condition of 37^C for 2hours is considered optimum
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3.1.6.3: Optimisation of the pH for hCG adsorption to polystyrene.
Assay layout
hCG is adsorbed to polystyrene @ 37°C for 2hrs in 3 different buffer systems:
(a) 0.2M citrate acetate, pH 5, (n=4).
(b) 0.05M sodium bicarbonate, pH 9.6, (n=4).
(c) 0.05M phosphate buffered saline, pH 7.4, (n=4).

pH 5;pH 7.4;-^-pH 9.6

Figure 72. Optimisation of the pH for hCG adsorption to polystyrene

Interpretation: A pH of 7.4 is considered optimum
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3.1.6.4: Optimisation of the molarity of the buffer for the adsorption of hCG to
polystyrene.
Assay layout
hCG is adsorbed to polystyrene @ 37°C for 2hrs in 3 different buffer systems:
(a) O.OIM PBS, (n=4).
(b) 0.05M PBS, (n-4).
(c) O.IOM PBS, (n=4).

-0.01 M; H^-0.05M; -*-0.1 OM

Figure 73. Optimisation of the molarity of buffer for hCG adsorption to polystyrene.

Interpretation: : A 0.05M phosphate buffered saline buffer, pH 7.4, is considered suitable.
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3.1.6.5: Optimisation of ionic strength for hCG adsorption to polystyrene.
Assay layout
hCG l|j.g/ml is adsorbed to polystyrene @ 37°C for 2hrs in 4 different buffer systems:
(a) 0.05M PBS, (n=3).
(b) 0.05M PBS containing 0.IM NaCl, (n=3).
(c) 0.05M PBS containing 0.5M NaCl, (n=3).
(d) 0.05M PBS containing l.OM NaCl, (n=3).

■OM NaCl; HH-0.1M NaCl; -^0. 5M NaCl: -)f-1. OM NaCl

Figure 74. Optimisation of the ionic strength for hCG adsorption to polystyrene.

Interpretation; A 0.05M phosphate buffered saline containing OM NaCl was selected.
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3.1.6.6: Precision study.
Assay layout
hCG is adsorbed to polystyrene @ 37°C for 2 hrs in 0.05M PBS buffer.

14-r

—J

!

n
i

12

i
i
1

i

10

8

j
___

i

>
d
'i

j
■
n

1

—

10

w

hCGconc. (ng/ml)

Figure 75. Precision profile.
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3.1.7: Optimisation of the conditions for ferritin antibody adsorption to
silicon.
3.1.7.1: Selection of a suitable ferritin antibody concentration for adsorption to silicon.
Assay layout
(a) Range of ferritin antibody concentrations:- 30, 15, 5 & 0|ig/ml, (n = 3).
(b) Ferritin antibody detected directly on surface with goat anti -mouse alk. phos.
conjugate antibody at 1/1000 dilution.
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Figur? 76. Selection of suitable anti-ferritin antibody concentration for adsorption to silicon.

Inteipretation: A ferritin concentration of Spg/ml is considered suitable.
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3.1.7.2: Optimisation of the time and temperature conditions for ferritin antibody
adsorption to silicon.
Assay layout
(a) Anti-ferritin antibody (5pg/ml) is adsorbed onto silicon for
(1)2 different time periods: 2 & 16hrs, (n=3).
(2) 2 different temperatures: 4 & 37°C, (n=3).
(b) Anti-ferritin antibody directly detected with goat anti-mouse alk. phos. conjugated antibody.
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Figure 77. Optimisation of the time and temperature condition for ferritin antibody adsorption to silicon.

Interpretation: An incubation condition of 37®C for 2hours is considered optimum.
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3.1.7,3: Optimisation of the pH conditions for anti-ferritin antibody adsorption to silicon
Assay layout
Anti-ferritin antibody (5pg/ml) is adsorbed onto silicon for 2hrs at 37°C using 3 different buffer
systems:
(1) 0.2M citrate acetate, pH 5, (n=4).
(2) 0.05M PBS, pH 7.4, (n=4).
(3) 0.05M sodium bicarbonate, pH 9.6,(n=4).
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Figure 78. Optimisation of the pH conditions for anti-ferritin antibody adsorption to silicon.

Interpretation: A pH of 5 is considered optimum.
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3.1.7.4: Optimisation of the molarity of the buffer for anti-ferritin antibody adsorption to
silicon
Assay layout
Anti-ferritin antibody (5|j.g/ml) is adsorbed @ 37°C for 2hrs using 3 different buffer systems:
(a) O.IM citrate acetate, pH 5, (n=4).
(b) 0.2M citrate acetate, pH 5, (n=4).
(c) 0.4M citrate acetate, pH 5, (n=4).
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Figure 79. Optimisation of the molarity of buffer for anti-ferritin antibody adsorption to silicon.

Interpretation: : A 0.4M citrate acetate buffer , pH 5, is considered suitable.
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3.1.7.5: Optimisation of the ionic strength of the buffer for anti-ferritin antibody
adsorption to silicon
Assay layout
Anti-ferritin antibody (5|ig/ml) is adsorbed @ 37°C for 2hrs using 3 different buffer systems:
(a) 0.4M citrate acetate, pH 5, (n=3).
(b) 0.4M citrate acetate, pH 5, containing 0. IM NaCl, (n=3).
(c) 0.4M citrate acetate, pH 5, containing 0.5M NaCl, (n=3).
(d) 0.4M citrate acetate, pH 5, containing l .OM NaCl, (n=3).
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Figure 80. Optimisation of the ionic strength of buffer for anti-ferritin antibody adsorption to silicon.

Interpretation: A 0.4M citrate acetate buffer containing OM NaCl is considered optimum.
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3.1.7.6: Precision study
Assay layout
Anti-ferritin antibody (5txg/ml) is adsorbed onto silicon @ 37°C for 2hrs in 0.4M citrate acetate
buffer, pH 5, (n = 14).
Mean absorbance = 0.61
S.D. =0.08
CV% = 13
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3.1.8: Optimisation of the conditions for adsorption of anti-alpha-fetoprotein
antibody to silicon
3.1.8.1: Selection of a suitable anti-alpha-fetoprotein antibody concentration for
adsorption to silicon.
Assay layout
(a) Range of anti-alpha-fetoprotein antibody concentrations;- 10, 2, 1 & 0.5 pg/ml (n == 3)
(b) anti-alpha-fetoprotein antibody detected directly on surface with goat anti-mouse
alk.phos. conjugated antibody.
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Figure 81. Selection of suitable alpha-fetoprotein antibody concentration for adsorption to silicon.

Interpretation: An alpha fetoprotein concentration of 2pg/ml is considered suitable.
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3.1.8.2: Optimisation of the time and temperature condition for anti-alpha-fetoprotein
antibody adsorption to silicon
Assay layout
(a) Anti-alpha-fetoprotein antibody (2|j,g/ml) is adsorbed onto silicon for
(1)2 different time periods: 2 & 16hrs (n==3)
(2) 2 different temperatures: 4 & 37°C (n==3)
(b) Anti-alpha-fetoprotein antibody directly detected with goat anti-mouse alk. phos. conjugated
antibody.
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Figure 82. Optimisation of the time and temperature condition for alpha-fetoprotein antibody adsorption.

Interpretation: An incubation condition of 37^C for 2hours is considered optimum.
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3.1.8.3: Optimisation of the pH condition for anti-alpha-fetoprotein antibody adsorption
to silicon
Assay layout
Anti-alpha-fetoprotein antibody (2pg/ml) is adsorbed onto silicon for 2hrs at 37°C using 3
different buffer systems:
(1) 0.2M citrate acetate, pH 5, (n=4).
(2) 0.05M PBS, pH 7.4, (n=4).
(3) 0.05M sodium bicarbonate, pH 9.6, (n=4).

0.62

Figure 83. Optimisation of the pH condition for alpha-fetoprotein adsorption to silicon.

Interpretation: A pH of 5 is considered optimum.
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3.1.8.4: Optimisation of the molarity of the buffer for anti-alpha-fetoprotein antibody
adsorption to silicon
Assay layout
Anti-alpha-fetoprotein antibody (2pg/ml) is adsorbed @ 37°C for 2hrs using 3 different buffer
systems;
(a) O.IM citrate acetate, pH 5, (n=4).
(b) 0.2M citrate acetate, pH 5, (n=4).
(c) 0.4M citrate acetate, pH 5, (n=4).
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Figure 84. Optimisation of the molarity of buffer for anti-alpha-fetoprotein antibody adsorption.

Interpretation: : A 0.2M citrate acetate buffer, pH 5, is considered optimum.
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3.1.8.5: Optimisation of the ionic strength of the buffer for anti-alpha-fetoprotein antibody
adsorption to silicon.
Assay layout
Anti-alpha-fetoprotein antibody (2|j.g/ml) is adsorbed @ 37°C for 2hrs using 3 different buffer
systems:
(a) 0.2M citrate acetate, pH 5, (n=3).
(b) 0.2M citrate acetate, pH 5, containing 0. IM NaCl, (n=3).
(c) 0.2M citrate acetate, pH 5, containing 0.5M NaCl, (n=3).
(d) 0.2M citrate acetate, pH 5, containing l .OM NaCl, (n=3).
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Figure 85. Optimisation of the ionic strength of buffer for alpha-fetoprotein antibody adsorption to silicon.

Interpretation: A 0.2M citrate acetate buffer containing OM NaCl is considered optimum.
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3.1.8.6: Precision study
Assay layout
Anti-alpha-fetoprotein antibody (2jj,g/ml) is adsorbed onto silicon @ 37°C for 2hrs in 0.2M
citrate acetate buffer, pH 5.
(n=14).
Mean absorbance = 1.08.
S.D. =0.141.
C.V/% = 13.
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3.1.9: Optimisation of the conditions for anti-hCG antibody adsorption to
silicon.
3.1.9.1: Selection of a suitable anti-hCG antibody concentration for adsorption to silicon.
Assay layout
(a) Range of hCG antibody concentrations:- 20, 10, 5 & 0 jig/ml (n = 3)
(b) hCG antibody detected directly on surface with goat anti-mouse alk. phos. conjugated
antibody.
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Figure 86. Selection of suitable anti-hCG antibody concentration for adsorption to silicon.

Interpretation: A hCG concentration of 20pg/ml is considered suitable.
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3.1.9.2: Optimisation of the time and temperature conditions for anti-hCG antibody
adsorption to silicon.
Assay layout
(a) anti-hCG antibody (20|j.g/ml) is adsorbed onto silicon for
(1)2 different time periods: 2 & 16hrs (n=3)
(2) 2 different temperatures: 4 & 37°C (n=3)
(b) anti-hCG antibody directly detected with goat anti-mouse alk. phos. conjugated antibody
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Figure 87. Optimisation of the time and temperature condition for anti-hCG antibody adsorption.

Interpretation: An incubation condition of 37®C for 2hours is considered optimum.
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3.1.9.3: Optimisation of the pH condition for anti-hCG antibody adsorption to silicon
Assay layout
Anti-hCG antibody (20|j.g/ml) is adsorbed onto silicon for 2hrs at 37°C using 3 different buffer
systems:
(1) 0.2M citrate acetate, pH 5, (n=4).
(2) 0.05M PBS, pH 7.4, (n=4).
(3) 0.05M sodium bicarbonate, pH 9.6, (n=4).
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Figure 88. Optimisation of the pH condition for anti-hCG antibody adsorption to silicon

Interpretation: A pH of 5 is considered optimum.
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3.1.9.4: Optimisation of the molarity of the buffer for anti-hCG antibody adsorption to
silicon.
Assay layout
Anti-hCG antibody (20|j,g/ml) is adsorbed @ 37°C for 2hrs using 3 different buffer systems;
(a) O.IM citrate acetate, pH 5, (n=4).
(b) 0.2M citrate acetate, pH 5, (n=4).
(c) 0.4M citrate acetate, pH 5, (n=4).
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Figure 89. Optimisation of the molarity of buffer for anti-hCG antibody adsorption to silicon.

Interpretation: : A O.IM citrate acetate buffer, pH 5, is considered optimum.
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3.1.9.5: Optimisation of the ionic strength of the buffer for anti-hCG antibody adsorption
to
silicon.
Assay layout
Anti-hCG antibody (20jig/ml) is adsorbed @ 37°C for 2hrs using 4 different buffer systems;
(a) O.IM citrate acetate, pH 5 (n=3).
(b) 0. IM citrate acetate, pH 5 containing 0. IM NaCl, (n=3).
(c) O.IM citrate acetate, pH 5 containing 0.5M NaCl, (n=3).
(d) O.IM citrate acetate, pH 5 containing l.OM NaCl, (n=3).

1.2 r

E

0.8

c
to
o
@)

(A

0.6

.o

<

0.4

02

0

0.1

0.5

1

Ionic Strength (NaCI,M)

Figure 90. Optimisation of the ionic strength of buffer for hCG antibody adsorption to silicon.

Interpretation: A 0. IM citrate acetate buffer containing no NaCl is considered optimum.
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3.1.9.6: Precision study
Assay layout
Anti-hCG antibody (20jig/ml) is adsorbed onto silicon @ 37°C for 2hrs in 0. IM citrate acetate
buffer pH 5, (n = 14).
Mean absorbance = 0.40.
S.D. = 0.045.
C.V/%= 11.
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3.1.10: Optimisation of the conditions for ferritin adsorption to
silicon.

3.1.10.1: Selection of a suitable ferritin concentration for adsorption onto silicon.
Assay layout
Range of ferritin concentrations 1000, 500, 100 & lOng/ml, (n = 3).
Adsorped to silicon wafers.
Ferritin detected on surface with mouse anti-ferritin alk phos conjugated antibody.
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Figure 91. Selection of a suitable ferritin concentration for adsorption to silicon.

Interpretation: A ferritin concentration of 500ng/ml was selected.
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3.1.10.2: Optimisation of the time and temperature condition for ferritin adsorption to
silicon.
Assay layout
Ferritin (500ng/ml) is adsorbed onto silicon at;
(a) 2 different time periods: 2 & 16hrs, (n=3).
(b) 2 different temperatures: 4 & 37°C, (n=3).
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Figure 92. Optimisation of the time and temperature for ferritin adsorption to silicon.

Interpretation: An incubation condition of 37°C for Ibhours is considered an optimum.
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3.1.10.3: Optimisation of the pH condition for ferritin adsorption to silicon.
Assay layout
Ferritin (500ng/ml) is adsorbed onto silicon for 16hrs at 37®C using 3 different buffer systems:
(1) 0.2M citrate acetate, pH 5, (n=4).
(2) 0.05M PBS, pH 7.4, (n=4).
(3) 0.05M sodium bicarbonate, pH 9.6, (n=4).
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Figure 93. Optimisation of the pH condition for ferritin adsorption to silicon.

Interpretation: A pH of 9.6 is considered the optimum.
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3.1.10.4: Optimisation of the molarity of the buffer for ferritin adsorption to silicon.
Assay layout
Ferritin (500ng/ml) is adsorbed @ 37°C for 16hrs using 3 different buffer systems;
(a) 0.02 sodium bicarbonate, pH 9.6, (n=4).
(b) 0.05 sodium bicarbonate, pH 9.6, (n=4).
(c) 0.20 sodium bicarbonate, pH 9.6, (n=4).
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Figure 94. Optimisation of the molarity of buffer for ferritin adsorption to silicon.

Interpretation: : A 0.05M sodium bicarbonate buffer, pH 9.6, is considered optimum.
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3.1.10.5: Optimisation of the ionic strength of the buffer for ferritin adsorption to silicon.
Assay layout
Ferritin (500ng/ml) is adsorbed @ 37°C for 16hrs using 4 different systems:
(a) 0.05M sodium bicarbonate (n=3).
(b) 0.05M sodium bicarbonate, containing O.IM NaCl, (n==3).
(c) 0.05m sodium bicarbonate, containing 0.5M NaCl, (n=3).
(d) 0.05M sodium bicarbonate, containing l .OM NaCl, (n=3).
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Figure 95. Optimisation of the ionic strength of buffer for ferritin adsorption to silicon.

Interpretation: A 0.05M sodium bicarbonate buffer containing 1 OM NaCl gave the higher
binding.
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3.1.10.6: Precision study.
Assay layout
Ferritin (500ng/ml) is adsorbed to silicon in 0.05M sodium bicarbonate buffer containing l.OM
NaCl @ 37°C for 16hrs, (n = 14).
Mean absorbance = 1.63.
S.D. = 0.19.
C.V%= 12.
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3.1.11: Optimisation of the conditions for alpha-fetoprotein adsorption to
silicon.

3.1.11.1: Selection of a suitable alpha-fetoprotein concentration for adsorption onto
silicon.
Assay layout
(a) Range of alpha-fetoprotein concentrations 1000, 500, 100 & 50ng/ml (n = 3).
(b) Alpha-fetoprotein detected on silicon with mouse anti alpha-fetoprotein alk. phos.
conjugated antibody.
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Figure 96. Selection of a suitable alpha-fetoprotein concentration for adsorption to silicon

Interpretation: An alpha fetoprotein concentration of 500ng/ml is considered suitable
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3.1.11.2: Optimisation of the time and temperature conditions for alpha-fetoprotein
adsorption to silicon.
Assay layout
Alpha-fetoprotein 500ng/ml is adsorbed onto silicon at:
(a) 2 different time periods: 2 & 16hrs, (n=3).
(b) 2 different temperatures: 4 & 37°C, (n=3).
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Figure 97. Optimisation of the time and temperature condition for alpha-fetoprotein adsorption.

Interpretation: An incubation condition of 37^C for 2hours is considered optimum.
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3.1.11.3: Optimisation of the pH condition for alpha-fetoprotein adsorption to silicon.
Assay layout
Alpha-fetoprotein (500ng/ml) is adsorbed onto silicon for 2hrs at 37°C using 3 different buffer
systems:
(1) 0.2M citrate acetate, pH 5, (n=4).
(2) 0.05M PBS, pH 7.4, (n=4).
(3) 0.05M sodium bicarbonate, pH 9.6, (n=4).
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Figure 98. Optimisation of the pH condition for alpha-fetoprotein adsorption to silicon.

Interpretation: A pH of 7.4 was selected.
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3.1.11.4: Optimisation of the molarity of the buffer for alpha-fetoprotein adsorption to
silicon.
Assay layout
Ferritin (500ng/ml) is adsorbed @ 37°C for 2hrs using 3 different buffer systems:
(a) O.OIM PBS, pH 7.4, (n=4).
(b) 0.05M PBS, pH 7.4, (n=4).
(c) 0.1 OM PBS, pH 7.4, (n=4).
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Figure 99. Optimisation of the molarity of buffer for alpha-fetoprotein adsorption to silicon.

Interpretation: : A 0. IM phoshate buffered saline buffer, pH 7.4, is considered optimum.
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3.1.11.5: Optimisation of the ionic strength of the buffer for alpha-fetoprotein adsorption
to silicon.
Assay layout
Alpha-fetoprotein (500ng/ml) is adsorbed @ 37°C for 2hrs using 4 different buffer systems:
(a) 0. IM phosphate buffe,r (n=3).
(b) O.IM phosphate buffer, containing O.IM NaCl, (n=3).
(c) O.IM phosphate buffer, containing 0.5M NaCl, (n=3).
(d) O.IM phosphate buffer,containing l.OM NaCl, (n^3).
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Figure 100. Optimisation of the ionic strength of buffer for alpha-fetoprotein adsorption to silicon.

Interpretation: A 0. IM phosphate buffered saline buffer containing 1 .OM NaCl is optimal.
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3.1.11.6: Precision study
Assay layout
Alpha-fetoprotein (500ng/ml) is adsorbed to silicon in 0. IM PBS buffer containing 1 OM NaCl
37°C for 2hrs.
(n=14).
Mean absorbance = 0.34.
S.D. =0.05.
C.V/%= 15.
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3.1.12; Optimisation of the conditions for liCG adsorpdon to silicon
3.1.12.1: Selection of a suitable hCG concentration for adsorption onto silicon
Assay layout
A range of hCG concentrations, 20, 10, 4 & 2 |J.g/ml (n = 3), was adsorbed to silicon wafers
hCG is detected on surface with mouse anti hCG alk phos conjugated antibody.

Q3
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E 02
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^ 015

<
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2

hCG cone, (pg/ml)
Figure 101. Selection of a suitable hCG concentration for adsorption to silicon.

Interpretation: A hCG concentration of lOpg/ml is considered suitable.
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3.1.12.2: Optimisation of the time and temperature condition for hCG adsorption to
silicon.
Assay layout
lOpg/ml hCG is adsorbed onto silicon at;
(a) 2 different time periods: 2 & 16hrs, (n=3).
(b) 2 different temperatures: 4 & 37®C, (n=3).
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<
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2hs

Time and Temperatir e

Figure 102. Optimisation of the time and temperature condition for hCG adsorption.

Interpretation: An incubation condition of 37‘^C for 2hours is considered optimum.
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3.1.12.3: Optimisation of the pH condition for hCG adsorption to silicon.
Assay layout
hCG

is adsorbed onto silicon for 2hrs at 37°C using 3 different buffer systems:
(1) 0.2M citrate acetate, pH 5, (n=4).
(2) 0.05M PBS, pH 7.4, (n=4).
(3) 0.05M sodium bicarbonate, pH 9.6,(n=4).
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0.14
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Figure 103. Optimisation of the pH condition for hCG adsorption to silicon.

Interpretation: A pH of 5 is considered optimum.
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3.1.12.4: Optimisation of the molarity of the buffer for hCG adsorption to silicon.
Assay layout
hCG (10|ig/ml) is adsorbed @ 37°C for 2hrs using 3 different buffer systems:
(a) O.IM citrate acetate, pH 5, (n=4).
(b) 0.2m citrate acetate, pH 5, (n=4).
(c) 0.4m citrate acetate, pH 5, (n=4).
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Figure 104. Optimisation of the molarity of buffer for hCG adsorption to silicon.

Interpretation: : A 0.2M citrate acetate buffer, pH 5, was selected.
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3.1.12.5: Optimisation of the ionic strength of the buffer for hCG adsorption to silicon
Assay layout
hCG (lOfig/ml) is adsorbed @ 37°C for 2hrs using 4 different buffer systems;
(a) 0.2M citrate acetate, pH 5, (n=3).
(b) 0.2M citrate acetate, pH 5, containing 0. IM NaCl, (n=3).
(c) 0.2M citrate acetate, pH 5, containing 0.5M NaCl,(n=3).
(d) 0.2M citrate acetate, pH 5, containing 1 OM NaCl, (n=3).
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Figure 105. Optimisation of the ionic strength of buffer for hCG adsorption to silicon.

Interpretation: A 0.2M citrate acetate buffer containing 1 .OM NaCl is considered optimum.
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3.1.12.6: Precision study.
Assay layout
hCG (10|ig/ml) is adsorbed to silicon in 0.2M citrate acetate buffer containing 1 OM NaCl
37°C for 2hrs.
(n=14)
Mean absorbance = 0.33
S.D. =0.004
C.V/%= 12.
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3.2: Detection of antigens via the AFM
3.2.1: Detection of the ferritin antigen on anti-ferritin antibody surface

1 Oue/ml anti-ferritin antibody AFM image data.

Ra (nm)
Scan area 1

1.54

Scan area 2

1.54

Scan area 3

1.38

Scan area 4

1.56

Statistical analysis

Mean Ra (nm) = 1.50
S.D.= 0.07
C.V. (%) =4.82

Tabic 8. 10fig/ml anti-fcrritin antibody AFM image data.

500ng/ml ferritin on lOug/ml anti-ferritin antibody AFM image data.

Ra (nm)
Scan area 1

2.53

Scan area 2

2.56

Scan area 3

2.41

Scan area 4

1.77

Statistical analysis

Mean Ra (nm) =2.32
S.D.=0.32
C.V. (%) =13.8

Table 9. 500ng/ml ferritin on lOfig/ml anti-ferritin antibody AFM image data.
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lOjig/ml anti-ferritin antibody

Ra = 1.54nni

Distance Heiolrt
1 3B.10 nm 7.35 nm
2 42.86 nm 7.06 nm
3 36.10 nm 6.16 nm
4 42.86 nm 6.92 nm
_5__61.90 nm__6.39 nm

Figure 106. 10|ag/inl anti-ferritin antibody on silanised silicon.

SOOng/ml ferritin on lOjug/ml anti-ferritin antibody

Ra = 1.77nni

Distance
47.62 nm
47.62 nm
33.33 nm
47.62 nm
19.05 nm

Height
13.24 nm
13.29 nm
7.81 nm
7.63 nm
7.26 nm

Figure 107. 500ng/ml ferritin on lOfig/ml anti-ferritin antibody.
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3.2.2: Detection of the alpha-fetoprotein antigen on anti-alpha-fetoprotein
antibody surface.
10|ag/ml anti alpha-fetoprotein antibody AFM image data.

Ra (nm)
Scan area 1

1.12

Scan area 2

1.18

Scan area 3

1.27

Scan area 4

1.20

Statistical analysis

Mean Ra (nm) = 1.19
S.D.= 0.05
C.V. (%) = 4.5

Tabic 10. lOfig/ml anti alpha-fetoprotein antibody AFM image data.

640ng/ml alpha-fetoprotein on lOpg/ml anti-alphafetoprotein antibody AFM image
data.

Ra
Scan area 1

1.64

Scan area 2

1.41

Scan area 3

1.80

Scan area 4

1.50

Statistical analysis

Mean Ra (nm) = 1.58
S.D.= 0.14
C.V. (%) = 9.3

Table 11. 640ng/ml alpha-fetoprotein on lOpg/ml anti-alpha-fetoprotein antibody AFM image
data.
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2jLig/inl anti-alpha-fetoprotein antibody.

Ra = 1.20nni

t Distance

HeiaM
5.S1 nm

1

23.81 nm

2

33.33 nm

3.83 nin

3
4

47.62 nm
23.81 nm

3.95 nm
4.06 nm

5

47.62 nm

3.14 nm

Figure 108. 2|ag/inl anti alpha-fetoprotein antibody on silanised silicon.

640ng/nil alpha-fetoprotein on 2|Lig/nil anti-alpha-fetoprotein antibody.

Ra = 1.41nni

V
1
2
3
4
5

Distance
33.33 nm
38.10 nm
33.33 nm
28.57 nm
52.38 nm

Height
B.11 nm
6.92 nm
6.21 nm
4.34 nm
6.28 nm

Figure 109. 640ng/nl alpha-fetoprotein on 2fig/nil anti alpha-fetoprotein antibody.
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imo

JCOnm

3.2.3: Detection of the hCG antigen on anti-hCG antibody surface.
500ng/ml hCG on 20}ig/ml anti-hCG antibody AFM image data.

Ra (nm)
Scan area 1

1.41

Scan area 2

1.72

Scan area 3

1.41

Scan area 4

1.73

Statistical analysis

Mean Ra (nm) =1.53
S.D.=0.14
C.V. (%)=9.6

Table 12. 20^g/fnl anti hCG antibody AFM image data.

500ng/ml alpha hCG on 10|ig/ml anti-hCG antibody AFM image data.

Ra (nm)
Scan area 1

1.23

Scan area 2

1.26

Scan area 3

1.33

Scan area 4

1.50

Statistical analysis

Mean Ra (nm)= 1.33
S.D.= 0.1
C.V. (%) = 8

Table 13. 500ng/ml hCG on 20|ig/ml anti hCG antibody AFM image data.
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20iLig/inl anti-hCG antibody.

Distance
33.33 nm
42.86 nm
36.10 nm
52.38 nm
23.81 nm

Height
6.15 nm
5.22 nm
6.34 nm
5.69 nin
5.80 nm

t4«l

Distance (nm)

Figure 110. 20^g/ml anti hCC antibody on silanised silicon.

SOOng/ml hCG on lOjug/ml anti-hCG antibody.

Ra = 0.95nni

f
1
2
3
4

Distance
38.10 nm
52.38 nm
38.10 mil
42.66 nm

Figure 111. SOOng/ml hCG on 20)j.g/nil anti-hCG antibody.
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Heiqbt
5.41 nm
4.61 nm
3.69 nm
5.82 nm

lOO

3.3. Estimation of anti-ferritin antibody coverage on silanised silicon

Anti-ferritin
antibody
cone, (ng/ml)

Anti-alphafetoprotein
antibody
cone, (ng/ml)

Abs @
405nm

Anti-ferritin
antibody
cone, (ng/ml)

Anti alphafetoprotein
antibody
cone, (ng/ml)

Abs @
405nm

200

0

2.00

200

0

1.77

150

0

1.96

150

50

0.57

100

0

1.97

100

100

0.30

75

0

2.00

75

125

0.23

50

0

1.80

50

150

0.09

25

0

1.3

25

175

0.10

12.5

0

0.74

12.5

187.5

0.09

6.2

0

0.38

6.2

193.5

0.09

3.1

0

0.22

3.1

196.9

0.09

1.55

0

0.15

1.55

198.5

0.08

0.725

0

0.12

0.725

199.25

0.08

0

0

0.08

0

200

0.08

Table 14. Estimation of anti-ferritin antibody eoverage on silianised silicon.

Q = A/B*C*V/F*1000.

(Esser,1988)

Where;
Q is the amount of specific antibody adsorbed per unit area (ng/cm^),
A is the maximum signal concentration,
C is the maximum IgG concentration (pg/ml),
B/C is the fraction of the saturation concentration S formed by A,
V is the reaction volume (ml),
F is the surface area - Hr^ (cm^).
Q - 1/24*200*0.006/3.14*(0.2)^*1000
Q = 398.08ng/ml
The surface coverage is equal to 398.08ng/ml, while the maximum signal anti-ferritin antibody
concentration is equal to 15pg/ml.
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Estimation of anti-ferritin antibody coverage on silanised silicon.
-^Anti-ferritin antibody;

Anti-ferritin & anti-alpha-fetoprotein antibodies

Anti-ferritin antibody cone, (^g/ml)

Figure 112. Estimation of anti-ferritin antibody coverage on silanised silicon
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3.4. Ferritin Millispot ELISA.

3.4.1. Construction of a standard curve for a Ferritin Millispot ELISA.

Ferritin cone, (ng/ml)

Mean Abs @ 405nni (n=10)

Mean Abs - Blank Abs

500

0.96

0.86

250

0.53

0.43

125

0.30

0.20

62.5

0.19

0.09

31.25

0.14

0.04

15.62

0.12

0.02

7.81

0.11

0.01

0

0.10

0

Table 15. Construction of a standard curve for a Ferritin Millispot ELISA.
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Construction of a standard curve for Millispot Ferritin ELISA

Figure 113. Construction of a standard curve for Millispot ferritin ELISA
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3.4.2. Precision Study.
3.4.2.1. Within-run Precision.
Assay layout
0.05M PBS, pH 7.4, was spiked with ferritin standard to give final ferritin concentrations of 250,
100 & 17ng/ml. Each of these samples was assayed 10 times. The concentration of each
replicate (measured conc.)( Table 17) was determined from a calibration curve set up in
triplicate(Table 16).

Ferritin cone.

Mean Ah.s

(a).

405nni - Blank Ahs

500

0 80

250

0.50

125

0.20

62.5

0.09

31,25

0.03

15.62

0.02

7.81

0.01

Rlk

0

Table 16. Construction of Ferritin standard curve for Within-run Precision.

Measured Ferritin
cone, (ng/ml)

S.D.

C.V.(%)

304

38.9

12.7

129

16.4

12.6

25.9

4.01

15

Table 17. Within-run Precision.
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(a).

40Snni

3.4.3 2. Precision Profile.

Ferritin cone,
(ng/ml)

Abs @ 405nni
(n=10)

S.D.

C.V.(%)

500

0.96

0.11

12

250

0.53

0.05

10

125

0.30

0.03

11

62.5

0.19

0.01

8

31.25

0.14

0.02

10

15.62

0.12

0.009

8

0.11

0.006

6

0.10

0.005

5.4

7.81

Blk

Table 18. Precision Profile.
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Precision Profile.

Figure 114 . Precision profile.
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3.4.3. Accuracy Study.
3.4.3.1. Recovery Study.

Ferritin cone, (ng/ml)

Abs @ 405nni (n=3)

500

1.03

250

0.76

125

0.21

62.5

0.08

31.25

0.02

15.62

0

7.8

0

Blk

0

Table 19. Standard curve for recovery study.

Spiked Ferritin cone,
(ng/ml)

Abs. @ 405nni
(n=4)

Measured Ferritin
cone, (ng/ml)

% Recovery

380

1.03

480

no

150

0.50

250

126

80

0.31

150

112

20

0.16

80

100

Unspiked

0.11

60

Table 20. Recovery study.
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3.4.3.2. Parallelism and Linearity.

Ferritin cone.
(ng/ml)
500

Mean Abs. @ 405nni - Blank Abs. @ 405nni

250

1.40

125

0.80

62.5

0.43

31.25

0.19

15.62

0.08

7.81

0.03

Blk

0

1.58

Table 21. Ferritin standard curve for parallelism and linearity studies

Ferritin
cone.
(ng/ml)

Mean Abs.
@ 405nm Blank Abs.
@405nm

Ferritin
cone.
(ng/ml)

Mean Abs.
@ 405nm Blank Abs.
@405nm

Ferritin
cone.
(ng/ml)

Mean Abs.
@ 405nm Blank Abs.
@405nm

300

1.39

180

1.01

58

0.45

150

1.13

90

0.82

29

0.27

75

0.80

45

0.47

14.5

0.11

37.5

0.51

22.5

0.26

7.2

0.06

18.7

0.27

11.25

0.13

3.6

0.03

9.4

0.13

5.6

0.05

1.8

0.01

4.6

0.07

2.8

0.01

0.9

0.01

Blk.

0

Blk.

0

Blk.

0

Table 22. Parallelism study
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Expected Ferritin cone, (ng/ml)

Observed Ferritin cone, (ng/ml)

300
150
75
37.5
18.7

240
160
125
78
41

9.4
4.6

21
12

Table 23. Linearity at high concentrations

Expected Ferritin cone, (ng/m!)

Observed Ferritin cone, (ng/ml)

180
90
45
22.5
11.2
5.6

140
126
74
41
22
11

2.8

5

Table 24. Linearity at medium concentrations

Expected Ferritin cone, (ng/ml)

Observed Ferritin cone, (ng/ml)

58
29
14.5
7.2
3.6
1.8

70
42
20
12
7.8
5

0.9

5

Table 25. Linearity at low concentrations
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Ferritin cone, (ng/ml)
500ng/ml std

—300ng/ml spl

180ng/mlspl

Figure 115. Parallelism.
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—x—58ng/ml spl

Linearity at High Concentrations.

50

100

150

200

Expected Ferritin cone, (ng/ml)
-♦—Linearity;

Correlation

Figure 116. Linearity at high concentrations
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250

300

Linearity at Medium concentrations.
180

T-

Figare 117. Linearity at Medium concentrations.
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Linearity at Low Concentrations.

Figure 118 . Linearity at low concentrations
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3.4.4. Sensitivity.

Ferritin cone,
(ng/ml)

Abs @ 405nni
(n=10)

S.D.

Mean Abs. @
405nni-Blank Abs

500

0.96

0.11

0.11

250

0.53

0.05

0.05

125

0.30

0.03

0.03

62.5

0.19

0.01

0.01

31.25

0.14

0.02

0.02

15.62

0.12

0.009

0.009

7.81

0.11

0.006

0.006

Blk

Blk

0.10

0.005

Table 26. Sensitivity Study.
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Sensitivity

Ferritin cone, (ng/ml)
Figure 119. Sensitivity of Millispot ELISA.
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3.4.5. Comparison Study

Sample No.

Millispot ELISA
Ferritin cone, (ng/ml)

Fluorescence Immunoassay
Ferritin cone, (ng/ml)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37

27
25
43
31
112
63
32
50
44
37
37
120
220
26
<7.8
19
25
71
24
<7
9
100
15
140
58
54
160
165
15
10
9
69
9
19
125
26
84

20.6
19.3
64.5
33.1
98.2
55.9
31.5
35.5
37.3
28
40.2
124.1
287.3
25
6.2
13.3
23.2
67.1
19.4
5.9
5.6
104.6
12
116.1
56
47.5
332
150.7
11.2
7.3
6.9
56
6.1
42
130.8
21
73.4

Table 27. Comparison study
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Fluorescence Immunoassay ferritin cone, (ng/mi)
Figure 120. Correlation cur\'e
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140

3.5. Quantitation of Ferritin on silicon surface using the AFM

3.5.1. Optimisation of anti-ferritin antibody coating concentration with a view to
the development of an AFM Immunosensor.

3.5.11. AFM Image Data.
40}ig/ml anti-ferritin antibody on silanised silicon.
Ra (nm)
Sample 1 / Area 1

0.65

Sample 1 / Area 2

0.74

Sample 1 / Area 3

0.75

Sample2 / Area 1

0.56

Sample 2 / Area 2

0.74

Sample 2 / Area 3

0.82

Sample 3 / Area 1

0.56

Sample 3 / Area 2

1.12

Sample 3 / Area 3

0.73
Mean Ra=0.74

Statistical Analysis

S.D.=0.16
C.V.(%)=21

Table 28. 40|ig/ml anti-ferritin on silanised silicon.
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40|ig/ml anti-ferritin antibody
5 nm

■ Whole Image ------------Aiea Ra:

0.7471 ntn

Area RMS:

1.0800 nm

9 93 nm

Avg. Height: 3.5653 nm
Max. Range: 23.9902 nm
- Partial Image
Area Ra:

0 nm

2.5 nm

Area RMS:
Avg. Height:
Height. Max
Include Area
Exclude Area
Clear

Apply
0 nfK'

Figure 121. Planar image of 4()|ig/ml anti- ferritin antibody on silanised

Figure 122. Line analysis of 40\)g/ml anti-ferritin antibody on silanised silicon

253

14/jj,g/ml anti-ferritin antibody on silanised silicon.
Ra (nm)
Sample 1 / Area 1

0.40

Sample 1 / Area 2

0.50

Sample 1 / Area 3

0.47

Sample2 / Area 1

0.43

Sample 2 / Area 2

0.51

Sample 2 / Area 3

0.65

Sample 3 / Area 1

0.40

Sample 3 / Area 2

0.41

Sample 3 / Area 3

0.41
Mean Ra=0.46
S.D.=0.07

Statistical Analysis

C.V.(%)=15.2

Table 29. 14|ig/inl anti-ferritin antibody on silanised silicon.

7|j.g/ml anti-ferritin antibody on silanised silicon.
Ra (nm)
Sample 1 / Area 1

0.75

Sample 1 / Area 2

0.43

Sample 1 / Area 3

0.48

Sample2 / Area 1

0.58

Sample 2 / Area 2

0.47

Sample 2 / Area 3

0.49

Sample 3 / Area 1

0.72

Sample 3 / Area 2

0.49

Sample 3 / Area 3

0.41
Mean Ra=0.53
S.D.=0.11

Statistical Analysis

C.V.(%)=22

Table 30. 7}ig/nil anti-ferritin antibody on silanised silicon.
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14|Lig/ml anti-ferritin antibody
5 urn
14 nrn

0 nm

2.5 urn

Area Ra:

0.4157 nm

Area RMS:

0.5761 nm

Avg. Height:

3 2319nm

Max. Range: 17 1953 nm
0 nm
0 nm

2.5 nm

5 nm

Figure 123. Planar image of 14ng/ml anti -ferritin antibody on silanised silicon

Standard Roughness

n

Ra;
Rp
Rpm:
Rt:
Rtm

□ .62
2 61
2.11
4 23
3.56

nm
nm
nm
nm
nm

5 jjm

1

Standard Roughness
Ra
Rp:
Rpm:
Rt:
Rtm

yl

□ 81
7 32
3 92
9.57
5.78

nm
nm
nm
nm
nm

5 |im

Standard Roughness
Ra;
Rp

Rpm:
Rt
Rtm:

□
3
2
5
4

72
16
33
41
82

nm
nm
nm
nm
nm

Figure 124. Planar image of 14|ig/ml anti- ferritin antibody on silanised silicon
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p Whole Image -----------Area Ra:

0.4633 nm

Area RMS:

0 6557 nm

5
9.98 nm

Avg. Height; 4 8002nm
Max. Range: 20.8008 nm
- Partial Image ------------Area Ra:

0 4567 nm

Area RMS:

0.6048 nm

i
Onm

2.5 urn

Avg. Height: 4 7945 nm
Height. Max 16.2246 nm

.V
• i.
Vi

f'-

.

■tv*’’-,?:
“I

0 urn

.■V.

Onm

2.5 nm

Figure 125. Planar image of 7|ig/ml anti- ferritin antibody on silanised silicon

Standard Rouqhness
Ra:
Rp;
Rprn:
Rt;
Rtm

0 46
1 44
1 32
2.98
2 66

nm
nm
nrn
nm
nm

Standard Rouqhness
Ra:
Rp:
Rpm:
Rt:
Rtm:

0.44
1.37
1.26
3 05
2.44

nm
ntn
nm
nm
nm

Standard Rouqhness
Ra
Rp:
Rprn:
Rt
Rtm.

0.40
1 37
1 15
2 70
2 12

Figure 126. Line analysis of 7)ig/ml anti- ferritin antibody on silanised silicon
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nm
nm
nm
nm
nm

3.5|ig/ml anti-ferritin antibody on silanised silicon.

Ra (nm)
Sample 1 / Area 1

0.47

Sample 1 / Area 2

0.36

Sample 1 / Area 3

0.81

Sample 2 / Area 1

0.87

Sample 2 / Area 2

0.74

Mean Ra=0.75
S.D.=0.39

Statistical Analysis

C.V.(%)=41.8

Table 31. 3.5|ig/ml anti-ferritin antibody on silanised silicon
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3.5)ag/ml anti ferritin
Whole Image ------------Area Ra:

0.3626 nm

Area RMS;

0 5428 nm

9.92 nm

Avg. Height: 2 2086 nfn
Max. Range; 22.1182 ntn
Partial Image -----------Area Ra;

0 3583nm

Area RMS;

0 5021 nm

I

0 nm

2.5 urn

Avg. Height; 2 2092 nm
Height. Max 13 3472 nm

Exclude Area

0 nm

2.5 nm

Figure 127. Planar image of 3.5|ig/ml anti -ferritin antibody on silanised silicon

Standard Roucrhness
Ra
Rp
R p fn;
Rt:
Rtrn;

0 35
3.13
2 14
4 19
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Figure 128. Line analysis of 3.5|ig/ml anti -ferritin antibody on silanised silicon
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Figure 129. 3D view of 7^g/lnl anti-ferritin Ab on silanised silicon
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Figure 130. 3D view of 3.5|ig/nil anti-ferritin Ab on silanised silicon
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259

3Dview 40|Lig/ml anti-ferritin antibody
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Fig 131. 3D view of 40|ig/ml anti -ferritin antibody on silanised silicon
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Fig 132. 3D view of 14|ig/ml anti -ferritin antibody
on silanised silicon
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3.5.2. Quantitation of ferritin on optimised anti-ferritin antibody surface using
AFM.

3.5.2.1. AFM Image analysis data.

Ferritin cone, (ng/ml)

Ra

No of Binding
Events/pm^

500

2.02

120

125

1.69

92

62.5

1.50

56

31.25

1.44

40

15.56

1.29

19

7.8

1.18

13

Blk

0.41

3

Table 32. Image analysis data for the quantitation of ferritin on anti-ferritin antibody surface.
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AFM Standard Curve
Ra(nm) versus Ferritin cone, (ng/ml)

Figure 133. AFM Standard Curve. Ra(nni) versus Ferritin conc.(ng/nil)
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AFM Standard Cui've
No. of Binding Events versus Ferritin cone, (ng/ml)

Figure 134. AFM Standard Curve. No of Binding Events versus Ferritin conc.(ng/nil)

263

Quantitation of Ferritin Antigen on Anti-Ferritin antibody
coated surface
Ong/ml ferritin on 14|ig/ml anti-ferritin antibody
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Figure 135. Planar image of 0 ng/ml ferritin on 14ng/ml anti-ferritin antibody
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Figure 136. Line analysis of Ong/ml ferritin on 14ng/ml anti-ferritin antibody
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Quantitation of Ferritin Antigen on Anti-Ferritin antibody
coated surface
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Figure 137. Planar image of 7.8ng/ml ferritin on 14)ig/ml anti -ferritin antibody
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Figure 138. Line analysis of 7.8ng/ml ferritin on 14|ig/ml anti-ferritin antibody
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Quantitation of Ferritin Antigen on Anti-Ferritin antibody
coated surface
15.5ng/nil ferritin on 14|ig/ml anti-ferritin antibody
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Figure 139. Planar image ofl5.5ng/ml ferritin on 14|ig/nil anti-ferritin antibody
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Figure 140. Line analysis of 15.5ng/ml ferritin on 14|ig/ml anti-ferritin antibody
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Quantitation of Ferritin Antigen on Anti-Ferritin antibody
coated surface
31.25ng/ml ferritin on 14jig/ml anti-ferritin antibody
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Figure 141. Planar image of 31.25ng/ml ferritin on 14ng/nil anti-ferritin antibody
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Figure 142. Line analysis of 31.25ng/ml ferritin on 14ng/ml anti-ferritin antibody
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coated surface
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Figure 143. Planar image of 62ng/ml ferritin on 14ng/ml anti-ferritin antibody

Standard Rouqhness
Ra;
Rp
Rpm:
Rt
Rtm;

1 -GO nm
1O S1
nm
7 4G nm
1 4.49 nm
1 0.53 n rn

Standard Rouqhness
Ra:
Rp:
Rpm;
Rt.
Rtm:

175 n m
1 3. GG n m
B. OG n m
1 7.54 rtm
1 1 .29 nm

Standard Rouqhness
Ra:
Rp:
Rpm:
Rt;
Rtm:

Figure 144. Line analysis of 62ng/ml ferritin on 14ng/ml anti-ferritin antibody
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coated surface
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Figure 145. Planar image of 250ng/ml ferritin on 14ng/ml anti-ferritin antibody
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Figure 146. Line analysis of 250ng/ml ferritin on 14ng/ml anti-ferritin antibody
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Quantitation of Ferritin Antigen on Anti-Ferritin antibody
coated surface
500ng/ml ferritin on 14jig/ml anti-ferritin antibody
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Figure 147. Planar image of 500ng/ml ferritin on 14)ig/ml anti- ferritin antibody.
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Figure 148. Line analysis of 500ng/ml ferritin on 14)ig/ml anti-ferritin antibody.
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Quantitation of Ferritin Antigen on Anti-Ferritin antibodycoated surface
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Figure 149. 31) view of 500ng/ml ferritin on 14|ig/ml anti-ferritin antibody.

3DView: 250ng/ml

Figure 150. 3D view of 250ng/ml ferritin on 14)ig/ml anti-ferritin antibody.
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Quantitation of Ferritin Antigen on Anti-Ferritin antibodycoated surface
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Figure 151. 3D view of 62.5ng/ml ferritin on 14|ig/ml anti-ferritin antibody

3p View: 31.25ng/ml
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Figure 152. 3D view of 31.25ng/ml ferritin on 14)ig/ml anti-ferritin antibody
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Quantitation of Ferritin Antigen on Anti-Ferritin antibodycoated surface
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Figure 154. 3D view of 7.8ng/ml ferritin on 14|ig/ml anti-ferritin
antibody
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155. 3D view of Ong/ml ferritin on 14pg/ml anti-ferritin
antibody
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Discussion

4.1: Optimisation of the conditions for the adsorption of immunoreactants
to sorbent surface

In this investigation immunoreactant adsorption to two different types of sorbent surface was
studied, namely. Nunc MaxiSorp polystyrene and ODDMMS-treated silicon (silanised silicon).
The structural characteristics of the Nunc MaxiSorp surface is outlined in Section 1.3.4.7. In
summary, the surface consists of a fine patchwork of hydrophobic and hydrophilic binding
sites. The silicon surface on the other hand is hydrophilic in nature due to the silanol groups
present on the spontaneously oxidised silicon surface. On treating the silicon surface with a
long chain hydrocarbon (ODDMMS),

a hydrophobic surface is produced.

consider the advantages/disadvantages of each surface.

Let us now

In an aqueous medium a repelling

effect exists between the silanised silicon surface and macromolecules rich in hydrophilic
groups, because these molecules will preferentially bind with the water molecules by strong
hydrogen bonds rather than bind to the silicon surface by weak hydrophobic bonds.

On a

MaxiSorp polystyrene surface, however, adsorption of hydrophilic macromolecules will be
facilitated because not only can this surface compete with the water molecules for binding to
the macromolecules by hydrogen bonding, but the molecules can also be captured from a much
longer distance by the long range hydrogen bond forces.

In contrast, hydrophobic

macromolecules can only be loosely adsorbed to MaxiSorp, because this surface tends to bind
water molecules by hydrogen bonds, against which the macromolecule cannot compete and,
therefore, exhibit poor ability for displacing water molecules and hydrophobic adsorption free
from water pocket interruptions (Esser, 1988). On the silanised silicon surface, however, no
hindrance exists for stable hydrophobic adsorption of hydrophobic molecules.
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This investigation involves the study of six different proteins, namely, anti-ferritin antibody,
anti-alpha-fetoprotein antibody, anti-hCG antibody, ferritin, alpha-fetoprotein and hCG. For
the purpose of this investigation the proteins are classified into two groups:
1. Immunoglobulins - anti-ferritin antibody, anti-alpha-fetoprotein antibody and antihCG antibody. All immunoglobulins are IgG class.
2. Antigens - ferritin, alpha-fetoprotein and hCG.
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4.1.1: Immunoglobulin Adsorption
An immunoglobulin is a glycoprotein with a basic structural unit consisting of four polypeptide
chains held together by disulphide bonds. Two of these peptide chains are called light chains,
of kappa and lambda type, normally present in a ratio of 2:1, respectively. The other two
peptide chain components of an immunoglobulin are called heavy chains.

The structural arrangement of the four polypeptide chains is shown in Fig. 156. Using papain
a proteolytic enzyme, the basic immunoglobulin structure is broken into three subunits:
(1) one Fc fragment of the heavy chain to the “hinge”.
(2) two Fab subunits consisting of a light chain portion and a heavy chain portion of
the hinge.

Figure 156. Immunoglobulin structure illustrating the antigen binding site, the Fab region, and the Fc
region which mediates effector function (Modified from Lu et al., 1996).

The hypervariable regions of the Fab fragments are variable in amino acid makeup and
determine the ability of the immunoglobulin to bind specifically to antigens. The amino acid
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make up of the Fc portion is fixed for each immunoglobulin class.

The heavy chains are

unique for each immunoglobulin class. IgG consists of a single immunoglobulin molecule with
heavy chain type G and has approximately 1,250 residues making up a molecular weight of
146,000 Da.
The adsorbed IgG molecules are detected via the conventional ELISA system whereby the
adsorbed antibody is incubated with the appropriate antigen. The antibody-antigen complex is,
in turn, detected with an appropriate conjugate antibody. Thus, this system only detects those
adsorbed IgG molecules which are immunologically active.
theoretical valency of two.

Each antibody molecule has a

However, experimentally depending on the orientation and

conformation of the adsorbed IgG molecule it may in practice have a valency of less than two.

4.1.1.1. Optimisation of the conditions for the adsorption of IgG molecules to
polystyrene.

Optimisation of the concentration of the IgG molecule for adsorption to polystyrene.
The most precise method for optimizing biomolecule concentration is the checkboard titration
method (section

1.3.4.6).

The optimum coating concentration corresponds to that

concentration which gives a monolayer of coverage.

At high concentrations there is a

tendency for protein molecules to bound to each other because there is no space left on the
surface of the plastic.

Such protein - protein interactions are generally weaker than those

between protein and plastic and can result in dissociation of supposedly bound protein during
the assay. The range of protein concentrations at which there is no interference with binding
to the plastic is termed the zone of independent binding. At low concentrations void spaces on
the surface may exist which can result in non-specific binding in subsequent steps. However,
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sometimes where the adsorbed antibody is used to capture a large molecule a concentration
less than that corresponding to a monolayer may be more suitable due to steric hindrance..

Optimisation of time and temperature condition for IgG adsorption to polystyrene.
The three different antibody molecules were adsorbed to MaxiSorp surface at two different
temperatures (4 & 37°C) for two different times (2 & 16 hours). The optimum condition was
found to be 4°C for 16 hours in the case of anti-hCG antibody (section 3.1.3.2.) and 4°C for
2hrs for anti alpha-fetoprotein antibody (section 3.1.2.2 ), while anti ferritin antibody adsorbs
best at 4°C for 2 hours (section 3.1.1.2.).

Typically as the temperature of incubation is

increased, the time can be decreased and vice versa. However, this is not the case in this
investigation. Possible reasons for this deviation may include;
(a) A forced hot air incubator was used and since polystyrene is a poor conductor of
heat it will take time for the plate to reach temperature equilibrium in this type of
incubator.
(b) A forced hot air incubator provides an unstable environment (i.e. air borne
contamination, increased air currents) which reduces the efficiency of binding.

Optimisation of the pH and ionic strength for IgG adsorption to MaxiSorp surface.
The charge expressed by a protein depends on the pH of the buffer in which it is dissolved. By
using buffers of different pH it is possible to create optimum conditions for a specific coating
material. In this investigation, we test with a citrate acetate buffer, pH 5, phosphate buffered
saline, pH 7.4, and a carbonate/bicarbonate buffer, pH 9.6. The role that the charge of protein
plays on immunoglobulin adsorption depends on whether hydrophobic or electrostatic forces
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play a major role due to the presence of both hydrophobic and hydrophilic groups on the
maxiSorp polystyrene surface.
Several groups have shown that the charge has little effect on hydrophobic interaction (Luey et
M-, 1990; Gibbs ^

1995a) However, immunoglobulins tend to bind best via hydrophobic

interactions at a pH that causes the exposure of hydrophobic regions due to partial
denaturation. Research groups have found that IgG tends to bind best when the pH is close to
but not equal to its isoelectric point pi (pi is the pH at which the net charge on the protein is
zero) of 7.8 (Bagchi and Birhaum, 1981) From the results of this investigation (sections
3.1.2.3. and 3.1.. 1.3.) if hydrophobic interaction is the driving force then both anti-alphafetoprotein and anti-ferritin antibodies show maximum exposure of hydrophobic regions at pH
5. This could indeed be the case since at pH 5 the Fc portion of the immunoglobulin is more
prone to partial denaturation than the Fab portion, thereby exposing hydrophobic regions in
the Fc portion giving rise to Fc orientated adsorption. It is again important to note that it is
the activity rather than the concentration of antibody we are measuring in this case. Anti-hCG
antibody however, adsorbs best at pH 9.6 (section 3.1.3.3.). Since all these immunoglobulins
have the same basic structure this requires further commentary. Jonnson et al showed that
IgG shows heterogeneity with respect to surface potential and configuration.(Jonnson et al.
1987) It is therefore possible that the anti-hCG antibodies exposed more hydrophobic regions
or is more conformationally unstable at pH 9.6.
If we assume that electrostatic interaction is the driving force in the adsorption process, then
one would expect maximum adsorption to occur under conditions which give rise to maximum
contrast between the charges of both surfaces. The polystyrene surface has a negative charge.
At a pH< pi of protein the IgG will become protonated thereby having a net positive charge,
whereas at pH >pl of protein the IgG will be deprotonated resulting in a net negative charge.
Let us now consider each IgG individually. Ferritin antibody shows maximum adsorption at
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pH 5, since this pH is less than the pi of the protein it will have a positive charge. Thus, as the
ferritin antibody approaches the negatively charged MaxiSorp surface the electrical layers
overlap and the molecule is attracted towards the surface. This attraction is dependant on the
ionic strength of the environment.

As the ionic strength of the environment increased the

negative ions in solution shield the positive charge of the IgG molecule resulting in a reduction
in the electrostatic attraction between IgG and MaxiSorp surfaces. Thus one would expect a
decrease in ferritin antibody adsorption as ionic strength is increased, which is the case in this
investigation (section 3.1.1.5.).
Anti-alpha-fetoprotein antibody also shows maximum adsorption at pH 5.

Adsorption

increases as the ionic strength is decreased (section 3.1.2.5 ). This phenomenon can also be
explained by the laws of electrostatics whereby an increase in ionic strength reduces the
attractive forces between both surfaces resulting in a decreased adsorbed amount
Anti-hCG antibody shows a maximum adsorption at pH 9.6.

At this pH the surface and

protein have a similar charge. In this case one would expect an increase in ionic strength to
result in increased adsorbed amount.

However, an increase in ionic strength results in

decreased adsorbed amounts (section 3.1.3.5.). So it is unlikely in this case that electrostatics
is the driving force in the adsorption process.

Optimisation of molarity of buffer for immunoglobulin adsorption to polystyrene.
The molarity of the buffer appeared to have little effect on the adsorption of IgG molecules to
MaxiSorp polystyrene surface (sections 3.1.1.4., 3.1.2.4 and 3.1.3.4).
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Optimisation of the conditions for the adsorption of immunoglobulin molecules to a
silanised silicon surface.
The IgG molecules are detected on the silanised silicon surface via a direct detection method.
The system involves the detection of the adsorbed antibody by an alk. phos. conjugated anti
species antibody. Thus, this method detects the antibody on a concentration basis rather than
on an activity basis.

Optimisation of the concentration for the adsorption of IgG molecules to silanised
silicon.
The optimum concentrations for anti-alpha-fetoprotein antibody (section 3.1.8.1.), anti-ferritin
antibody (section 3.1.7.1) and anti-hCG antibody (section 3.1.9.1.) were 2, 5 and 20pg/ml
respectively. The differences in optimum concentrations can be explained as follows:
(a) immunoglobulin heterogeneity which leads to differences in affinity for the silanised
silicon surface.
(b) orientation of the immunoglobulin molecule. Since the detection of the antibody on the
surface is on a molecular basis rather than activity, the exposure of the antigen binding
sites to the aqueous medium is not important.
molecule is important.

However, the orientation of the

Assume IgG is a globular protein with a lens-shaped spheroid

having a diameter (d) of about 15nm and a thickness (t) of about 3nm.

Consider this

spheroid molecule in a lying down and an upright position. Then the maximum surface
coverage on geometric basis is;
Surface coverage in upright position Q lens = 2/V3.MW/N. 10^. 1/td = 650ng/cm^
Surface coverage in lying position Q lens = 2/V3.MW/N.10^ .l/d2 = 130ng/cm^
Thus, five times as much antibody can be accommodated if the IgG molecules are in an upright
as opposed to a lying position.
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Optimisation of the time and temperature condition for IgG adsorption to silanised
silicon.
Adsorption at 37°C for 2hrs was the optimum condition for the adsorption of all three
immunoglobulin molecules (sections 3.1.7.2.; 3.1.8.2. and 3.1.9.2.). As discussed in section
1.2.4.6. it is typical for the time of incubation to decrease as the temperature is increased. This
is more the case for silicon than polystyrene due to its higher heat conductivity.

Optimisation of the pH and ionic strength for IgG adsorption to silanised silicon.
All three antibodies showed maximum adsorption at pH 5 (sections 3.1.7.3.; 3.1.8.3 and
3.1.9.3.). Considering the chemistry of the silanised silicon surface hydrophobic interaction is
the most likely driving force for the adsorption process. As discussed in Section 1.3.4.6. IgG
molecules bind best at a pH which leads to exposure of the hydrophobic groups. Research
groups have found this pH to be close to but not equal to the pi of the protein (pi of IgG = 7 8) (Bagchi and Birhaum, 1981). However, at pH 5 the Fc portion is more prone to partial
denaturation than the Fab portion resulting in Fc orientated adsorption.

As discussed in

Section 4.1.1.6. it is the concentration of the adsorbed molecule which is measured in this case
and not activity, so the exposure of the Fab portion to the aqueous environment does not
appear to be important.

However, by binding to the surface via the Fc portion the IgG

molecules orientate themselves in an upright manner giving rise to more efficient packing. So
while it is possible that the IgG molecules have a greater affinity for the hydrophobic surface at
pH close to the pi, a greater amount of antibody binds at pH 5 due to the orientation of the
molecule in an upright manner.
As the ionic strength is increased the adsorbed amount decreases (sections 3.1.7.5.; 3.1.8.5.
and 3.1.9.5.). If we assume a hydrophobic interaction to be the driving force then we can
conclude that a increase in ionic strength of the environment leads to a more conformationally
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unstable molecule. Incidentally, the results of the investigation are in agreement with the laws
of electrostatics whereby at a pH 5 the IgG molecules will have a net positive charge and will
be attracted to the negatively charged silicon surface.

While increasing the ionic strength

results in an decrease in the adsorbed amount due to the shielding effect of the oppositively
charged ions.

Optimisation of the molarity of the buffer for IgG adsorption to silanised silicon.
Again in this case the molarity of the buffer had little effect on the adsorbed amount (sections
3.1.7.4.;3.1.8.4and3.1.9.4.).
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4.1.2: Antigen Adsorption.

4.1.2.1: Structure and clinical significance of antigens.

Ferritin.
Ferritin is a soluble, spherical protein enclosing a core of iron. It is found in all cells and in low
concentrations in plasma and urine. Particularly high concentrations are present in the liver,
spleen and bone marrow. Human apoferritin (approx. 480kDa) is composed of 24 subunits.
The subunits are roughly cylindrical in shape and form a nearly spherical shell that encloses a
central core containing up to 4500 atoms of iron in the form of ferric hydroxyphosphate.
Human ferritins are made up of two subunits in varying proportions.

In liver and spleen

ferritin, the L subunit predominates and has an apparent molecular mass of about 21kDa. DNA
sequencing has demonstrated about 55% homology between the two subunits sequences
(Williams and Marks, 1994).
In most normal adults, serum ferritin concentrations lie within the range of 15 - 300|ig/L
(Williams and Marks, 1994). Serum ferritin concentrations are relatively stable in healthy
persons. In patients with iron deficiency anaemia, serum ferritin concentrations are less than
15|j.g/L, and, as far as is known, a reduction in the level of reticuloendothelial stores is the only
cause of a low serum concentration. This is the key to the use of ferritin assays in clinical
practice. Following infection, inflammation and chronic disease in which iron is transferred
from haemoglobin to the reticuloendothelial stores, the increased level of stored iron is
reflected in the serum ferritin concentration. The serum ferritin concentration can be used in
these circumstances to assess the adequacy of the iron stores.
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Alpha-fetoprotein.
AJpha-fetoprotein (aFP) is a protein which is very similar to albumin in its amino acid content,
molecular mass (70kDa), isoelectric point (4.8 - 5.2) and carbohydrate content (4%) (Stuart,
1996). It displays some heterogeneity in its carbohydrate content, depending on its tissue of
origin. The normal concentration of aFP in serum is less than 5jj.g/L (Devlin, 1992).
Although the concentration of aFP is elevated in a variety of non-malignant liver disease, an
elevation of more than 400p,g/L in a child or non-pregnant adult has a very high degree of
specificity (60 - 99%) for hepatocellular cancer and yolk-sac tumours. Where cancer of the
liver is endemic (China, Alaskan, Eskimos), Alpha-fetoprotein has been used successfully to
screen populations for hepatoma, with some evidence of improved survival due to the early
detection of small tumours (Williams and Marks, 1994). From a prognosis point it is useful in
teratoma where patients with Alpha-fetoprotein of more than 500pg/L are less likely to have
the tumour eradicated by those therapeutic regumens that are successful in patients with a
lower alpha-fetoprotein.

Serum alpha-fetoprotein measurements can also be used to monitor

the effect of treatment. Whereby, if alpha-fetoprotein concentrations do not decline with the
expected half-life or a further rise is shown, these suggest an incomplete tumour kill or
regrowth of tumour and second line therapy may be adopted.

hCG.
hCG is a glycoprotein consisting of about 237 a. a. It is quite similar in structure to the
pituitary glycoproteins in that it consists of 2 chains: an alpha chain, which exhibits an
approximate molecular weight of 14.5kDa and is species-specific; and a beta chain, which
exhibits an approximate molecular weight of 22.2kDa (Williams and Marks, 1994).
subunit determines receptor interaction and ultimate biological effect.

This

The alpha chain is

almost identical in sequence to the alpha chains of the hormonal glycoproteins TSH, FSH and
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LH. The p chain has significant sequence homology with LH but is not identical, of the 145
amino acids in P-hCG, 67% are identical to those of p-LH. In addition, the placental hormone
has a carboxy terminal segment of 30 a.a. not found in the pituitary LH molecule.
Carbohydrate constitutes approximately 30% by weight of each subunit.

Sialic acid alone

accounts for 10% by weight of the molecule and confers a high degree of resistance to
degradation.
The normal source of hCG is the syncytiotrophoblast in pregnancy, appearing in maternal
seiiam at 6 - 9 days after conception it rises exponentially, peaking at about 8-12 weeks after
the last menstrual period, decreasing to a minimum at 17-22 weeks, and remaining constant
in the last part of pregnancy. Its early rise and extremely high sensitivity for the trophoblast
make it the most reliable indicator of pregnancy.
Clinically P-hCG measurement is used primarily for the detection and monitoring of
choriocarcinoma, in which role it approaches the ideal as a tumour marker. Measurement of
serum p-hCG also has a useful role in the diagnosis and monitoring of testicular tumours,
where it is thought to reflect the activity of tumour cells of trophoblastic origin.

4.1.2.2: Optimisation of antigen adsorption to MaxiSorp polystyrene surface.
The three different proteins i.e. alpha-fetoprotein, ferritin and hCG were adsorbed to
MaxiSorp surfaces and were detected with an appropriate enzyme conjugated antibody.
Therefore only those proteins which when adsorbed expose the appropriate intact epitope are
detected. Thus, both the orientation and conformation of the adsorbed protein on the surface
is crucial.
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Selection of a suitable concentration for antigen adsorption to MaxiSorp surface.
Due to the expense and availability of the protein reagents a suitable rather than optimum
concentration of antigen were coated to the surface. The criteria used for the selection of this
suitable concentration was based on the following points:
(1) At the concentration selected the adsorbed amount was dependent on the input
concentration.
(2) The concentration selected was less than or equal to that which produced a monolayer.

The concentration selected for ferritin (section 3.1.4.1.), alpha-fetoprotein (section 3.1.5.1.)
and hCG (section 3.1.6.1.) were 500, 640 and lOOOng/ml, respectively. However, it is not
appropriate to compare and contrast these suitable concentrations since economic
considerations are taken into account in the selection process.

Optimisation of the time and temperature conditions for antigen adsorption.
The adsorption of the ferritin (MW 420,000 Da) (section 3.1.4.2) and alpha-fetoprotein (MW
70,000 Da) (section 3.1.5.2.) require 16hrs while 2hrs @ 37°C is sufficient for the adsorption
of hCG (36,700 Da) (section 3.1.6.2.). These results would imply that the time of adsorption
is inversely proportional to the molecular weight of the protein. However, a greater number of
time intervals and range of proteins are required to make this conclusion.
It is difficult to determine a pattern for the effect temperature has on protein adsorption. The
largest protein, ferritin, adsorbs well at both 4°C and 37°C (section 3.1.4.2.), alpha-fetoprotein
adsorbs best at 4°C (section 3.1.5.2.) while the smallest of the three, hCG, adsorbs best at
37°C (section 3.1.6.2.).
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Optimisation of the pH and ionic strength for antigen adsorption to MaxiSorp
polystyrene.
If we consider the effect pH and ionic strength have on the adsorption of each antigen
separately.

Ferritin:
The ferritin protein adsorbs best at pH 7.4 (section 3.1.4.3.). Ferritin has a pi 5.45 thus at pH
7.4 the protein has a net negative charge. At pH 7.4 there is a repulsive force between the
protein and polystyrene surface. This suggests that hydrophobic interactions are, more likely
to be, the driving force in the adsorption process, whereby the ferritin molecule exposes a
maximum number of hydrophobic groups at pH 7.4.
adsorbed amount increases (section 3.1.4.5.).

As the ionic strength increases the

Increasing the ionic strength can have a two

fold effect. It:
(a) creates an environment where the molecule is less stable in solution thus driving the
adsorption process.
(b) shields the repulsive force between both surfaces.

Alpha-fetoprotein
Alpha-fetoprotein adsorbs best at a pH where it has a charge close to zero (pi 4.75) (section
3.1.5.3.).

Therefore it is not likely that electrostatics play a role in alpha-fetoprotein

adsorption to polystyrene. It is therefore, assumed that hydrophobic interaction is the driving
force behind the adsorption process.

It is probable that at a pH 5 the protein exposes a

maximum number of hydrophobic groups to the surface which make contact with hydrophobic
patches on the surface forming a foothold on the surface while maintaining the exposure and
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integrity of the epitope. Altering the ionic strength of the environment appears to have little
effect on the adsorption of alpha-fetoprotein (section 3.1.5.5.).

hCG
hCG has a pi range 4-11. At pH 7.4 it is thus very difficult to assess the role electrostatics
play in the adsorption process. If we take the pi of the protein to be >7.4 then the protein has
a net negative charge resulting in a repulsive force between both surfaces. Alternatively, if the
pi of hCG is taken to be< 7.4 then the protein has a net positive charge resulting in an
attractive force between both surfaces. However, since ionic strength has little effect on the
adsorptive process, in this particular case, a hydrophobic interaction is more likely the driving
force (section 3.1.6.5.) Thus, if this is the case we can conclude that at pH 7.4 the protein
presents a maximum number of hydrophobic groups to the exterior while maintaining the
exposure and integrity of the epitope.

Optimisation of the molarity of the buffer for antigen adsorption to the MaxiSorp
surface
Altering the molarity of the buffer appears to have little effect on the adsorption of the
different antigens except for ferritin (section 3.1.4.4.; 3.1.5.4. and 3.1.6.4.).
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Optimisation of the conditions for the adsorption of antigens to silanised silicon surface.
The proteins adsorbed on the silicon surface are detected with an appropriate alk-phos labelled antibody. Therefore the exposure and integrity of the appropriate epitope following
adsorption is critical.

Selection of a suitable concentration for protein adsorption to silanised silicon.
Due to the expense and availability of the protein reagents a suitable rather than optimum
concentration of antigen was coated to the surface.

The suitable concentration was

determined on the following basis:
(a) at the concentration selected the adsorbed amount was dependent on input
concentration.
(b) the concentration selected was less than or equal to that which produced a
monolayer.

As can be seen from the absorbance values, ferritin adsorbs well to the silanised silicon
(section 3.1.10.2.) while alpha-fetoprotein (section 3.1.11.2.) and, especially, hCG (section
3.1.12.2.) adsorbs very poorly (absorbance readings taken after 4hr substrate incubation in
the case of alpha-fetoprotein and hCG). There appears to be a direct relationship between the
adsorbed amount and molecular weight. A possible explanation for this relationship is the fact
that protein molecules must come very close to the surface to establish hydrophobic bonds.
Small proteins in close proximity to the surface have a greater chance of having the
appropriate epitope disrupted rather than a larger protein

290

Optimisation of the time and temperature condition for protein adsorption.
Ferritin adsorbs best over a 16hr period (section 3.1.10.2.) while maximum adsorption of hCG
(section 3.1.12.2.) and alpha-fetoprotein (section 3.1.11.2.) occurs after 2 hrs. So again the
time required appears to be in some way inversely related to the molecular weight of the
proteins. All three proteins adsorb best at 37°C. A possible explanation is that the kinetic
energy of the protein is higher therefore protein molecules arrive at the sorbent surface at a
greater frequency. This occurs to a greater extent on silicon rather than plastic due to its
higher heat conductivity.

Optimisation of the pH and ionic strength for antigen adsorption to the ODDMMS
surface.
Ferritin adsorbs best at pH 9.6 (section 3.1.10.3.) where it has a net negative charge (pi 5.45).
Thus there is repulsion between the protein and the silanised silicon surface. However, since
ferritin adsorbs well to the silanised silicon surface, which is very hydrophobic in nature, it is
more likely that hydorphobic interaction is the driving force. Considering this assumption we
propose that at pH 9.6 the molecule exposes a maximum number of hydrophobic groups while
exposing and maintaining the integrity of the antigenic epitope.

An increase in the ionic strength causes an increase in the adsorbed amount (section 3.1.10.5.).
This could be due to the fact that:
(1) It causes a decrease in the repulsive force due to the shielding effect of the
oppositively charged ions in solution.
(2) It causes an intrinsic effect on protein structure resulting in the exposure of greater
numbers of adsorbed molecules with intact epitopes being exposed.
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Alpha-fetoprotein adsorbs best to silanised silicon at pH 7.4 (section 3.1.11.3.) where it has a
negative charge (pi 4.75). Thus, again there is repulsion between the silicon surface and the
surface of the protein. Therefore, it is unlikely that electrostatics plays a major role in alphafetoprotein binding to the silanised silicon surface . It is thereby more likely that at pH 7.4 the
alpha-fetoprotein exposes a maximum number of hydrophobic groups which combine with
similar groups on the surface while maintaining the exposure and integrity of the appropriate
epitope. An increase in ionic strength causes an increase in adsorbed amount for the same
reasons as outlined for ferritin (section 3.1.11.5 ).
hCG adsorbs best at pH 5 (section 3.1.12.3.). At this pH level the protein can have either a
positive or negative charge since hCG has a pi range (4-11).

If the pi of the protein is

greater than 5 then the protein will have a net positive charge and is attracted to the surface.
On the other hand if the protein has a pi < 5 the protein will have a net negative charge
resulting in a repulsive force. If we consider hydrophobic interaction to be the driving force in
the adsorption process then at pH 7.4 hCG exposes a maximum number of hydrophobic
groups which bind the surface while maintaining the exposure and integrity of the appropriate
epitope.

Ionic strength has little effect on hCG binding to silanised silicon (3.1.12.5.). hCG adsorbs
very poorly to the hydrophobic ODDMMS treated silicon surface presumably due to the low
number of hydrophobic groups present and the amount of time they spend on the surface.

While the adsorption of proteins depends on;
protein concentration (Cantarero ^ d., 1980)
time and temperature of incubation (Gibbs, 1995a)
pH molarity and ionic strength of buffer (Ramsden and Prenosil, 1994)
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charge of sorbent surface (Esser, 1988)
Hydrophobicity/hydrophilicity of surface (Esser, 1988)

It is difficult to determine any pattern of the results obtained. However we can suggest the
following conclusions:

In cases where the surface shows good heat conductivity, the time of incubation decreases
with increasing temperature.
Where electrostatics is the driving force for the adsorption process optimum conditions for pH
and ionic strength correspond with those which result in maximum contrast in surface charge
between the protein and sorbent.
Where hydrophobicity is the driving force optimum condition of pH and ionic strength
correspond with those which give rise to maximum exposure of the hydrophobic component of
the protein.
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4.2: Detection of various analytes on optimised immunosensor surface via

AFM.

4.2.1: AFM data analysis.
A total of four 2.4|im^ areas was imaged for each sample. The Ra (the arithmetic mean of the
deviations in height from the profile mean value ~ an indication of surface roughness) was
determined for each area. When lOpg/ml anti-ferritin antibody is adsorbed to silanised silicon
(section 3.2.1.) the mean Ra of the areas is l.SOnm, while the reproducibility of the process is
reflected in a coefficient of variation (C.V.) of 4.82%. When this surface is incubated with
500ng/ml of ferritin repeated imaging shows a surface with an increased mean Ra value of
2.32nm and a (C.V.) of 13.8%.
On adsorbing 2pg/ml of anti-alpha-fetoprotein antibody to the silanised silicon repeated
imaging shows a surface with a mean Ra value of 1.19nm (section 3.2.2 ).

Following

incubation of the anti-alpha- fetoprotein antibody surface with 640ng/ml of alpha fetoprotein
repeated imaging shows a surface with an increased roughness of 1.58nm.
Lastly, when 20pg/ml of anti-hCG antibody is adsorbed to the silanised surface repeated
imaging shows the surface to have a mean Ra of 1.53nm (section 3.2.3 ). When this antibody
surface is incubated with 500ng/ml of hCG the mean Ra of the surface in this case is reduced
to 1.33nm.

Possible reasons for this decrease in surface roughness are outlined in section

4.2.2.

4.2.2: Morphological analysis of the AFM images.
The 3-D image of anti-ferritin antibody adsorption under optimum conditions to silanised
silicon shows high surface coverage (Fig. 106). The Ra value of the surface is 1.54nm. Line
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analysis of the surface reveals that the height of the structures on the surface range from 5 to
10 nm, the difference is presumably due to the different orientations and clumping of the
antibody molecules. When the ferritin antibody coated silicon surface is incubated with ferritin
antigen the Ra of the surface increases to 1.72nm (Fig. 107). The line profile of this image
reveals that a fraction of the peaks increased in height to 18nm with the binding of the ferritin
antigen. It is again important to note that researchers have found only a fraction of adsorbed
antibody binds antigen which is in agreement with our finding in this experiment (Butler et M1993).

The 3-D image of alpha-fetoprotein antibody adsorption to silanised silicon

shows high

surface coverage, however, in this case there is also evidence of antibody clumping (Fig. 108).
Line analysis of the surface shows the majority of the structures to have a height of 8nm while
a few peaks present have a height of lOnm. When an anti-alpha-fetoprotein antibody-coated
silanised wafer is incubated with alpha-fetoprotein the Ra value of the surface increases to
1.42nm (Fig. 109). While the image indicates that the antibody dumbing effect has been
reduced due perhaps to the increased number of washing steps. The line profile of this image
shows the majority of peaks to correspond with a height of 8nm while a smaller proportion
correspond with a height of 10 - llnm indicating alpha-fetoprotein binding or antibody
clumping.

Anti-hCG antibody adsorbed under optimum conditions shows high surface coverage
(Fig. 110). The surface has a Ra value of 1.72nm. A line profile of the image indicates that the
height of the structures range from 10 - 13nm. When the anti-hCG antibody-coated silanised
silicon is incubated with hCG antigen the Ra value of the surface decreases to 0.95nm (Fig.
111). Line analysis reveals that the structures present have a height of 9nm. One possible
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explanation for the decrease in surface roughness is the low molecular weight of the hCG
molecule on binding to Fab portion of the IgG molecule may have a “filling in the gaps” effect
(Fig. 157) resulting in a smoother surface.
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Figure 157. hCG binding to adsorbed anti-hCG antibodies.

We can thus conclude that from a combined study of the AFM

image analysis data and

morphological study of the image, that both ferritin and alpha-fetoprotein can be detected on
their specific antibody-coated surfaces. While for low molecular weight proteins such as hCG
the process requires some adaptation, one possibility being the tagging of the antigen with
spherical gold labels.
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4.3: Estimation of anti-ferritin antibody coverage on silanised silicon.
A surface coverage of 398.08ng of anti-ferritin antibody per cm^ of silanised silicon surface
was estimated from an ELISA-based experiment (Fig 112). To bring this result into context it
is appropriate to relate this figure to the estimates derived by Esser (outlined in section
4.1.1.6.) on the geometric considerations of how many IgG molecules can maximally be
packed into one layer on a surface. Esser estimated a maximum coverage of 650ng/cm^ for
molecules in the “upright” position and 130ng/cm^for molecules in the “lying” position, if we
assume a monolayer coverage of anti-ferritin antibody molecules on the silanised silicon
surface. Then the estimated value of 398.08ng/cm^ corresponds to a coverage significantly
lower than the geometric maximum in the upright position. This result can be explained as
follows: As outlined in section 4.1.1. IgG is a glycoprotein with the carbohydrate moiety
located in the Fc region.

On a high binding surface (patchwork of hydrophobic and

hydrophilic groups), one would expect an orientation in favour of exposing the antigen
recognising sites because the surface would favour a binding through the hydrophilic
carbohydrate moiety associated with the non-recognising leg of the molecule.

On a

hydrophobic surface (silanised silicon ) one would expect an adsorption in favour of obscuring
the antigen recognising sites, because of the repelling effect between this surface and the
carbohydrate moiety. Thus, the anti-ferritin antibody molecules are preferentially adsorbed in
the “lying” position leading to a reduction in surface coverage. From the experimental setup
the anti-ferritin antibody concentration giving the maximum detectable signal can also be
deduced.

Therefore this value of ISp-g/ml is taken as the

optimum anti-ferritin antibody

coating concentration for subsequent ferritin ELISA-based experiments.
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4.4: Development and evaluation of ferritin Millispot ELISA.
The ferritin Millispot ELISA is a quantitative assay for ferritin on a silanised silicon surface. A
6|il volume of monoclonal anti-ferritin forms
millispot.

\ 2mm^ area on the silicon surface known as a

A 6pl volume of standard/sample is applied to this millispot area.

Due to the

difference in hydrophobicity between the millispot area and the remainder of the wafer, surface
tension allows us to selectively apply this sample/standard to the millispot area. On washing
off the excess standard/sample, a 6|j.l volume of enzyme-labelled detector antibody is applied
to the millispot area overlapping the previous incubations.

The wafer is then thoroughly

washed with PBST and incubated in the appropriate substrate solution.

4.4.1: Ferritin Millispot ELISA standard curve.
A typical curve for the ferritin Millispot ELISA is depicted in Figure 113. The standard curve
ranges from a concentration of 500 to 7.8ng/ml ferritin.

The shape of the curve is

characteristic of the two site non-competitive ELISA. The absorbance values depicted are the
mean values for each of the 7 serial 1:2 dilutions of the 500ng/ml working standard with the
mean background (NSB) value subtracted.
In this way the values are corrected for any signal which does not represent specific antibody
binding. With the Millispot ELISA, the amount of ferritin present can be determined directly
from the standard curve since the absorbance at 405nm is directly proportional to the ferritin
concentration.
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4.4.2: Precision study.
Precision is a measure of the reproducibility of the assay. The precision of a method is usually
determined from within

- run precision studies, between - run precision studies and the

construction of a precision profile.

The precision of the ferritin Millispot ELISA was

evaluated on the basis of a within - run precision study and precision profile. The between run precision study was omitted due to the limited number of silicon wafers available.

Within - run precision.
The results attained for the within - run precision study of three different samples assayed in
replicate n = 4 are presented in Table 17.

In summary, the mean measured ferritin

concentrations of 304, 129 and 25.9ng/ml gave % C.V.’s of 12.7, 12.6 and 15%, respectively.
The precision appears poorest at the low ferritin concentration. This tends to be the common
trend for immunometric assays. It can be attributed to imprecisions in extrapolating the ferritin
concentration from the calibrating curve as the curve flattens out.

In other words the

sensitivity of the assay affects precision.

Precision Profile.
The precision profile is a way of visualising the performance of an immunoassay over the
entire range of concentrations.

It is constructed by plotting C.V. (%) versus analyte

concentration. The precision profile for the ferritin Millispot ELISA for ferritin concentrations
ranging from 500 to 7.8ng/ml is represented in Figure 114. Analysis of the curve indicates
that;
1. In general as the ferritin concentration is increased the precision decreases.
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2. From the curve the dynamic range of the ELISA is determined by using the values
below the 10% threshold .

The curve is precise between 13 andlOOng/ml of

ferritin.
In contrast to the within - run precision study the method appears more precise at the lower
concentrations. A possible reason for the conflicting results is the different data processing
procedures.

The within - run precision of the method was determined from ferritin

concentration values interpolated from the calibration curve.

Where the calibration curve

flattens out at the lower concentrations the error in interpolating the concentration increases.
In constructing the precision profile nominal ferritin concentrations are plotted versus C.V.
(%). The % C.V. is determined from replicate absorbance readings.

Sources of random error.
Despite the conflict

in the precision pattern attained both experimental set-ups indicate

elevated imprecision above the generally accepted 10% level. It is thus necessary to focus on
the assay design and identify possible sources of error which may lead to poor precision.
1. The solid phase in the Millispot ELISA is produced “in house” by chemical cleaning and
silanisation of silicon wafers. This is in contrast to the conventional ELISA performed on
modified polystyrene surfaces, whereby the modified polystyrene is prepared by specialised
commercial companies, who adhere to strict Q.C. regimes.

Incomplete or defective

washing or cleaning of the silicon can lead to imprecision in antibody coverage.
2. The pipetting steps of the assay must be reviewed.

The precise pipetting of very small

volumes (i.e. 6|il) requires a careful and consistent wipe of the pipette tip.
3. The application of sample/standard or conjugate to the millispot area may result in either
spreading outside the millispot area resulting in non-specific binding which can affect the
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precision of the assay (Fig. 158).

Where the non-specific binding is considered significant

blocking of the unreacted silane layer with bovine inert protein serum albumen is advised.

Poor overlap
of sample/
conjugate

Good overlap
of sample/
conjugate

Figure 158. Application of sample/standard to the miliispot area. The blue shaded areas correspond
to the milispot area while the pink shaded areas represent sample/standard application areas.

4. The separation of free from bound material was carried out manually using a multihead
pipette. It is important when dispensing and aspirating washing solution from the wells
that the angle of the pipette tip with the plate is constant.
5. Imprecision may also be contributed to by variations in the biochemical reaction
conditions. Due to the reduced assay incubation time, 10 minutes, the antigen - antibody
reaction may not be at a steady state.

Under this condition what appear to be minor,

technical variations can have a large effect on method precision.
6. Other sources of imprecision common to the conventional ELISA e g. spectrophometer
inefficiency, variations in enzyme - substrate reaction conditions etc.
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4.4.3: Accuracy study.
Accuracy is the closeness of the result to the actual or “correct” value. The most useful tests
to reflect assay accuracy include tests of recovery, parallelism and linearity.

Recovery study.
A recovery study was performed to evaluate whether known amounts of ferritin spiked into
horse serum could be measured quantitatively. Aliquots spiked with a minimum volume of
ferritin standard to give final ferritin concentrations, 380, 150, 80 and 20ng/ml were tested,
with results shown in Table 20.

In summary, the 380, 150, 80 and 20ng/ml spikes had

recovery values of 110, 126, 112 and 100% respectively. A % recovery range (90 - 110%) is
commonly considered acceptable. On analysing the results the most notable feature is that all
the measured ferritin concentrations correspond with recoveries greater than or equal to
100%. This may indicate possible positive co-operatively between the horse serum matrix and
ferritin binding to the solid phase antibody.

Parallelism.
To further determine the accuracy of the Millispot ELISA, a parallelism study was conducted.
To assess whether dilutions of a sample containing ferritin parallel the standard curve. Three
patient samples were selected 300ng/ml, 180ng/ml and 58ng/ml and portions were diluted to
give 7 serial 1:2 dilutions of the respective sample.

The accuracy was assessed by two

different procedures:
(a) the standard curve and the dilution series for each sample are constructed on a
single plot and parallelism observed between the curves (Fig. 115).
appear parallel up to a ferritin concentration of lOOng/ml.
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The curves

(b) the observed values for each of the samples are plotted against the expected values
for each dilution. In this form a straight line can be interpreted as parallel to the
standard curve. The results are shown in Figures 116-118. In summary, when the
300ng/ml sample is dilute linearity is lost between 75ng/ml and 150ng/ml. For the
180ng/ml sample linearity is lost between 90 and 180ng/ml.

While the dilution

series for the 58ng/ml sample appears linear from 58ng/ml down to 1.8ng/ml with
linearity lost at concentrations below 1.8ng/ml.
On combining both approaches to data analysis for accuracy the dynamic range of the assay
can be defined as (7.8 - lOOng/ml).

Sources of systematic error.
The above experimental set-up makes several important assumptions. First, it is assumed that
the standards themselves, against which recovery samples are to be compared, are accurate,
that is that they are pure and are properly prepared according to the highest standards of
analytical chemistry. Having made this assumption possible reasons for a lack of parallelism
may include;
1. A difference between the matrix of the diluted sample and the standard curve
matrix at high ferritin concentrations.

In this situation, failure of the test of

parallelism suggest that the assay may be sensitive to matrix composition and
further investigation is required.
2. A lack of dose response at the high concentrations. On examination of Fig. 113
this does not appear to be the problem.
3. Inherent imprecision in the assay. As discussed in Section 4.3.2. the imprecision
of the Millispot assay, is significant at high concentrations the upper limit of the
dynamic range, based on precision, also correlating to lOOng/ml.
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4.4.4: Sensitivity.
Ekins defined the sensitivity of the immunoassay to be essentially equivalent to the limit of
detection (LOD) which in turn is defined as the smallest quantity of an analyte that is not zero
with 95% confidence (i.e. xo + 2 S.D.) (Ekins, 1991). The sensitivity of the ferritin Millispot
ELISA is 13ng/ml (Fig. 119).

4.4.5: Method Comparison.
In order to develop more confidence in the validity of a new assay, a set of samples were run
by both the Millispot ELISA and a clinically established fluorescent immunoassay system used
routinely at Cork University Hospital, Cork for the estimation of ferritin concentrations in
serum samples. The level of correlation between both methods is indicated by the calculated
correlation coefficient of 0.96 (Fig 120). Perfect positive correlation results in a coefficient r
= 1. Analysis of the scatter plot reveals that the methods correlate well at concentrations less
than lOOng/ml and poorly at concentrations greater than lOOng/ml.
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4.4.6: Characteristics and future directions of Millispot ELISA.
1. The millispot Elisa is based on the novel approach of performing a non-competitive ELISA
on a silicon solid phase.
2. It involves the use of minute quantities of reagents and samples. This may be particularly
useful for specialised assays where often the reagents are very expensive.

It may also

prove to be a valuable assay in paediatric units where it may be set up as a qualitative
screening test with minute (bpl) sample requirement.
.3. The assay has an assay incubation time of 10 minutes. This is worthy of further comment
since it is widely accepted that the used of high antibody concentrations
competitive assay implies faster binding of the analyte.

in a non

However, Chu et al recently

showed that the diftusion flux increases in proportion to the spot radius. While the number
of sites within the spot increases in proportion to the square of the radius; implying that the
rate at which binding sites are occupied is proportional to the reciprocal of the spot radius
equation:

CJl\
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molecules/sec/cm^

ADrm

where D = diffusion coefficient cm^/sec
rm

= radius (cm)

An = analyte concentration (molecules/cm^)
dAb = antibody surface density
ka

= association rate constant
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Chu M

also developed computer models revealing the full sequence of events following

introduction of antibody spot of differing diameters into an analyte containing solution. They
concluded that the smaller the spot, the lower the diffusion constraints on the rate of analyte
binding to antibody, and the more closely the reaction kinetics approximate those
characterising a homogeneous liquid phase system (Chu ^ d., 1997).

4. The results reveal that the ferritin Millispot ELISA has a dynamic working range (13 lOOng/ml). Serum samples with a concentration > lOOng/ml should be diluted.
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4.5: Development of Atomic Force Immunosensor for the ferritin antigen.

4.5.1: Optimisation of anti-ferritin antibody coating concentration.
In the investigation outlined in Section 4.3. the optimum anti-ferritin antibody coating
concentration for the millispot ELISA was determined on the basis of biochemical
measurements. However, for this particular investigation our objective is to test the ability of
the AFM to quantify the ferritin antigen on an anti-ferritin antibody coated surface. Its success
is dependent on the ability of the AFM to resolve the antigen on the antibody coated surface.
Accordingly it is more appropriate in this case to optimise the coating concentration on the
basis of a combined surface roughness and morphology study of the anti-ferritin antibody
images attained at the different concentrations studied.

Surface Roughness Study.
A summary of the AFM image analysis data is outlined in Tables 28-31. We can conclude
from these results that an anti-ferritin antibody-coating concentration of 14pg/ml produces the
smoothest (lowest mean Ra value) and most reproducible (lowest C.V. (%)) surface.

It is

worth commenting a this point that the image analysis data for the lowest coating
concentration (3.5jig/ml) is incomplete.

This is due to instability of the imaging of this

surface. A possible explanation for this instability is the presence of void spaces on the anti
ferritin antibody surface. On scanning this submonolayer coverage the tip interacts with both
the silane layer and the anti-ferritin antibody molecules. Tip contamination with either of these
species results in unstable imaging.
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Morphological study of Images.
A typical planar image with the associated roughness parameter attained on laying down
40pg/ml anti-ferritin antibody is represented in Figure 121. The Ra of the 5|im^ surface area is
0.74nM.

Line analysis of the image (Fig. 122) suggests that there exists a heterogeneous

population on the surface consisting of features of heights « 4nM and 7nM representing
antibody and antibody - antibody binding, respectively (Fig. 159).

Where the antigen under investigation has dimensions « 2 - 6nm this antibody - antibody
binding can represent artefacts on the surface which can reduce the sensitivity of the assay. In
addition protein - protein interaction has a weaker binding constant than protein - sorbent
interaction, and may be removed during subsequent washing steps in the assay, further
reducing the assay sensitivity.
A planar image of a Hpg/ml anti-ferritin antibody-coated surface is represented in Figure 123.
The Ra of this surface is 0.4nm. While the line analysis reveals a relatively homogeneous
population of features with heights

3 - 4nM representative of an antibody monolayer (Fig

124).
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A planar image of a Tpg/ml anti-ferritin antibody-coated surface is represented in Figure 125.
The Ra of this surface is 0.45nm.
present (Fig 129).

There is only minute amounts of antibody aggregation

However, there exists “holes” in the antibody monolayer which are

probably indicative of void spaces indicating sub-monolayer coverage. These “holes” can
affect the precision of the assay in cases where the antigen becomes masked or buried in the
antibody layer and thus may be undetectable by AFM.
On further reducing the coating concentration to 3.5pg/ml a planar image with a surface
roughness value of 0.36nM was produced (Fig 127).

Again the absence of antibody

aggregates is noted. The 3D image indicates the presence of glitches (Fig. 130), indicative of
tip skipping, present as a possible result of tip contamination with either the antibody or silane
molecules.
We can thus conclude that a Mpg/ml anti-ferritin concentration is optimum since it contains
only minute levels of antibody aggregates. While one may argue that a concentration slightly
less than 14pg/ml may represent a monolayer coverage (no aggregates), there is a risk of void
spaces which can both affect precision and image stability.
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4.5.2: Quantitation of ferritin on the anti-ferritin antibody-coated surface.
A range of ferritin concentrations (7.5 - 500ng/ml) are reacted with anti-ferritin antibodycoated silanised silicon wafers. Following incubation a Sjim^area of each surface is imaged.

Image Analysis data.
The image analysis data for each surface is represented in Table 32.

As the ferritin

concentration is increased, one would expect an increase in the fractional occupancy of the
anti-ferritin monolayer, this is reflected by an increase in the surface roughness (Ra).
calibration curve of Ra versus ferritin concentration is outlined in Figure 133.

A

The curve

appears linear throughout the calibrant range. Care must be taken when relating the Ra of the
surface to the ferritin concentration. In theory, as the ferritin concentration on the anti-ferritin
surface is increased a point can be reached where the Ra value levels out and then decreases.
Hence, a particular Ra value could represent two ferritin concentrations (Fig. 160)
Analyte
concentration A

A
.Analyte
concentration B

A
.Analyte
concentration C

/ 7 7~7 /?/?/// T /

7 / 7//////// /
Figure 160. Schematic representation of problem associated with relating Ra to analyte concentration
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However, in practice this event is highly unlikely since only approx. 5% of the antibody layer is
expected to bind ferritin at saturating concentrations.
A calibration curve relating the number of binding events per pm^ area versus ferritin
concentration is outlined in Figure 134.

The curve appears linear throughout the calibrant

range. However, the counting of binding events in a selection of 20 different 1 pm^ images is
a rather tedious and subjective practice. Presently, a software programme is being developed
at the Centre of Surface and Interface Analysis, Cork Institute of Technology which is hoped
to facilitate the counting of binding events in a large number of areas in a short time period

Image Morphology.
As expected where the ferritin concentration is increased, the number of structure present on
the planar image increases (Figs. 135-147). The increase in surface roughness is more evident
from the 3D view of each of the surfaces presented in a montage format (Figs. 149 -155).
Line analysis of the blank ferritin surface reveals structures of « 4nm in height characteristic of
the antibody molecules (Fig 136). While line analysis of the ferritin surfaces indicate a dual
population. Again there exists structures of
(Fig 136-148).

4nm in height indicative of antibody molecules

While in addition there also exists structures ranging in height 16 - 18nm

characteristic of the ferritin - anti-ferritin immune complex.

The height of the immune

complexes is revealed by the Rt (peak to valley height) of the line profile.

311

4.5.2.1. Characteristics and future directions of the AFM Tmmunosensor.

1. Direct quantitation of analytes.
The AFM immunosensor has the ability to directly quantify ferritin antigens on the solid phase
antibody monolayer. Hence, this immunoassay system is not dependent on relating a signal
produced by a secondary system, such as an enzyme; fluorescent or radioactive labelled
detector antibody, to the bulk analyte concentration.

Thus, this novel immunoassay has

numerous advantages over conventional immunoassays which include;
1. A direct stoichiometric relationship between the number of binding events and the bulk
analyte concentration. The conventional ELISA system is dependant on relating a signal
produced by the product of an enzyme-substrate reaction to analyte concentration in the
bulk solution.

This dependency adds a number of variables to the assay layout. Which

include, the time and temperature of reaction incubation, the pH and ionic strength of the
incubation buffer, the activity of the enzyme label and substrate concentration. Deviations
in any of the above conditions leads to increased imprecision of the assay and thus reduced
sensitivity.
2. The AFM immunosensor involves a reduced number of steps in the assay procedure when
compared with the conventional ELISA. This should result in better precision.
The sensitivity of the assay is not limited by non-specific binding of labelled detector
antibody to the solid phase or antibody monolayer. Since the introduction of solid phase
immunoassays scientists in the immunoassay field have led the continuous search for a
means of reducing non-specific binding or background noise in immunoassays.

These

strategies involve incubations of reaction solid phase antibody surfaces with inert proteins
at various steps in the assay procedure. However, while these strategies lead to a reduced
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background noise they also reduced the specific signal, thus limiting the sensitivity
attainable.
3. The specificity and sensitivity of the AFM immunosensor is dependent on the solid phase
coating antibody. It is thus imperative that this antibody is of high affinity and specificity.
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2. Sensitivity.
The APM immunosensor shows a window effect with respect to sensitivity. The sensitivity of
the assay can be increased by two opposing strategies which need to be integrated to form the
optimum condition.
Firstly the assay sensitivity can be increased by decreasing the antibody-coated area.

The

theoretical consideration behind this strategy are outlined and referenced in Section 1.3.5.6. In
summary, Ekins et

showed that for a constant surface coating density, as the spot size and

the amount of antibody decrease the fractional occupancy, the s/b ratio and hence - implicitly assay sensitivity increase, despite a decrease in total analyte bound.

Since the AFM

immunosensor directly quantifies the fractional occupancy of a small proportion of the
antibody monolayer we can thus conclude that the sensitivity can be increased by reducing the
microspot.

This adaptation requires the potential to develop a microspotting technique,

whereby antibody can be applied to silicon surface in volumes to cover areas in the order of
100 - lOOOpm^. These microspot areas are then incubated with sample volumes, which satisfy
ambient analyte conditions.
Secondly the assay sensitivity can be increased by increasing the AFM scan size. Since the
AFM immunosensor does not involve a labelled detection antibody the background signal
should essentially equal zero.

Therefore, by increasing the scan area we increase the

signal/background ratio.
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3. Multianalyte assays.
The AFM immunosensor has the ability to measure numerous analytes in small samples. To
achieve this the silicon wafer must be divided into “reaction cells” by simple ascription. For
example if we take a 4 x 4mm silicon wafer and divide it into lOOOpm^ areas, it results in 16
possible reaction cells (Fig. 161).

1

1

2
3

5

7

6

4
I

8
4mm

9

10

11

12

13

14

15

16

4mm
Figure 161. Silicon wafer divided into 16 “reaction cells’

A microspot area in each reaction cell can in turn be coated with an antibody specific for
different analytes.

Resulting in a particular 4 x 4mm silicon wafer having the potential to

specifically capture 16 different analytes. The 4 x 4mm silicon wafer is incubated in a « 1ml
sample volume.

Following incubation a micron size area of a microspot from each cell is

imaged and the number of binding events or Ra for each cell can be converted into analyte
concentration by relating the value to a calibration curve in-built on the software of the system.
Great care must be taken when using a preformed calibration system. It is imperative that the
calibration curve be run under identical conditions as the assay, at regular intervals to maintain
the validity of the system.
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The possible applications of the multianalyte AFM immunosensor include:
•

measurement of a complete array of hormones relating to endocrine dysfimction (such as
infertility testing, investigation of thyroid disease).

•

monitoring of transfusion blood for an increasing number of possible pathogens, including
cytomegalouirus (CMV) hepatitis and HIV related viruses.

•

environmental monitoring.
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4. Low Molecular weight analytes.
The AFM immunosensor developed in this investigation is based on the ferritin antigen as an
analyte. As outlined in Section 4.1.2.1. the ferritin molecule is spherical with a diameter of «
12nm and a molecular weight of 450KDa. As a result of its large molecular size it is an ideal
molecule to detect on our immunosensor surface.

As is discussed in Section 4.2., low

molecular weight analytes such as hCG cannot be directly detected or resolved using the AFM
in its present state.

However, the assay set up can be adapted to quantify hCG.

This

adaptation involves detecting the captured hCG using antibodies tagged with gold spheres.
Using the above proposed assay w^e will discuss to what extent the assay characteristics are
retained. The system still involves direct quantitation of the analyte however the sensitivity
may be lost to some extent, the sensitivity of the assay can be increased by reducing the
antibody coated area. It is imperative, in this revised assay, that the field of view of detection
is limited to a similar extent due to the presence of non-specific binding. This can easily be
achieved by reducing the scan area. . Multi -analyte assays can be achieved by tagging the
different detection antibodies with gold spheres of differing diameters.
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5. Ambient Analyte Assay.
This term is used to describe assay systems that measure the analyte concentration in the
medium to which an antibody is exposed, being independent both of sample volume, and the
amount of antibody present. The conditions or assay layout which give rise to ambient analyte
type assays are outlined in Section 1.3. In summary, ambient analyte conditions exist where
the binding site concentration is so low as not to affect the analyte concentration in the
medium to which the antibody is exposed. In theory, this condition can be achieved by either
decreasing the antibody coated area or increasing the sample volume. In practice, it is more
ideal to decrease the antibody coated area. Ekins showed that assuming maximal antibody
surface densities in the order of 10“^ - 10^ molecules/pm^ (i.e. spots in the order of 10 - 50pm
in diameter) are sufficient to accommodate numbers of molecules falling within ambient
analyte immunoassay limits, when exposed to volumes in the order of 1 ml. The AFM
immunosensor assay can be adapted to attain ambient analyte conditions. Under ambient
analyte conditions the binding site fractional occupancy is independent of both the amount of
binding agent used in the system and the sample volume. Thereby the fractional occupancy is
solely dependent on the analyte concentration and the affinity constant governing the reaction.
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5. Conclusion
The conditions for the adsorption of six different proteins, including three different
immunoglobulins, to two different types of sorbent surfaces were optimised. The conditions
studied include concentration of protein, time and temperature of incubation and the pH,
molarity and ionic strength of the incubation buffer.

From the results obtained we can

conclude that the optimum conditions for the different proteins show wide differences even
within the immunoglobulin G class molecule.

On combining the results from the different

adsorption experiments detailed patterns cannot be determined from which informative
decisions on the optimum condition for other proteins could be determined. However, we can
conclude that the conventional practice in immunoassay design of adsorbing proteins to a
polystyrene surface overnight at 4°C in a 0.05M sodium bicarbonate buffer, pH 9.6 may in
many cases be a waste of valuable reagents and time.

The optimum conditions derived from the first part of the investigation is carried
forward to the second part, where the optimum adsorption conditions for the three different
immunoglobulins to the silanised silicon surface is used to detect the appropriate antigens on
the immunosensor surface via the atomic force microscope (APM). We can conclude from this
investigation that the AFM can directly detect the ferritin and alpha-fetoprotein molecules on
the antibody surface by an increase in the surface roughness (Ra) of the immunosensor.
However, the binding of the low molecular weight protein hCG results in a decrease in surface
roughness suggesting that the detection of low molecular weight proteins via atomic force
microscopy may require labelling of the protein with spherical gold spheres.
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The optimum condition for the adsorption of the ferritin protein on silanised silicon was
also used to develop a Millispot ELISA on a silicon substrate.

This assay involves the

fabrication of an approx. 12mm^ antibody coated surface area which is facilitated by the
extreme hydrophobicity of the surface. The analyte and detector antibody steps are confined to
this millispot area by the “reagent overlap” theory. The assay is characterised by an incubation
volume of 6|il and an assay incubation time of 10 minutes. Combined precision and accuracy
studies show the assay to have a dynamic range of 7.8 - 500ng/ml ferritin. The detection limit
corresponds to a ferritin concentration of 13ng/ml of ferritin.

In the final part of the investigation the AFM is used to quantify the ferritin antigen on the
optimised anti-ferritin antibody-coated silanised silicon surface. The ferritin concentration is
related in the first instance to the surface roughness of the immunosensor surface, this
produces a linear response throughout the calibration range (7.8 - 500ng/ml). In the second
instance the number of binding events is plotted against the ferritin concentration Once again
this produces a linear relationship for the entire calibration curve.

The sensitivity of the

developed assay can be altered by novel strategies which involve (1) decreasing the antibody
spot area and (2) increasing the scan area. The assay also has the unique potential of directly
detecting multianalytes in a stoichiometric manner under ambient analyte conditions.
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